Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,sterol binding (GO:0032934),0.6514397429113645,1.9257756889284174,0.0,0.31498844453267794,0.231,5/56,0.67%,PTCH1;RORA;APOD;CAV1;VDAC2
prerank,G protein-coupled receptor binding (GO:0001664),0.5910215724745089,1.9178957042633764,0.0,0.18128489028240224,0.259,11/132,4.96%,PTCH1;GNA14;ITGB4;PTCH2;HOMER2;WNT10A;WNT2B;WNT16;GNAQ;UTS2B;WNT5A
prerank,cholesterol binding (GO:0015485),0.6410918352312593,1.8544188164537938,0.0,0.3245047117391032,0.554,4/47,0.67%,PTCH1;APOD;CAV1;VDAC2
prerank,insulin-like growth factor receptor binding (GO:0005159),-0.7571634017312993,-1.8416931942418358,0.0,0.5119011525465434,0.336,5/12,3.56%,IGF1;INSR;GNAS;PIK3R1;IGF2
prerank,death receptor binding (GO:0005123),0.7932416521639882,1.8254931432384063,0.003372681281618887,0.3611423404838407,0.679,2/15,0.24%,NGF;EDA
prerank,platelet-derived growth factor receptor binding (GO:0005161),-0.6932228438296176,-1.7925456812925011,0.012195121951219513,0.43775238045020937,0.485,4/13,1.14%,PDGFD;IL1R1;PDGFRB;PDGFRA
prerank,gap junction channel activity (GO:0005243),-0.5899243918749704,-1.7871863430058854,0.008174386920980926,0.3127064265198484,0.512,4/22,2.70%,GJB6;GJC1;GJD3;GJA1
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),0.6519619367012016,1.7813829517200603,0.005698005698005698,0.4864715795924621,0.861,10/35,8.36%,PKDCC;TEC;ITK;CLK1;TXK;PEAK1;SRC;FER;ABL2;DYRK1A
prerank,wide pore channel activity (GO:0022829),-0.5823423114556854,-1.7690563057519577,0.005649717514124294,0.28890558609386463,0.589,4/23,2.70%,GJB6;GJC1;GJD3;GJA1
prerank,receptor antagonist activity (GO:0048019),0.7348692420105292,1.7340184704667547,0.009230769230769232,0.6816819408869333,0.967,2/17,0.99%,PXDN;DKKL1
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),-0.7339396023931122,-1.7312892865263665,0.006818181818181818,0.3319667989261061,0.718,4/10,8.23%,SLCO3A1;SLCO1C1;SLC22A6;SLCO2A1
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),-0.7155909744943459,-1.6996735642916394,0.00975609756097561,0.3771517790578968,0.814,4/11,15.13%,PPP1R1A;PPP1R11;PPP1R14A;PABIR1
prerank,ionotropic glutamate receptor binding (GO:0035255),-0.7086154016807192,-1.671807912571251,0.014634146341463415,0.40534662079329303,0.873,5/10,13.44%,SHANK3;GNAS;SQSTM1;IGSF11;SHANK2
prerank,insulin-like growth factor I binding (GO:0031994),0.7458645738730905,1.6657231827565768,0.011784511784511785,1.0,1.0,3/13,0.32%,ITGB4;ITGA6;IGFBP6
prerank,insulin-like growth factor binding (GO:0005520),0.7248706345022187,1.6640805599369815,0.016863406408094434,0.9699455350149002,1.0,3/15,0.32%,ITGB4;ITGA6;IGFBP6
prerank,NAD-retinol dehydrogenase activity (GO:0004745),0.7250574478541196,1.6424127186662731,0.03833333333333333,1.0,1.0,2/14,2.53%,RDH10;RDH5
prerank,inorganic anion transmembrane transporter activity (GO:0015103),-0.5145402679785356,-1.6347790329463006,0.022922636103151862,0.49144158394959203,0.954,10/27,9.89%,SLC22A8;SLC26A7;ANO1;SLC39A8;SLC22A6;SLC26A2;SLC39A14;SLC25A30;SLC25A11;LRRC8A
prerank,neuropeptide receptor activity (GO:0008188),0.6215316259152132,1.6280322906662497,0.02148997134670487,1.0,1.0,3/29,2.77%,SORCS2;SSTR1;KISS1R
prerank,transforming growth factor beta receptor binding (GO:0005160),-0.5715898880784649,-1.6107054560278486,0.020253164556962026,0.5410724390173647,0.978,6/18,2.84%,ENG;SMAD3;SMAD6;TGFBR3;FKBP1A;TGFBR1
prerank,lipoprotein particle receptor binding (GO:0070325),-0.492885030502178,-1.591436330199488,0.03225806451612903,0.57100047015814,0.987,8/27,13.61%,PICALM;LRP1;AP2A1;APOE;DNAJA1;LDLRAP1;ANKRA2;MESD
prerank,CoA-ligase activity (GO:0016405),-0.5993108500803682,-1.584926237844005,0.03764705882352941,0.5457549353622435,0.989,5/14,20.85%,ACSL1;ACSS3;ACSS1;AACS;SLC27A2
prerank,O-acyltransferase activity (GO:0008374),0.594956100596443,1.5767275838523775,0.03361344537815126,1.0,1.0,6/30,7.21%,MBOAT2;MOGAT2;MOGAT3;GPAT3;AWAT2;SOAT1
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),0.7140820936294132,1.5720329650595763,0.05536332179930796,1.0,1.0,2/11,3.04%,ROR2;STK38
prerank,calcium-release channel activity (GO:0015278),0.6645480259793272,1.5713652235100803,0.040453074433656956,1.0,1.0,4/17,3.58%,ITPR2;ITPR3;TPCN1;FKBP1B
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),0.6613934571559733,1.567841132903944,0.04,1.0,1.0,7/16,15.79%,MTMR7;MTMR6;INPP5F;MTMR3;PTEN;MTMR12;MTMR1
prerank,voltage-gated ion channel activity (GO:0005244),0.6904806096464546,1.5647421236150945,0.04258943781942078,1.0,1.0,3/14,4.79%,VDAC2;ANO6;CACNA1H
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",-0.3989767230438496,-1.5598377004565103,0.014018691588785047,0.6008796790621443,0.993,23/72,9.30%,PLCB1;PICALM;HIP1;PARD3;SVIL;ADAP2;MYO1B;ACTN2;MARK1;KCNJ2;GSDME;COMMD1;SNX21;ANXA2;SYT7;HIP1R;TWF1;RPH3A;FRMPD4;TULP3;LDLRAP1;SLC9A1;CAPG
prerank,actinin binding (GO:0042805),0.6302360825418605,1.5508295892377157,0.045454545454545456,1.0,1.0,6/21,7.45%,MAGI1;KCNA5;PDLIM4;CSRP3;DAG1;RARA
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),-0.49797481544635336,-1.5345351923155097,0.0273224043715847,0.674394700969621,0.996,10/23,15.51%,PDE7B;PDE5A;PDE8A;PDE8B;PDE1A;PDE10A;PDE2A;CNP;PDE4A;PDE1B
prerank,ephrin receptor binding (GO:0046875),0.6042080032689778,1.534382302606888,0.0624,1.0,1.0,8/21,16.82%,EFNA5;EFNB1;SRC;EFNB2;ANKS1B;ANKS1A;EFNA3;EFNB3
prerank,kinase activator activity (GO:0019209),-0.4728175869323512,-1.5300764540668734,0.02346041055718475,0.6459181924836214,0.996,13/30,27.58%,PRKAG2;MADD;GPRC5C;BCL10;RPLP1;CDK5R1;GPRC5B;WNT11;GPRC5A;NCKAP1L;WNK1;AGAP2;TPX2
prerank,GABA receptor binding (GO:0050811),-0.6123279537785536,-1.528848311385972,0.05092592592592592,0.608642414708773,0.997,4/11,17.92%,ARFGEF2;GABARAPL1;GABARAP;LHFPL4
prerank,low-density lipoprotein particle receptor binding (GO:0050750),-0.5056191272302407,-1.520047097453771,0.04899135446685879,0.6085005250831566,0.999,9/22,21.63%,PICALM;AP2A1;APOE;DNAJA1;LDLRAP1;ANKRA2;MESD;APBB3;CLU
prerank,syntaxin binding (GO:0019905),-0.39706569540674225,-1.5168750992387565,0.028,0.5864053218076094,0.999,22/61,21.82%,DAPK1;UNC13C;STXBP3;NAPA;TMED9;STX8;SYT9;LRRK2;RAB11A;GOLGA2;SYPL1;SYNPR;STX6;SCFD1;STXBP4;CPLX2;STX16;BLOC1S6;UNC13A;SNAP47;SYT6;SNAP25
prerank,tropomyosin binding (GO:0005523),0.6463792704605651,1.51089326034425,0.06482982171799027,1.0,1.0,6/16,9.25%,SMTNL1;SMTNL2;TMOD2;S100A6;TMOD1;CALD1
prerank,growth factor activity (GO:0008083),0.5035036376041689,1.5104874806584392,0.031486146095717885,1.0,1.0,4/74,2.29%,NGF;FGF7;FGF1;JAG1
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",-0.5916059566392241,-1.5059082053087187,0.05955334987593052,0.5975841780800851,1.0,8/12,26.21%,SDHB;XDH;AOX1;CIAPIN1;FXN;ISCA2;ISCU;CISD2
prerank,Lys48-specific deubiquitinase activity (GO:1990380),0.6665156880642611,1.5042424559352103,0.07425742574257425,1.0,1.0,7/14,18.81%,MINDY3;MINDY2;USP13;OTUD7B;MINDY4;USP15;USP9X
prerank,amino acid transmembrane transporter activity (GO:0015171),-0.42119661777216366,-1.5024479122013146,0.03424657534246575,0.57989254122903,1.0,20/47,24.62%,SLC7A11;SLC6A6;SLC47A1;SLC7A5;SLC22A4;SLC7A1;SLC38A11;SLC7A6;SLC43A2;SLC16A2;SLC6A1;SLC38A7;SLC3A2;SLC22A2;SLC38A5;SLC25A29;SLC38A1;SLC38A9;SLC7A10;SLC1A5
prerank,alpha-actinin binding (GO:0051393),0.5992503219325869,1.4998343611299356,0.06,1.0,1.0,5/24,7.45%,MAGI1;KCNA5;PDLIM4;DAG1;RARA
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),-0.483660957291737,-1.4959632290250455,0.03343465045592705,0.5744058211729347,1.0,9/26,12.97%,SLC16A12;SLC6A6;ABCG2;SLC5A6;SLC16A6;SLC16A4;SLC16A2;SLC16A7;SLC6A1
prerank,protein tyrosine kinase activity (GO:0004713),0.4683078142410501,1.4940110744794872,0.026963657678780773,1.0,1.0,18/108,6.48%,ROR2;PKDCC;ROR1;TEC;NTRK3;FGFR1;EGFR;MUSK;ITK;CLK1;WEE1;TXK;PEAK1;SRC;HIPK1;FER;EPHB2;ABL2
prerank,peptidase activator activity (GO:0016504),0.5907940850593263,1.4920690685636153,0.08,1.0,1.0,5/22,8.37%,CAV1;APH1B;PSME3;NLRC4;EBAG9
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),0.6464386112584971,1.4916156912247345,0.07020280811232449,1.0,1.0,6/14,15.79%,MTMR7;MTMR6;MTMR3;PTEN;MTMR12;MTMR1
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),-0.6016230663335081,-1.490185498837833,0.06912442396313365,0.5679246692415514,1.0,8/11,27.93%,CASP3;CFLAR;CASP12;CASP6;CASP8;CASP4;PYCARD;CASP1
prerank,alanine transmembrane transporter activity (GO:0022858),-0.5953998797058248,-1.4827830913337734,0.04827586206896552,0.5697222152317656,1.0,5/12,20.33%,SLC6A6;SLC38A7;SLC3A2;SLC38A5;SLC1A4
prerank,I-SMAD binding (GO:0070411),-0.5730678696990434,-1.4814598494814475,0.0671462829736211,0.5495367289793365,1.0,5/13,4.13%,SMAD3;SMAD6;SMAD9;TGFBR1;SMAD5
prerank,carbohydrate kinase activity (GO:0019200),0.6651232904254712,1.4793452843263388,0.09106529209621993,1.0,1.0,6/11,16.91%,HK2;NAGK;GALK1;GALK2;FGGY;POMK
prerank,mechanosensitive ion channel activity (GO:0008381),0.6683214548869908,1.477924605021831,0.08812949640287769,1.0,1.0,5/12,14.45%,PIEZO2;TMC2;PIEZO1;TMC4;TMEM63A
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),-0.6210942225209743,-1.475390995548652,0.06206896551724138,0.5475566423385461,1.0,6/10,17.68%,CASP3;CFLAR;CASP12;CASP6;CASP8;CASP4
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),0.6054213058138631,1.4726854333372508,0.0941358024691358,1.0,1.0,14/20,30.68%,USP50;UFSP2;USP47;COPS5;USP9X;SENP3;SENP2;OTUB1;SENP5;SENP1;DESI2;OTULINL;OTUD5;EIF3H
prerank,aminopeptidase activity (GO:0004177),0.5709137118141451,1.4668175652310946,0.0838235294117647,1.0,1.0,10/26,12.55%,XPNPEP2;MMP15;RNPEP;LVRN;BLMH;LNPEP;XPNPEP3;KDM8;MMP16;LTA4H
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),-0.5170318502940962,-1.4622098977710056,0.07027027027027027,0.5694186296867516,1.0,5/18,3.88%,ENG;TGFBR3;TGFBR1;ACVRL1;BMPR2
prerank,ATPase binding (GO:0051117),0.48238661968738916,1.4622011190735829,0.051347881899871634,1.0,1.0,19/71,10.71%,CAV1;EGFR;SLC2A13;SLC26A9;NUFIP1;PDE4D;PGR;SRC;NCSTN;SELENOS;RDX;SNX10;ALDOB;ATP6V0A1;SNU13;ATP1B3;ABCA1;CHMP4A;ANK1
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",-0.48938375389358146,-1.4599465296044432,0.0425531914893617,0.5566016658672964,1.0,9/21,15.51%,PDE7B;PDE5A;PDE8A;PDE8B;PDE1A;PDE10A;PDE2A;PDE4A;PDE1B
prerank,cell-cell adhesion mediator activity (GO:0098632),0.5290211792688091,1.4558660456542543,0.061813186813186816,1.0,1.0,2/42,0.08%,STXBP6;NTNG1
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),-0.35710603151325065,-1.4539375132173693,0.023255813953488372,0.5567362399814736,1.0,25/91,9.30%,PLCB1;PICALM;HIP1;PARD3;SVIL;ADAP2;MYO1B;ACTN2;MARK1;KCNJ2;GSDME;COMMD1;SNX21;ANXA2;SYT7;KCNH1;HIP1R;TWF1;RPH3A;FRMPD4;TULP3;WIPI1;LDLRAP1;SLC9A1;CAPG
prerank,voltage-gated anion channel activity (GO:0008308),0.6329906274687004,1.4517186000735944,0.0978441127694859,1.0,1.0,4/15,6.18%,VDAC2;ANO6;CLCN2;CLCN1
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),-0.5850619795764543,-1.4512645331417557,0.06829268292682927,0.5460723591581345,1.0,5/12,3.88%,ENG;TGFBR3;TGFBR1;ACVRL1;BMPR2
prerank,fibroblast growth factor receptor binding (GO:0005104),0.583682882529054,1.4499377206910138,0.09924812030075188,1.0,1.0,3/21,8.47%,FGF7;FGF1;FGF18
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),0.6091309770259703,1.4486038079065373,0.096,1.0,1.0,1/18,0.06%,STXBP6
prerank,peptide hormone receptor binding (GO:0051428),0.6627715385116628,1.448338932526548,0.0929054054054054,0.9819108415759203,1.0,2/11,4.00%,GNRH1;PTHLH
prerank,metalloaminopeptidase activity (GO:0070006),0.6236596786626812,1.4483022826580079,0.09838709677419355,0.9542097074557042,1.0,10/16,21.76%,MMP15;RNPEP;LVRN;LNPEP;XPNPEP3;MMP16;LTA4H;MMP14;ENPEP;XPNPEP1
prerank,transforming growth factor beta binding (GO:0050431),-0.49243451335554295,-1.4423501728118058,0.06363636363636363,0.5567502693598562,1.0,7/23,8.48%,ENG;TGFBR3;TGFBR1;ACVRL1;NRROS;TGFB3;VASN
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),-0.5917855575591632,-1.4381355416033468,0.06388206388206388,0.55203303117251,1.0,4/10,11.33%,NOX4;CYBA;NOX1;NCF2
prerank,gated channel activity (GO:0022836),0.6268007648565472,1.436386114367803,0.09027777777777778,0.988845899049884,1.0,6/14,15.49%,PIEZO2;TMC2;PIEZO1;TMC4;TMEM63A;TMEM266
prerank,death receptor activity (GO:0005035),-0.5600127117542938,-1.434304748770114,0.09691629955947137,0.5468405500552581,1.0,4/11,13.48%,TNFRSF19;FAS;TNFRSF1B;TNFRSF11A
prerank,androgen receptor binding (GO:0050681),-0.4567743986047599,-1.4233227529077501,0.06804733727810651,0.5648694652061006,1.0,7/25,13.08%,FOXP1;EP300;WIPI1;RNF6;SNW1;KDM1A;ARID5A
prerank,protein kinase activator activity (GO:0030295),-0.372704497610945,-1.4200571763287475,0.03515625,0.5581047420727888,1.0,26/60,28.39%,PRKAG2;FAM20A;AFAP1L2;IGF2;MADD;GPRC5C;CALM1;MAP2K2;ABI1;RPLP1;RICTOR;CALM3;CDK5R1;GPRC5B;WNT11;CD24;GPRC5A;NCKAP1L;MAP2K1;ERBB3;WNK1;AGAP2;MLST8;TPX2;DDX3X;PARP16
prerank,mannose binding (GO:0005537),0.6308827274296782,1.4134174532446433,0.125,1.0,1.0,2/12,3.61%,COLEC11;LMAN2
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",0.6483426722267551,1.413165704809788,0.1322314049586777,1.0,1.0,4/10,14.77%,DPYS;CAD;DPYSL2;DPYSL5
prerank,retinoic acid binding (GO:0001972),0.641303098782326,1.4108538633331997,0.11973018549747048,1.0,1.0,2/12,7.45%,NR2F2;RARA
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),0.6088067174976969,1.4106842095801408,0.11001642036124795,1.0,1.0,6/15,11.04%,PHLDA3;SESTD1;LANCL2;SH3PXD2B;OBSCN;SAP30L
prerank,amyloid-beta binding (GO:0001540),-0.3589422241455318,-1.4099629806722187,0.010416666666666666,0.5737402592098914,1.0,17/79,12.75%,PICALM;INSR;ITM2A;COL25A1;FZD6;LRP1;EPHA4;GRIA2;LDLR;GRIN2B;APOE;APBB2;LDLRAP1;GRIN1;VBP1;CRYAB;TGFB2
prerank,histone acetyltransferase binding (GO:0035035),-0.4769185685787688,-1.409213669370738,0.06951871657754011,0.5596388382009452,1.0,5/21,10.59%,GLI3;HIF1A;MEF2A;CITED2;EPAS1
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",0.5927808896880008,1.4056070330586847,0.09822866344605476,1.0,1.0,2/18,2.53%,HSD17B3;RDH5
prerank,retinoid binding (GO:0005501),-0.46308292214831737,-1.4032605932843614,0.09217877094972067,0.5635001540341571,1.0,6/22,10.07%,ALDH1A2;RBP1;CYP26B1;RBP4;ABCA4;PTGDS
prerank,transcription corepressor binding (GO:0001222),0.5433717954719893,1.3944974672665613,0.11503067484662577,1.0,1.0,1/27,0.04%,RORA
prerank,transcription coactivator binding (GO:0001223),0.5791397234864469,1.3935073539249256,0.11745513866231648,1.0,1.0,3/20,4.12%,RORA;VGLL4;PGR
prerank,syntaxin-1 binding (GO:0017075),-0.45823684518531954,-1.3886899908454846,0.0676056338028169,0.597316975297756,1.0,9/22,21.82%,DAPK1;UNC13C;STXBP3;LRRK2;SYPL1;SYNPR;CPLX2;UNC13A;SNAP25
prerank,Wnt-activated receptor activity (GO:0042813),0.5930369134283878,1.3886021076458395,0.13013698630136986,1.0,1.0,6/15,14.90%,ROR1;FZD2;PKD1;FZD7;FZD9;FZD3
prerank,alpha-tubulin binding (GO:0043014),0.5242658384986523,1.3873716725172454,0.11290322580645161,1.0,1.0,11/31,18.20%,DLEC1;TRPV4;RACGAP1;SPAST;FNTA;HDAC6;INO80;ARL8B;TBCE;SETD2;OFD1
prerank,pyrophosphatase activity (GO:0016462),-0.37650488163131735,-1.38228565462076,0.049429657794676805,0.602816508586688,1.0,32/50,39.36%,ENPP1;ENTPD1;ENPP3;ALPL;PLPP1;NUDT3;LHPP;ENTPD5;TRPM2;PPA1;PLPP4;ENTPD3;NUDT11;DHX29;CILP;DCP2;FITM2;NUDT16;NUDT16L1;CILP2;NUDT22;DDX3X;BNIPL;ENTPD6;PRUNE1;NUDT10;ATCAY;RNGTT;DCTPP1;NUDT14;PLPP5;PRUNE2
prerank,GTPase inhibitor activity (GO:0005095),-0.5286219142689575,-1.3822468778867274,0.11694510739856802,0.5875286750835451,1.0,7/13,19.54%,SLIT2;TNK2;CPEB2;IQGAP2;RHOH;ARL2;GPS1
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),0.3874088892694991,1.382243740721422,0.003,1.0,1.0,84/730,8.29%,EBF2;RORA;MEOX2;ZBTB7C;KLF5;ETV4;NFATC2;ETV1;GLI1;PAX9;RBPJL;FOXD2;NR2F2;NR3C2;DLX1;POU4F3;RARB;FOXP2;ZNF423;FOXD1;NFATC1;ZBTB32;KLF12;PBX1;ZSCAN25;BHLHE22;ZBTB20;NEUROD6;RUNX2;NFIA;ZSCAN18;HIVEP2;HOXB6;GLI2;TEF;ZKSCAN7;KLF3;CIART;SPI1;FOXK1;ZNF418;FOXO3;SOX9;PGR;FOXP4;NPAS2;GLIS2;ZNF585B;ZNF585A;HDAC4;REL;CHD2;SATB1;ZBTB3;KLF10;POU5F2;CREB3L1;HEYL;ZFP1;SP3;BHLHE40;ONECUT1;NRIP1;ZFP14;TEAD3;CTCF;NRF1;NFE2L1;HIC1;ZNF431;PAX3;HOXC10;ZFP62;TBX2;ONECUT3;RREB1;RARA;MAFG;USF2;MYPOP;PKNOX2;ZNF628;E4F1;FOXK2
prerank,enoyl-CoA hydratase activity (GO:0004300),0.6382935890450475,1.3798872131691862,0.147005444646098,1.0,1.0,3/10,7.97%,EHHADH;HADHB;HSD17B4
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),0.3861206436257425,1.3782017726838622,0.003,0.9987124177576567,1.0,84/731,8.29%,EBF2;RORA;MEOX2;ZBTB7C;KLF5;ETV4;NFATC2;ETV1;GLI1;PAX9;RBPJL;FOXD2;NR2F2;NR3C2;DLX1;POU4F3;RARB;FOXP2;ZNF423;FOXD1;NFATC1;ZBTB32;KLF12;PBX1;ZSCAN25;BHLHE22;ZBTB20;NEUROD6;RUNX2;NFIA;ZSCAN18;HIVEP2;HOXB6;GLI2;TEF;ZKSCAN7;KLF3;CIART;SPI1;FOXK1;ZNF418;FOXO3;SOX9;PGR;FOXP4;NPAS2;GLIS2;ZNF585B;ZNF585A;HDAC4;REL;CHD2;SATB1;ZBTB3;KLF10;POU5F2;HEYL;ZFP1;SP3;BHLHE40;ONECUT1;NRIP1;ZFP14;TEAD3;CTCF;NRF1;NFE2L1;HIC1;ZNF431;PAX3;HOXC10;ZFP62;TBX2;ONECUT3;RREB1;RARA;MAFG;USF2;MYPOP;ISL1;PKNOX2;ZNF628;E4F1;FOXK2
prerank,signaling receptor complex adaptor activity (GO:0030159),0.5077416174743562,1.3768741124440664,0.09628610729023383,0.9841956596326851,1.0,12/38,12.61%,SORBS1;RGS14;AXIN1;CD3G;NUP62;CARD10;TRADD;NCK2;GAB2;LAT;SPAG9;SH2B1
prerank,hexosaminidase activity (GO:0015929),0.6394982625178323,1.376315610219977,0.1443478260869565,0.9671001711201789,1.0,6/12,20.31%,NAGA;HEXA;CEMIP2;HEXB;OGA;CEMIP
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),0.4681045001662353,1.3751488155407368,0.07793923381770146,0.953903161033088,1.0,8/60,2.13%,ROR2;ROR1;NTRK3;FGFR1;EFEMP1;EGFR;MUSK;NRP2
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),0.5671851955553757,1.3747000153883198,0.12924071082390953,0.937553625485337,1.0,5/21,18.61%,CHRNB3;GRIA1;GRM1;CHRNA7;CHRFAM7A
prerank,beta-tubulin binding (GO:0048487),0.521257363234757,1.371752326223983,0.12481644640234948,0.9338330964886306,1.0,9/31,13.97%,DLEC1;TRPV4;RACGAP1;SMC3;SPAST;IFT74;ARL8B;EMD;HTT
prerank,LRR domain binding (GO:0030275),-0.5151486823368383,-1.3680922045417698,0.11778846153846154,0.6165882337432936,1.0,7/14,19.53%,ROBO1;PAWR;LRRFIP2;ZXDC;ATF4;POLR2J;DAPK3
prerank,NADP binding (GO:0050661),-0.4176663203531597,-1.363500888034487,0.06976744186046512,0.6167677447723976,1.0,15/32,23.37%,DPYD;NOS3;CRYZL1;CAT;NOX1;QDPR;ME1;DHFR;MTRR;PGD;NOS1;DHCR7;CRYZ;ME3;TM7SF2
prerank,clathrin adaptor activity (GO:0035615),-0.5178605334631059,-1.3632629413604413,0.10071942446043165,0.6027628224804639,1.0,5/15,8.47%,HIP1;DAB2;AP2A1;HIP1R;LDLRAP1
prerank,endopeptidase inhibitor activity (GO:0004866),0.4350811537885699,1.3625062672491155,0.07099143206854346,0.9584467121404696,1.0,4/82,1.58%,NGF;SPINK1;SERPINB2;SERPING1
prerank,phosphatase activator activity (GO:0019211),-0.507276660528922,-1.3593433989601875,0.11056511056511056,0.6018504467932937,1.0,9/14,32.61%,FRS2;CALM1;BMP2;CALM3;PPP2R5A;PPP2R5E;PPP2R5D;PPP1R15A;B3GAT3
prerank,acid-thiol ligase activity (GO:0016878),-0.5234586207057977,-1.3547506590199232,0.14908256880733944,0.6024525318035818,1.0,5/13,20.85%,ACSL1;ACSS3;ACSS1;AACS;SLC27A2
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",-0.5310025263346552,-1.353403216489677,0.1070559610705596,0.5937760436119277,1.0,7/14,23.72%,SDHB;NFU1;CIAO3;ISCA2;RSAD2;ISCU;EXO5
prerank,peptidase inhibitor activity (GO:0030414),0.49697034330080775,1.3471709658785809,0.13380281690140844,1.0,1.0,2/33,0.61%,GPC3;SPINK1
prerank,receptor ligand activity (GO:0048018),0.394910087664051,1.3437273358557702,0.0384204909284952,1.0,1.0,28/245,10.21%,NGF;EDA;FGF7;INHBB;IL19;WNT10A;FGF1;JAG1;SEMA4B;INSL6;WNT2B;GNRH1;IL1A;WNT16;PTHLH;NBL1;BMP5;WNT5A;BMP15;APLN;ARTN;SEMA3A;DPP4;FGF18;TAFA5;HMGB1;LEFTY1;C1QTNF12
prerank,protein kinase A regulatory subunit binding (GO:0034237),-0.45383786970190787,-1.343422938876192,0.11382113821138211,0.61222288896416,1.0,10/21,30.95%,ARFGEF2;WASF3;AKAP6;AKAP1;PJA2;AKAP8L;AKAP7;ACBD3;KCNQ1;RYR2
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),0.635351014010865,1.3427277706060896,0.155668358714044,0.9956686730820928,1.0,1/10,0.29%,CXADR
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),-0.3552150224580179,-1.3427144603878916,0.07434944237918216,0.6015341047890781,1.0,13/55,13.07%,SLC16A12;SLC13A3;SLC6A6;SLC7A5;SLC22A4;SLC7A1;SLC38A11;SLC7A6;SLC16A6;SLC16A4;SLC16A2;SLC16A7;SLC38A7
prerank,protein phosphatase 1 binding (GO:0008157),0.5478319618298818,1.3424538229198217,0.17128874388254486,0.9799622266175255,1.0,4/21,6.22%,SMTNL1;SH3RF2;SMTNL2;AKAP11
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),0.5725148552100423,1.3410034994575362,0.15953947368421054,0.9703527989928022,1.0,2/15,1.67%,ALDH1A3;ALDH9A1
prerank,solute:proton symporter activity (GO:0015295),-0.49505898806610027,-1.3369992556273909,0.11559139784946236,0.6057542742647737,1.0,8/16,10.33%,SLC39A8;SLC17A5;SLC15A2;SLC11A2;SLC15A4;SLC33A1;SLC2A10;CTNS
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",-0.4921119287845203,-1.3357826242144346,0.12702702702702703,0.5969564636073118,1.0,6/14,25.01%,NOX4;CYBA;NOX1;NCF2;AIFM1;KMO
prerank,tau protein binding (GO:0048156),-0.388732255648773,-1.3354169661045714,0.0931899641577061,0.585874164590501,1.0,10/40,12.53%,PICALM;ROCK2;MARK1;EP300;APOE;ACTB;LGMN;GSK3A;TTBK1;TAOK2
prerank,endopeptidase activator activity (GO:0061133),0.6034713055330101,1.3329567542564598,0.1687612208258528,0.9910082064317881,1.0,3/10,6.98%,APH1B;PSME3;NLRC4
prerank,phosphatase binding (GO:0019902),0.4193521310531138,1.3267394903994423,0.10401891252955082,1.0,1.0,20/105,10.73%,NFATC2;PXN;CEACAM1;EGFR;PDLIM4;SH3RF2;CDH5;SPRED1;EIF2AK3;SFI1;MAP3K5;PIK3R2;ELL;ANAPC5;MTMR3;ANAPC7;PTPRT;DLG3;ANK1;TRPC4AP
prerank,serine-type endopeptidase activity (GO:0004252),0.43356691287296645,1.3235712389442316,0.1103030303030303,1.0,1.0,16/80,17.95%,CORIN;CTRC;FAP;KLK2;PCSK5;CD5L;DPP4;PCSK7;PROC;CELA1;HTRA2;PLG;TYSND1;MBTPS1;MASP2;RHBDF1
prerank,acetylcholine receptor activity (GO:0015464),0.5385382311991738,1.3226906281147335,0.16355140186915887,0.9880906397477867,1.0,5/22,18.61%,CHRNB3;CHRM2;CHRM3;CHRNA7;CHRFAM7A
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",0.6102398680246157,1.3218045699059888,0.1867572156196944,0.9768002212370284,1.0,2/11,5.37%,ARG1;DDAH2
prerank,sequence-specific DNA binding (GO:0043565),0.3742220609297478,1.3200889316508737,0.01002004008016032,0.9693416180575694,1.0,81/590,11.82%,RORA;MEOX2;KLF5;ETV4;NFATC2;ETV1;PPARGC1A;PAX9;FOXD2;NR2F2;NR3C2;DLX1;POU4F3;RARB;FOXP2;ZNF423;FOXD1;NFATC1;ZBTB32;KLF12;PBX1;BHLHE22;ZBTB20;MYBBP1A;ETV5;RUNX2;HOXB6;GLI2;TEF;HLX;KLF3;KMT2A;FOXK1;FOXO3;SOX9;NPAS2;GLIS2;HDAC4;SATB1;KLF10;CREB3L1;ZFP1;SP3;BHLHE40;STN1;ONECUT1;SIRT3;CTCF;HIC1;PAX3;HOXC10;TBX2;ONECUT3;RARA;MAFG;USF2;LHX6;ISL1;PKNOX2;FOXK2;UPF2;LIN28B;TBX18;TET1;SLTM;MECP2;RORB;POU4F1;HDAC2;DBP;TLX3;TFEB;LONP1;MMP12;RARG;FBXL19;EN2;EGR1;ZBTB49;ZNF148;ERF
prerank,SH2 domain binding (GO:0042169),0.48798773350087343,1.3157858315060087,0.15701219512195122,0.973095996203694,1.0,6/31,7.05%,DLC1;TRPV4;SRC;NUP62;SH3PXD2B;DAG1
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),-0.5610215739352269,-1.3154196237060167,0.13785557986870897,0.6348039538774607,1.0,2/10,1.72%,PRKAG2;PKIG
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),0.5766287286906959,1.3152235037537592,0.1558219178082192,0.9609583438583842,1.0,8/13,24.55%,TARBP1;WDR4;FTSJ1;TRMT5;THUMPD3;TRMT1L;TRMT1;THUMPD2
prerank,antiporter activity (GO:0015297),0.5432684681800783,1.3148557628347097,0.15151515151515152,0.9485619228216386,1.0,4/20,8.07%,SLC35A1;SLC35D3;SLC35C2;SLC35D2
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",0.5899414695140967,1.314029162971353,0.18620689655172415,0.9382074047123115,1.0,1/13,0.72%,EHHADH
prerank,inorganic cation transmembrane transporter activity (GO:0022890),0.4567554623503663,1.3131968908592166,0.13918918918918918,0.9282982713193517,1.0,8/48,8.00%,PIEZO2;NALCN;TRPM3;SLC12A2;TRPV4;SLC12A4;SLC4A11;PIEZO1
prerank,cytokine receptor activity (GO:0004896),-0.3235812429774005,-1.3104819389686213,0.06557377049180328,0.6374893149718159,1.0,14/83,8.26%,IL1R1;OSMR;IL31RA;GHR;IL13RA1;IL6R;IFNAR2;IL1RAP;IL10RB;F3;LIFR;CNTFR;IL15RA;CMKLR1
prerank,platelet-derived growth factor binding (GO:0048407),-0.5376857956348651,-1.305455118412973,0.1736111111111111,0.6412132948551468,1.0,3/11,1.97%,PDGFRB;PDGFRA;COL5A1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",-0.5521423227979982,-1.3024845950514885,0.1722488038277512,0.6393068479208481,1.0,8/10,40.88%,LACC1;CDA;GDA;ADA;DCTD;ADARB2;CDADC1;APOBEC1
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.3648309677378401,1.301715039781481,0.006006006006006006,0.961813147511381,1.0,89/830,8.29%,EBF2;RORA;MEOX2;ZBTB7C;KLF5;ETV4;NFATC2;ETV1;GLI1;PAX9;RBPJL;FOXD2;NR2F2;NR3C2;DLX1;POU4F3;RARB;FOXP2;ZNF423;FOXD1;NFATC1;ZBTB32;KLF12;PBX1;ZSCAN25;BHLHE22;ZBTB20;NPAS3;NEUROD6;ETV5;RUNX2;NFIA;ZSCAN18;HIVEP2;HOXB6;GLI2;TEF;ZKSCAN7;KLF3;CIART;SPI1;FOXK1;ZNF418;FOXO3;SOX9;PGR;FOXP4;NPAS2;ZBTB8A;GLIS2;ZNF585B;ZNF585A;HDAC4;REL;CHD2;SATB1;ZBTB3;KLF10;POU5F2;HEYL;ZFP3;ZFP1;SP3;BHLHE40;ZFP90;ONECUT1;NRIP1;ZFP14;TEAD3;CTCF;NRF1;NFE2L1;HIC1;ZNF431;PAX3;HOXC10;ZFP62;TBX2;ONECUT3;RREB1;RARA;MAFG;USF2;LHX6;MYPOP;PKNOX2;ZNF628;E4F1;FOXK2
prerank,nucleoside monophosphate kinase activity (GO:0050145),0.5381233463251155,1.2977768213932206,0.18241042345276873,0.9664694540769977,1.0,4/20,3.57%,MPP1;CASK;TJP2;MAGI3
prerank,calcium-dependent phospholipid binding (GO:0005544),-0.35824519259825105,-1.2966708687148971,0.08015267175572519,0.6441406192266318,1.0,9/49,7.39%,ANXA3;DYSF;C2CD5;SYT9;ANXA2;SYT7;RPH3A;MCTP2;ANXA1
prerank,cGMP binding (GO:0030553),-0.5296338342663205,-1.29524992608156,0.15762273901808785,0.636835948705684,1.0,4/11,9.39%,RAPGEF2;PDE5A;PDE10A;PDE2A
prerank,myosin II binding (GO:0045159),-0.5370491001992598,-1.2926723180737039,0.17016317016317017,0.6329481798466278,1.0,5/10,28.08%,TRIOBP;LLGL2;MYL4;SHROOM1;STXBP5
prerank,transition metal ion transmembrane transporter activity (GO:0046915),-0.3967905779970139,-1.291607030309431,0.13870967741935483,0.6251035052463618,1.0,7/30,6.86%,SLC30A10;SLC39A10;SLC39A8;ATP7A;SLC31A1;SLC11A2;SLC39A14
prerank,alkali metal ion binding (GO:0031420),0.5784359859433332,1.2873588511183323,0.19859402460456943,0.9980608902168973,1.0,4/13,7.77%,TDG;HDAC4;ATP1A2;ACAT1
prerank,protein tyrosine kinase activator activity (GO:0030296),0.521574118503021,1.2833818338973282,0.1984375,1.0,1.0,1/19,0.26%,EFNA5
prerank,telomerase RNA binding (GO:0070034),0.5358432579113214,1.2819946958095978,0.19314641744548286,0.9945641182779225,1.0,6/22,12.93%,HNRNPC;NAF1;WRAP53;EXOSC10;TEP1;SMG7
prerank,metalloendopeptidase inhibitor activity (GO:0008191),0.5632311692933386,1.2806210215000642,0.1915966386554622,0.9873878510919402,1.0,1/14,0.03%,NGF
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",-0.5096217500173617,-1.2764146700128172,0.17703349282296652,0.6595656626522625,1.0,10/12,28.18%,PDE7B;PDE8A;PDE8B;PDE2A;PDE4A;PDE1B;PDE4C;PDE4B;PDE3B;PDE7A
prerank,protein phosphatase binding (GO:0019903),0.39995437154434194,1.2738442769628973,0.12888377445339472,1.0,1.0,31/117,16.35%,PXN;SMTNL1;CEACAM1;EGFR;PDLIM4;SH3RF2;CDH5;SMTNL2;EIF2AK3;ATP2B4;AKAP11;MAP3K5;PIK3R2;BOD1L1;ANAPC5;MTMR3;ANAPC7;MASTL;PTPRT;ANK1;STRN;ENSA;MVP;PTPA;SMG7;ANAPC4;BAD;ADCY8;ERBB2;TBK1;AP3B1
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),0.5910617497861217,1.2737675049728154,0.22596964586846544,0.9907166182443092,1.0,3/11,12.99%,CNGB1;CNGA4;AQP1
prerank,BMP binding (GO:0036122),-0.5178746920957928,-1.2694718536306626,0.19437939110070257,0.6694993328441345,1.0,3/11,6.66%,ENG;BMPR2;GREM2
prerank,protein tyrosine phosphatase activity (GO:0004725),0.41457095733090427,1.2690403943519888,0.15203145478374835,0.9972807114176604,1.0,22/71,15.19%,UBASH3B;PTPN13;PTPRF;EYA1;PTPDC1;PTPN14;TPTE;PTPN22;PTPRC;PTP4A2;PTPRJ;MTMR6;MTMR3;PTPRT;HACD2;PTPN18;PTEN;PTPRA;PALD1;PTPRU;PTPRO;PTPN6
prerank,metal ion transmembrane transporter activity (GO:0046873),0.49395178603498324,1.2668064465415438,0.18723404255319148,0.994319074397357,1.0,9/27,12.99%,ITPR2;SLC12A2;SLC12A3;ATP2B4;CNNM2;MRS2;ZDHHC13;TUSC3;AQP1
prerank,NAD binding (GO:0051287),-0.40940198297120406,-1.262963857459771,0.17827298050139276,0.6783509644436694,1.0,10/26,22.06%,ALDH1A1;CRYL1;BDH2;QDPR;ZC3HAV1;ME1;HADH;CRYZ;SORD;ALDH2
prerank,active ion transmembrane transporter activity (GO:0022853),-0.37252290400139654,-1.2613777883937707,0.12987012987012986,0.6722467648456649,1.0,7/37,8.23%,SLC22A8;SLCO3A1;SLCO1C1;SLC22A6;SLC22A4;COX6B1;SLCO2A1
prerank,5'-3' RNA polymerase activity (GO:0034062),-0.3981046332274846,-1.2537458922788638,0.1606060606060606,0.6837031164419414,1.0,11/27,22.65%,MED21;POLR3B;TENT2;POLR3A;POLR3H;POLR2F;POLR2A;POLR2J;POLR2D;POLR1C;POLR1F
prerank,ephrin receptor activity (GO:0005003),-0.4515027463318968,-1.2519776046510014,0.19121447028423771,0.6682599991414797,1.0,7/17,18.50%,EPHA7;EPHA3;EPHA4;EPHA8;EPHA10;EPHB3;EPHB1
prerank,transmembrane-ephrin receptor activity (GO:0005005),-0.4515027463318968,-1.2519776046510014,0.19121447028423771,0.6682599991414797,1.0,7/17,18.50%,EPHA7;EPHA3;EPHA4;EPHA8;EPHA10;EPHB3;EPHB1
prerank,Lys63-specific deubiquitinase activity (GO:0061578),0.569803826390276,1.2472850207727038,0.2275132275132275,1.0,1.0,7/10,29.79%,TNFAIP3;STAMBPL1;STAMBP;CYLD;OTUD4;DESI2;OTUD5
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),0.5589813614359674,1.2470504161347395,0.21379310344827587,1.0,1.0,2/13,1.67%,ALDH1A3;ALDH9A1
prerank,serine-type peptidase activity (GO:0008236),0.40072979568188705,1.2465838163561622,0.14487632508833923,1.0,1.0,22/96,20.97%,CORIN;CTRC;FAP;KLK2;NAALAD2;PCSK5;CD5L;DPP4;PCSK7;PROC;CELA1;HTRA2;PLG;TYSND1;MBTPS1;MASP2;TMPRSS7;RHBDF1;GZMK;HGF;PLAT;PRSS8
prerank,acylglycerol O-acyltransferase activity (GO:0016411),0.499497780697469,1.2447605373986332,0.2237871674491393,1.0,1.0,6/20,11.27%,MOGAT2;MOGAT3;GPAT3;AGPAT4;LCLAT1;AGPAT5
prerank,voltage-gated chloride channel activity (GO:0005247),0.5899110229514604,1.244751298075484,0.2306338028169014,1.0,1.0,3/10,6.18%,ANO6;CLCN2;CLCN1
prerank,vinculin binding (GO:0017166),0.5770982269864294,1.2446871680552667,0.21943048576214405,1.0,1.0,3/11,7.05%,UTRN;PXN;DAG1
prerank,channel activity (GO:0015267),0.4553480476456827,1.2427153824546193,0.2087912087912088,1.0,1.0,9/41,19.71%,CHRNB3;TRPV4;MPV17;PANX2;AQP1;TRPV2;TMEM266;CHRNA7;BAX
prerank,store-operated calcium channel activity (GO:0015279),-0.5143098096448024,-1.2419672691704624,0.23094170403587444,0.688776349194746,1.0,5/10,18.96%,TRPC3;TRPC1;ORAI1;TRPC7;STIM2
prerank,transaminase activity (GO:0008483),0.5796223124840665,1.2418003675983569,0.22591362126245848,1.0,1.0,4/11,13.14%,AADAT;ABAT;BCAT2;GOT1
prerank,diacylglycerol kinase activity (GO:0004143),0.5745102159489374,1.2403537968442848,0.23559322033898306,0.9977752703761625,1.0,2/11,3.58%,DGKA;DGKZ
prerank,transmembrane receptor protein kinase activity (GO:0019199),0.42152423841176795,1.2343441159765824,0.1831357048748353,1.0,1.0,6/60,1.81%,ROR2;ROR1;NTRK3;FGFR1;EGFR;MUSK
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),-0.5198512451409559,-1.233551899532405,0.21136363636363636,0.7041223143060615,1.0,3/10,7.01%,MECOM;SETD5;PRDM16
prerank,cell adhesion mediator activity (GO:0098631),0.49183545082707997,1.2330120627901378,0.22340425531914893,1.0,1.0,2/24,4.59%,NTNG1;DSCAM
prerank,acetylglucosaminyltransferase activity (GO:0008375),0.427674815262415,1.2328851490201092,0.18131101813110181,0.9940258285546373,1.0,12/46,14.78%,MGAT3;OGT;B3GALT1;GCNT4;B4GAT1;B3GLCT;EXTL2;GCNT2;PIGA;HEXA;HEXB;EXT1
prerank,ion gated channel activity (GO:0022839),-0.38991845044926676,-1.2322911496603233,0.18732782369146006,0.6973053916205361,1.0,9/24,17.69%,ANO1;ANO4;ANO3;KCNT1;TTYH2;TMEM63B;TTYH3;ANO5;TTYH1
prerank,chemokine activity (GO:0008009),-0.37294200358754126,-1.229395241562835,0.19093851132686085,0.6967516931392508,1.0,24/31,52.22%,CXCL16;CXCL12;CCL13;CCL19;CCL2;CXCL10;CCL25;CCL28;CCL5;CXCL5;CCL11;CCL15;CXCL1;CCL4;PF4;CCL7;PPBP;CCL8;CKLF;CCL1;CCL3;XCL1;CXCL13;CXCL2
prerank,sialyltransferase activity (GO:0008373),-0.4287292234801086,-1.2275776378927616,0.16237113402061856,0.6919296633378967,1.0,6/20,5.46%,ST3GAL6;ST3GAL5;ST3GAL1;ST8SIA4;ST6GALNAC3;ST6GALNAC2
prerank,double-stranded DNA binding (GO:0003690),0.3485360965516488,1.2273945078075055,0.052313883299798795,1.0,1.0,66/531,11.91%,MEOX2;KLF5;ETV4;NFATC2;ETV1;PAX9;FOXD2;NR3C2;DLX1;POU4F3;RARB;NFATC1;ZBTB32;KLF12;PBX1;EGFR;BHLHE22;ZBTB20;ETV5;RUNX2;TDG;MSH6;HOXB6;GLI2;TEF;KLF3;FOXK1;FOXO3;SOX9;NPAS2;GLIS2;SATB1;KLF10;NTHL1;CREB3L1;ZFP1;SP3;BHLHE40;ONECUT1;HIC1;PAX3;HOXC10;TBX2;ONECUT3;MSH2;RARA;MAFG;USF2;LHX6;ISL1;PKNOX2;LIN28B;TBX18;MECP2;HMGB1;RORB;POU4F1;DBP;TLX3;TFEB;RARG;EN2;EGR1;TDP1;TOP1;MEN1
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",-0.5181996984692641,-1.2272939892784303,0.21621621621621623,0.6830041824084858,1.0,6/10,37.88%,TATDN1;DCLRE1B;DCLRE1C;EXO1;MGME1;FEN1
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),-0.48132140372558996,-1.225325485431444,0.205,0.6788121745082503,1.0,3/12,13.66%,POU2F1;HDAC1;TBPL1
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),-0.4442679075219543,-1.2204879624743417,0.2078239608801956,0.6736182142517414,1.0,4/16,3.27%,PTPRB;PTPRM;PTPRG;PTPRK
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),-0.4442679075219543,-1.2204879624743417,0.2078239608801956,0.6736182142517414,1.0,4/16,3.27%,PTPRB;PTPRM;PTPRG;PTPRK
prerank,cadherin binding (GO:0045296),0.35095825376165046,1.2182158121352347,0.10218978102189781,1.0,1.0,92/315,20.19%,STXBP6;AHNAK;ITGA6;DOCK9;FMNL2;CDH13;F11R;PARVA;ARHGAP18;CDH11;PLCB3;EGFR;CDH5;CAPZB;CDH17;STK38;PFKP;CDH9;GIGYF2;TJP2;ADD1;EXOC3;SRC;ATIC;LRRC59;USP8;ZC3H15;PACSIN2;RDX;CKAP5;BAG3;CDH2;PTPRJ;PKP4;CHMP5;STK24;CALD1;SFN;FLNB;PTPRT;CGN;IST1;DIAPH3;TBC1D2;SH3GLB2;COBLL1;CHMP4B;APC;SNX2;NOP56;EMD;CTTN;CEMIP2;AHSA1;DDX6;KIF5B;RTN4;BZW1;PTPRO;CTNNA1;GLOD4;RAN;CDH1;SNX5;EZR;SNX1;YWHAE;TNKS1BP1;PPP1CA;MB21D2;SCRIB;UBFD1;SPTBN1;STX5;EHD1;KLC2;CDH15;CDH3;PSMB6;PRDX6;CDH22;MRE11;GCN1;BAIAP2;TBC1D10A;UNC45A;MRTFB;ARGLU1;LYPLA2;ACVR1;EIF4G2;GOLGA3
prerank,zinc ion binding (GO:0008270),-0.261324979189347,-1.217968355892687,0.0,0.6718574468801859,1.0,52/293,10.98%,SMAD3;MYRIP;ECE1;SHANK3;ENPP1;MSRB3;KDM5C;ARHGEF2;CLIP1;PAPPA;ENPP2;PHF8;KDM2B;CHD4;SAMHD1;PDXK;UBA5;MT1B;MT1G;MT1A;MT1F;MT1E;MT1M;MT1H;MT1X;LITAF;NAPEPLD;RPS29;ENPP3;CXXC5;ACE;RPS27;GRIN2B;BLM;KLF4;RNF125;RBSN;UPB1;ARIH1;RPH3A;ZFP37;MNAT1;GCH1;ZCCHC4;RNF11;PRDM2;PDE2A;USP33;TRIM28;TES;SEC23A;BMI1
prerank,Tat protein binding (GO:0030957),0.5764015012792332,1.2146432783853387,0.26362038664323373,1.0,1.0,1/10,0.33%,MDFIC
prerank,AMP binding (GO:0016208),-0.49741622425033677,-1.2128603781183696,0.2239819004524887,0.6776012545567528,1.0,2/11,2.26%,PRKAG2;MPPED2
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),0.4985848564758088,1.2115287339604455,0.24154589371980675,1.0,1.0,11/18,20.74%,SOCS5;WDR81;SOCS6;PIK3R2;SOCS4;SOCS7;CCKBR;SOCS1;WDR91;SOCS2;CISH
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",0.48133301462961575,1.2111137612960534,0.22928994082840237,1.0,1.0,6/25,11.64%,POR;FMO4;FMO2;FMO1;MICAL3;MSMO1
prerank,ribosome binding (GO:0043022),-0.34440111707469745,-1.2098701759449588,0.13953488372093023,0.6774751109784922,1.0,22/46,25.11%,CPEB4;EIF3C;NOMO1;NAA15;CPEB2;SEC61B;ZC3H12A;EIF2A;YTHDF1;SERBP1;NCLN;CPEB1;MRPS27;RACK1;MAIP1;SHFL;TMCO1;C1QBP;EEF2;OXA1L;YTHDF3;GEMIN5
prerank,phosphate ion binding (GO:0042301),-0.5136068862705373,-1.2088762887751139,0.2590909090909091,0.6712682000379236,1.0,2/10,9.39%,RPH3A;PDE2A
prerank,transcription coregulator binding (GO:0001221),0.4237148552960652,1.2069403877559102,0.23796423658872076,1.0,1.0,8/50,11.63%,RORA;VGLL4;UBE2I;PGR;CTCF;CHD6;HDAC6;ZBTB49
prerank,MAP kinase kinase kinase activity (GO:0004709),0.5685635115068189,1.2039055173100681,0.2569444444444444,1.0,1.0,3/11,7.79%,EGFR;MAP3K1;MAP3K5
prerank,glutamate receptor binding (GO:0035254),-0.42830404099596,-1.1992768422084066,0.24338624338624337,0.6898582055777452,1.0,6/17,8.50%,HIP1;SHANK3;GNAS;SQSTM1;IGSF11;CAMK2A
prerank,G protein-coupled amine receptor activity (GO:0008227),0.47976854491851506,1.1986711993850243,0.2562893081761006,1.0,1.0,1/22,0.35%,HRH1
prerank,G protein-coupled serotonin receptor activity (GO:0004993),0.47976854491851506,1.1986711993850243,0.2562893081761006,1.0,1.0,1/22,0.35%,HRH1
prerank,serotonin receptor activity (GO:0099589),0.47976854491851506,1.1986711993850243,0.2562893081761006,1.0,1.0,1/22,0.35%,HRH1
prerank,anion transmembrane transporter activity (GO:0008509),-0.473764859314226,-1.1920099069358279,0.24349881796690306,0.7021751404981919,1.0,3/12,3.59%,ABCG2;SLC39A8;SLC22A6
prerank,secondary active transmembrane transporter activity (GO:0015291),-0.3283037709875635,-1.1906023624018083,0.16605166051660517,0.6977646955882002,1.0,13/51,13.12%,SLC22A8;SLCO3A1;SLC7A5;SLCO1C1;SLC22A6;SLC22A4;SLC5A6;SLCO2A1;SLC25A30;SLC25A11;SLC16A2;TMEM241;MFSD2A
prerank,pre-mRNA binding (GO:0036002),0.4515989121089605,1.1896511359562034,0.2518628912071535,1.0,1.0,8/28,17.58%,RNPC3;CELF1;ZRSR2;RBM22;CELF2;CELF4;TRA2B;SLU7
prerank,calmodulin-dependent protein kinase activity (GO:0004683),-0.3958531608312538,-1.1895005057942813,0.22492401215805471,0.692604456396128,1.0,7/24,13.56%,DAPK1;MKNK2;CAMK2A;MKNK1;CAMK4;MAPKAPK2;MAPKAPK3
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.38639485135225177,1.1866814322600812,0.22249388753056235,1.0,1.0,11/75,10.76%,RDH10;EHHADH;RDH5;MDH1B;HADHB;DHRS4;HSD17B4;ADH5;MDH1;AKR1B10;KCNAB1
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),-0.3691940591003367,-1.185686071236957,0.22077922077922077,0.6952315927211832,1.0,14/32,24.62%,SLC6A6;SLC6A9;SLC7A5;SLC25A38;SLC43A2;SLC38A7;SLC1A1;SLC3A2;SLC38A5;SLC1A4;SLC38A1;SLC38A9;SLC7A10;SLC1A5
prerank,intracellular chloride channel activity (GO:0061778),-0.4194656835677928,-1.185535184503937,0.2693333333333333,0.6793901436347334,1.0,8/16,21.28%,ANO1;ANO4;ANO3;TTYH2;TTYH3;ANO5;TTYH1;ANO2
prerank,intracellular calcium activated chloride channel activity (GO:0005229),-0.4194656835677928,-1.185535184503937,0.2693333333333333,0.6793901436347334,1.0,8/16,21.28%,ANO1;ANO4;ANO3;TTYH2;TTYH3;ANO5;TTYH1;ANO2
prerank,C-C chemokine receptor activity (GO:0016493),0.48405213187905527,1.1846698675323335,0.2667706708268331,1.0,1.0,1/21,0.78%,ACKR3
prerank,ATPase activator activity (GO:0001671),-0.4137181549273867,-1.1839920231253496,0.22074468085106383,0.6757054339183589,1.0,5/20,10.36%,DNAJC1;DNAJB2;DNAJA1;ATP1B1;ATP1B2
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),0.449539872040839,1.1776496983746882,0.2708333333333333,1.0,1.0,1/28,0.24%,EDA
prerank,exopeptidase activity (GO:0008238),0.41490413947188454,1.174924992052983,0.2395128552097429,1.0,1.0,13/50,12.55%,XPNPEP2;FAP;NAALAD2;CPE;CPA2;RNPEP;DPP4;BLMH;LNPEP;MME;XPNPEP3;KDM8;LTA4H
prerank,mRNA methyltransferase activity (GO:0008174),-0.46855724881780253,-1.1733698319367196,0.28674698795180725,0.6976108400719385,1.0,8/12,36.62%,NSUN2;TRMT61B;METTL16;METTL8;CMTR2;METTL14;TRMT61A;TRMT10C
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.3317475921284738,1.1725389955592012,0.11122244488977956,1.0,1.0,65/597,10.24%,MEOX2;BNC2;KLF5;ETV4;NFATC2;ETV1;GLI1;PAX9;FOXD2;NR3C2;DLX1;POU4F3;RARB;NFATC1;ZBTB32;KLF12;PBX1;BHLHE22;ZBTB20;ETV5;RUNX2;HOXB6;GLI2;TEF;CHD3;KLF3;SPI1;FOXK1;BEND3;FOXO3;SOX9;NPAS2;GLIS2;HDAC4;KLF10;CREB3L1;ZFP1;SP3;BHLHE40;ONECUT1;ORC5;CTCF;HIC1;NCOR1;PAX3;HOXC10;TBX2;ONECUT3;RARA;SUV39H1;MAFG;USF2;LHX6;ISL1;PKNOX2;FOXK2;LIN28B;TBX18;FOXJ1;HMGB1;RORB;POU4F1;DBP;ORC3;TLX3
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",0.33683030795437835,1.1717668076041154,0.1689545934530095,1.0,1.0,30/254,10.15%,MEOX2;KLF5;ETV4;ETV1;FOXD2;POU4F3;NFATC1;ETV5;NFIA;FOXO3;SOX9;PGR;GLIS2;ZNF585B;ZNF585A;REL;KLF10;CREB3L1;ONECUT1;NRF1;HOXC10;ZFP62;RREB1;E4F1;FOXK2;PLSCR1;FOXJ1;SMARCD2;POU4F1;DBP
prerank,GTPase activator activity (GO:0005096),0.3378937156140396,1.1716035051213614,0.15714285714285714,1.0,1.0,39/313,6.43%,ARHGAP42;SIPA1L1;DOCK9;DLC1;ARHGEF28;RGS6;DOCK5;RGS14;ARHGAP31;PLCE1;ARHGAP18;ARHGAP32;GRTP1;RAPGEF3;PSD;RAP1A;ARHGAP9;RGL1;ARAP1;RAB3IL1;DOCK1;DENND2D;SGSM2;DENND2C;NF1;AKAP13;EIF2B3;OPHN1;RACGAP1;VAV2;GNAQ;WDR41;NUCB1;HPS1;DOCK2;RAPGEF4;ARHGEF5;ARHGAP26;RAB3GAP2
prerank,hydro-lyase activity (GO:0016836),0.4214721735638774,1.1693243291293507,0.2641770401106501,1.0,1.0,12/41,17.95%,EHHADH;CYP2S1;HADHB;HACD4;HSD17B4;HACD2;NAXD;ENO3;GMDS;PCBD2;ENO2;CDYL
prerank,adenyl ribonucleotide binding (GO:0032559),-0.239306552523972,-1.1688301068881193,0.023809523809523808,0.7020166069282217,1.0,69/291,16.54%,PRKAG2;DAPK1;KSR1;RAPGEF2;INSR;MYO1B;ENPP1;MAP3K20;MARK1;LATS2;MPPED2;MTHFS;MYO6;SNRK;TGFBR1;AKT3;ATP7A;PDXK;ACVRL1;RPS6KA5;STK17B;RHOBTB3;SIK1;BLM;SMC4;TRNT1;HSPA8;TWF1;HARS1;ABCC6;MCM6;ABCD4;PDE10A;CDK6;UBA2;TAP2;SYN1;MKNK2;AKT1;MYH10;PDE2A;CDKL5;VPS4A;TRIB1;MKNK1;OXSR1;ACLY;ABCD2;PMVK;ABCE1;ABCA2;PDE4A;PXK;SMARCA5;ME1;SPHK1;MYO18A;SYN3;MTHFD1L;ABCG1;MVK;MTPAP;P2RX7;HACL1;PEX6;P2RX4;EIF4G1;NOL9;PEX1
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),-0.47985200998557187,-1.1670532072751387,0.28431372549019607,0.6991399162088635,1.0,4/12,13.15%,PIK3R3;PIK3R6;PIK3C2A;IPMK
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),0.4996317977493394,1.1608264192771716,0.31217838765008576,1.0,1.0,5/15,12.99%,SLC25A12;SLC1A7;SLC1A6;SLC25A13;SLC25A22
prerank,adenyl nucleotide binding (GO:0030554),0.534826407026599,1.1585752712629218,0.2991596638655462,1.0,1.0,5/11,19.35%,HSPH1;SIL1;BAG3;BAG2;GRPEL2
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),0.534826407026599,1.1585752712629218,0.2991596638655462,1.0,1.0,5/11,19.35%,HSPH1;SIL1;BAG3;BAG2;GRPEL2
prerank,protein kinase inhibitor activity (GO:0004860),0.41823717804667837,1.1579004204620957,0.2726008344923505,1.0,1.0,18/42,22.31%,PARVA;SPRED1;SPRY4;IBTK;GMFB;MAPK8IP1;HEXIM1;SPRED2;CDKN1C;CIT;SOCS1;INKA2;RPTOR;CEP43;NCK1;GSKIP;YWHAB;TAOK3
prerank,3'-5' DNA helicase activity (GO:0043138),-0.4192841315676614,-1.1559946481300947,0.2925531914893617,0.7219954429324198,1.0,4/16,7.16%,WRN;BLM;NAV2;MCM6
prerank,transition metal ion binding (GO:0046914),-0.24388033777023216,-1.155248738127683,0.13333333333333333,0.7163187848915693,1.0,78/397,13.43%,MOXD1;SMAD3;MYRIP;ECE1;SHANK3;ENPP1;MSRB3;KDM5C;ARHGEF2;CLIP1;NOS3;PAPPA;MPPED2;ENPP2;PHF8;KDM2B;FTH1;ATP7A;CHD4;SAMHD1;WRN;PDXK;UBA5;MT1B;MT1G;MT1A;MT1F;MT1E;MT1M;MT1H;MT1X;COMMD1;LITAF;HMGCL;NAPEPLD;LACC1;RPS29;ENPP3;CXXC5;ACE;FTL;SOD3;RPS27;AOX1;GRIN2B;BLM;KLF4;SLC11A2;RNF125;RBSN;UPB1;ARIH1;RPH3A;ZFP37;MNAT1;GCH1;ADCY2;ZCCHC4;RNF11;PRDM2;PDE2A;USP33;TRIM28;TES;SEC23A;B4GALT1;BMI1;B4GALT7;ETHE1;DPP3;LOXL3;NUDT12;NFU1;ABCE1;KDM7A;CALB1;ME1;ADH1A
prerank,regulatory RNA binding (GO:0061980),0.4203866845562449,1.1538397241232412,0.2725988700564972,1.0,1.0,17/38,25.77%,DND1;PIWIL2;RBM10;ZNF346;TLR7;AGO1;PUM2;DICER1;SPOUT1;DHX9;PUM1;ELAVL1;ZC3H7B;DDX21;FMR1;PNPT1;AGO2
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),0.34983894579198965,1.152853966547699,0.22408026755852842,1.0,1.0,25/147,8.67%,DOCK9;ARHGEF28;DOCK5;PLCE1;RAPGEF3;PSD;RAP1A;RGL1;RAB3IL1;DOCK1;DENND2D;DENND2C;AKAP13;EIF2B3;VAV2;WDR41;NUCB1;HPS1;DOCK2;RAPGEF4;ARHGEF5;RAB3GAP2;FRMD7;KALRN;RAPGEF6
prerank,fatty acid synthase activity (GO:0004312),0.5427198982730391,1.1526295633092616,0.31314878892733566,1.0,1.0,4/10,13.29%,ELOVL5;ELOVL1;ELOVL2;ELOVL6
prerank,cytokine receptor binding (GO:0005126),-0.28495723730510497,-1.1490128203474226,0.16939890710382513,0.726001254391852,1.0,14/83,9.58%,SMAD3;OSMR;IL13RA1;TGFBR3;IL6R;FKBP1A;IL1RAP;IL18;LIFR;CXCL12;TRAF6;JAK2;VEGFC;IL34
prerank,phospholipase C activity (GO:0004629),0.4550874826424123,1.1483166421290496,0.3195718654434251,1.0,1.0,4/25,3.86%,PLCD3;PLCE1;PLCB3;PLCL1
prerank,L-amino acid transmembrane transporter activity (GO:0015179),-0.3071138929299593,-1.145510543895841,0.21810699588477367,0.7282230342147653,1.0,22/53,24.62%,SLC7A11;SLC47A1;SLC6A9;SLC7A5;SLC7A1;SLC7A6;SLC15A4;SLC25A38;CTNS;SLC43A2;SLC1A3;SLC38A7;SLC1A1;SLC3A2;SLC22A2;SLC38A5;SLC25A18;SLC1A4;SLC38A1;SLC38A9;SLC7A10;SLC1A5
prerank,cation:chloride symporter activity (GO:0015377),0.536766476239299,1.1454437464044813,0.3268206039076377,1.0,1.0,3/10,4.35%,SLC12A2;SLC12A4;SLC12A3
prerank,C-C chemokine binding (GO:0019957),0.466045113235343,1.1450546848220549,0.29067930489731436,1.0,1.0,1/22,0.78%,ACKR3
prerank,C2H2 zinc finger domain binding (GO:0070742),-0.45492437315643,-1.1440343761169889,0.2987951807228916,0.7245310829315393,1.0,6/11,29.18%,LEF1;GATA2;ZXDC;EHMT2;THAP7;TAF9
prerank,hormone activity (GO:0005179),0.39653510604742853,1.143088950501613,0.27694406548431105,1.0,1.0,5/54,5.61%,INHBB;INSL6;GNRH1;PTHLH;APLN
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",0.5019482058386127,1.1416374602224542,0.30398671096345514,1.0,1.0,5/16,13.32%,TDG;NTHL1;SARM1;OARD1;ADPRS
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),-0.44184194759351114,-1.1373011698730926,0.3007518796992481,0.7358795877131697,1.0,5/13,16.26%,PIP5K1B;PIK3C2A;PIP4K2A;PIP4K2C;PIP5K1A
prerank,gamma-tubulin binding (GO:0043015),0.4647031409617886,1.137130127530762,0.30128205128205127,1.0,1.0,10/22,22.06%,RACGAP1;BRSK1;TUBGCP5;CENPJ;RAB11FIP5;B9D2;ARHGEF7;OFD1;TUBGCP6;BLOC1S2
prerank,ATP binding (GO:0005524),-0.236008829333454,-1.135722668387695,0.07692307692307693,0.7325166349566239,1.0,62/266,16.54%,PRKAG2;DAPK1;KSR1;INSR;MYO1B;ENPP1;MAP3K20;MARK1;LATS2;MTHFS;SNRK;TGFBR1;AKT3;ATP7A;PDXK;ACVRL1;RPS6KA5;STK17B;RHOBTB3;SIK1;BLM;SMC4;TRNT1;HSPA8;TWF1;HARS1;ABCC6;MCM6;ABCD4;CDK6;UBA2;TAP2;SYN1;MKNK2;AKT1;MYH10;CDKL5;VPS4A;TRIB1;MKNK1;OXSR1;ACLY;ABCD2;PMVK;ABCE1;ABCA2;PXK;SMARCA5;SPHK1;MYO18A;SYN3;MTHFD1L;ABCG1;MVK;MTPAP;P2RX7;HACL1;PEX6;P2RX4;EIF4G1;NOL9;PEX1
prerank,mRNA 5'-UTR binding (GO:0048027),-0.36343118483182835,-1.1347159414846917,0.2674772036474164,0.727977299411462,1.0,11/24,24.73%,LARP6;RPS7;RPL26;RPL41;MYH10;NCL;DHX36;MRPS11;GNL3;RPL5;RPS14
prerank,glutathione transferase activity (GO:0004364),0.4493194226596953,1.1324533630289726,0.31343283582089554,1.0,1.0,6/23,12.22%,MGST2;GSTZ1;GSTA4;GSTA3;GSTK1;LANCL1
prerank,potassium ion transmembrane transporter activity (GO:0015079),0.42297161368791897,1.1319647490570637,0.31851851851851853,1.0,1.0,9/31,15.26%,SLC12A2;SLC12A4;SLC12A3;KCNK1;KCNK5;AQP1;KCNK10;KCNK4;SLC12A8
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),-0.4479007610855763,-1.1296972932335934,0.3137254901960784,0.7345940709498494,1.0,6/12,27.93%,CTSH;NOD1;RACK1;RPS27L;PYCARD;CASP1
prerank,manganese ion binding (GO:0030145),0.3875409110084872,1.1280410586391025,0.30303030303030304,1.0,1.0,5/48,6.48%,FAM20C;ARG1;XYLT2;PPM1M;ABL2
prerank,dynactin binding (GO:0034452),0.5180609397090123,1.1265014901418189,0.3441226575809199,1.0,1.0,5/12,15.48%,PAFAH1B1;GSK3B;HOOK3;HTT;SNX5
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",0.4667654177496286,1.1252274342632578,0.3150912106135987,1.0,1.0,4/18,9.05%,ALDH1A3;ALDH9A1;ALDH18A1;AKR1B10
prerank,inward rectifier potassium channel activity (GO:0005242),0.44754435480688753,1.1225105182209583,0.3389570552147239,1.0,1.0,4/24,5.58%,KCNJ4;KCNJ16;KCNK1;KCNJ13
prerank,chemoattractant activity (GO:0042056),0.4358962061720935,1.1182024120709422,0.3440366972477064,1.0,1.0,1/26,0.26%,FGF7
prerank,monocarboxylic acid binding (GO:0033293),0.46909840308845147,1.1171824915469324,0.32643312101910826,1.0,1.0,2/18,7.45%,NR2F2;RARA
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",0.5079184185839973,1.116801017985412,0.33157894736842103,1.0,1.0,2/12,4.76%,B3GALT1;B4GAT1
prerank,sodium channel regulator activity (GO:0017080),0.4116956014044574,1.1167369512941498,0.3150492264416315,1.0,1.0,8/37,11.95%,NEDD4L;CAMK2D;GPLD1;ATP2B4;FXYD6;SCN2B;NEDD4;SGK1
prerank,PDZ domain binding (GO:0030165),0.3709318582902236,1.11548216757453,0.30808080808080807,1.0,1.0,4/61,1.66%,CXADR;F11R;KCNJ4;FZD2
prerank,tRNA-specific ribonuclease activity (GO:0004549),0.48570637604295336,1.114717000457671,0.3344316309719934,1.0,1.0,8/14,25.73%,POP4;POP7;TSEN34;RPP14;RPP21;RPP30;PRORP;TSEN2
prerank,SUMO transferase activity (GO:0019789),0.4812920294276902,1.1130429804249238,0.33115823817292006,1.0,1.0,4/16,11.54%,UBE2I;HDAC4;PIAS2;RANBP2
prerank,frizzled binding (GO:0005109),0.40877775403850514,1.110668752735578,0.33775811209439527,1.0,1.0,8/34,14.10%,WNT10A;WNT2B;WNT16;WNT5A;ZNRF3;DVL3;WNT9A;FZD7
prerank,basic amino acid transmembrane transporter activity (GO:0015174),-0.4175620959024573,-1.1105753663351197,0.33080808080808083,0.7806564700093653,1.0,6/13,20.04%,SLC7A1;SLC7A6;SLC15A4;SLC38A7;SLC38A5;SLC25A29
prerank,nucleotide diphosphatase activity (GO:0004551),-0.4123983152906544,-1.1094993060923493,0.29850746268656714,0.7760685112684164,1.0,7/14,21.53%,ENPP1;NUDT13;NUDT3;ENPP4;NUDT12;NUDT11;CILP
prerank,myosin binding (GO:0017022),-0.3058421702619356,-1.1091523629421134,0.2868525896414343,0.7693526500591689,1.0,12/55,18.80%,MYRIP;DMD;RAB6B;RAB3C;LARP6;TRIOBP;RAB11A;NKD2;LLGL2;RAB3B;RAB11B;MLPH
prerank,metalloendopeptidase activity (GO:0004222),0.3657705176127303,1.1082639511614396,0.32226322263222634,1.0,1.0,19/76,16.91%,ADAMTS14;MMP28;ADAMTS12;ADAMTSL5;ADAMTS1;ADAM19;MMP15;ADAMTS19;ADAM10;ADAMTS2;MMP12;MME;MMP16;ADAMTSL4;MIPEP;NLN;ZMPSTE24;ADAMTS20;MMP14
prerank,glycine binding (GO:0016594),-0.44819120884869473,-1.1064947410095036,0.3486238532110092,0.7694564008666349,1.0,4/11,11.73%,GRIN3A;GRIN2B;GRIN1;GLRA2
prerank,calcium channel regulator activity (GO:0005246),-0.3273264674084028,-1.1057489986493774,0.2706766917293233,0.764033640303384,1.0,9/37,15.43%,ITPR1;PRKG1;FKBP1A;CALM1;CACNG7;NRXN1;REM1;NRXN2;SRI
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),0.4513370125461954,1.1037301169256768,0.3481717011128776,1.0,1.0,3/23,1.51%,PLCD3;PLCE1;PLCB3
prerank,cation channel activity (GO:0005261),0.3500039849585828,1.1036925570079295,0.32107843137254904,1.0,1.0,18/94,14.45%,PIEZO2;OTOP1;NALCN;TRPM3;ANO6;SLC24A1;TRPV4;KCNK1;SLC4A11;PIEZO1;KCNK5;ANO10;AQP1;PKD1;TRPV2;KCNK10;KCNK4;TMEM63A
prerank,peptidoglycan binding (GO:0042834),-0.46432221508340205,-1.1014729080534096,0.34976525821596244,0.7691509167069731,1.0,6/10,39.97%,NOD1;PGLYRP1;NOD2;JCHAIN;NLRP3;TLR2
prerank,phosphoric diester hydrolase activity (GO:0008081),-0.3284377008208491,-1.0999168281249783,0.25925925925925924,0.7665753760585097,1.0,7/35,4.50%,PLCB4;GPCPD1;ENPP1;MPPED2;ENPP2;NAPEPLD;ENPP3
prerank,calcium channel inhibitor activity (GO:0019855),-0.4462999367693378,-1.0999108060717242,0.33568075117370894,0.7593538960987818,1.0,3/11,6.63%,ITPR1;FKBP1A;CALM1
prerank,actin monomer binding (GO:0003785),0.4429764041209467,1.096325562517447,0.3601236476043277,1.0,1.0,4/22,10.66%,PRKCE;COBL;ABL2;MTSS1
prerank,phosphatidylinositol phosphate binding (GO:1901981),-0.26388563780534147,-1.095177555691378,0.2469879518072289,0.7657060599561067,1.0,25/100,12.04%,HIP1;PARD3;OSBPL8;ADAP2;MYO1B;CYTH3;COMMD1;SNX21;ZFYVE28;MYO10;ARAP3;DAPP1;KCNH1;HIP1R;SNX24;RPH3A;WIPI1;AKT1;FCHSD2;OSBPL5;IQGAP2;RUBCN;TECPR1;PLEKHF1;DENND1A
prerank,leak channel activity (GO:0022840),0.4623133735560957,1.0927116618619321,0.3697068403908795,1.0,1.0,5/18,13.89%,NALCN;KCNK1;KCNK5;KCNK10;KCNK4
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),0.46545309423313536,1.0880879983140208,0.36710963455149503,1.0,1.0,9/15,20.74%,SOCS5;SOCS6;PIK3R2;SOCS4;SOCS7;CCKBR;SOCS1;SOCS2;CISH
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),0.43519040863812253,1.087490042219192,0.37261146496815284,1.0,1.0,4/21,6.67%,CDK15;CDKL3;CDK13;CDK7
prerank,cyclin-dependent protein kinase activity (GO:0097472),0.43519040863812253,1.087490042219192,0.37261146496815284,1.0,1.0,4/21,6.67%,CDK15;CDKL3;CDK13;CDK7
prerank,death domain binding (GO:0070513),0.49957714951802307,1.0872443716207116,0.36772046589018303,1.0,1.0,3/11,8.83%,TRADD;MCL1;IRGM
prerank,GDP binding (GO:0019003),0.3653988761725871,1.0846137632060082,0.3359477124183007,1.0,1.0,21/63,23.20%,RAP1A;RAB8B;RAB29;MRAS;RASEF;NRAS;KRAS;ARF6;MIEF1;ARL8B;RAN;GEM;RAB21;RAB27B;RAB5A;RALA;RAB18;RHEBL1;GNAI3;ARL3;RAB9A
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",0.49886189200375103,1.0829502253865009,0.3719723183391003,1.0,1.0,1/11,0.64%,SGMS2
prerank,lysophospholipase activity (GO:0004622),-0.36939216080376536,-1.082768359005003,0.3593314763231198,0.793666486512613,1.0,5/20,14.11%,ENPP2;LYPLA1;ASPG;PNPLA6;LYPLAL1
prerank,WW domain binding (GO:0050699),-0.3439728095448599,-1.0825471219801215,0.31563421828908556,0.786969665709621,1.0,3/26,4.00%,RAPGEF2;TNK2;LITAF
prerank,RNA polymerase binding (GO:0070063),-0.39274916870191945,-1.082010496121956,0.327455919395466,0.7813233373798091,1.0,11/18,25.26%,YTHDC2;CCNT2;CCNT1;PHRF1;STOM;PPIB;ZFP36;SCAF8;ANP32B;BRCA1;TCERG1L
prerank,semaphorin receptor activity (GO:0017154),-0.43509816743766216,-1.080392579431809,0.3665893271461717,0.7788268356940006,1.0,2/11,1.37%,PLXNA2;PLXNA4
prerank,myosin V binding (GO:0031489),-0.40060255096633224,-1.07958702267963,0.36650485436893204,0.7739523288520798,1.0,6/15,22.08%,RAB6B;RAB3C;RAB11A;RAB3B;RAB11B;RAB10
prerank,bicarbonate transmembrane transporter activity (GO:0015106),0.463984407014308,1.0775388570440372,0.3858520900321543,1.0,1.0,3/15,7.04%,SLC4A3;SLC26A9;SLC4A11
prerank,protein tyrosine kinase binding (GO:1990782),0.3588729168942484,1.075789143200202,0.3543990086741016,1.0,1.0,8/71,5.32%,LRP4;CEACAM1;SOCS5;CDH5;ITGAX;TJP2;PTPN14;BANK1
prerank,calcium channel activity (GO:0005262),-0.2690134117245961,-1.075437413921284,0.3005181347150259,0.7785450948382967,1.0,26/84,26.28%,CACNA2D3;SLC24A3;TRPC3;TRPC1;ANXA2;CACNB2;ORAI1;GRIN1;CACNG7;TRPC7;TRPM7;P2RX4;ANXA6;CACHD1;TRPM2;OPRM1;STIM2;CACNA2D4;TPCN2;TMCO1;CACNG4;PKD2L2;ANXA9;PKD2L1;PKD1L3;CACNA1B
prerank,general transcription initiation factor binding (GO:0140296),-0.34908438766449806,-1.0716976304962138,0.3409090909090909,0.7814673512983232,1.0,10/25,28.83%,RUVBL1;AR;ESR1;DRAP1;AHR;HHEX;DR1;PSMC5;TAF11;THAP7
prerank,ion channel inhibitor activity (GO:0008200),0.3959233906602142,1.0711966996839732,0.3825214899713467,1.0,1.0,7/35,12.30%,NEDD4L;CAMK2D;STX1A;FKBP1B;VAMP8;NEDD4;ENSA
prerank,mRNA 3'-UTR binding (GO:0003730),0.3492217692978081,1.0711457290917885,0.3564356435643564,1.0,1.0,17/79,15.60%,HNRNPC;FXR2;DND1;CELF1;HNRNPA0;SECISBP2;PABPC4L;PABPC4;TUT1;IGF2BP2;ELAVL2;CELF2;ILF3;ZFP36L2;FXR1;PUM2;CPEB3
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),-0.44877725358232246,-1.0711128688226628,0.37986270022883295,0.776286300898535,1.0,3/10,12.83%,PHF8;KDM2B;KDM7A
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),-0.33007511634803055,-1.0708188242099217,0.33727810650887574,0.7705222209949322,1.0,13/28,28.14%,TNK2;RPS6KB1;MAP2K2;AKT1;LRRK2;MAP2K3;MAPKAPK3;MAP2K6;RPS6KA1;MAP2K1;TTK;MAP2K4;MAP2K5
prerank,pyridoxal phosphate binding (GO:0030170),-0.36678014255929126,-1.0701819246689663,0.3463687150837989,0.7656453392734223,1.0,13/20,35.47%,PDXK;CBS;PYGB;ACCS;AGXT;CTH;OAT;PNPO;PYGL;THNSL2;SHMT2;SHMT1;PYGM
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),-0.3421294715309997,-1.0686889608814376,0.35668789808917195,0.7630574265436556,1.0,11/27,26.20%,MED21;POLR3B;POLR3A;POLR3H;POLR2F;POLR2A;POLR2J;POLR2D;POLR1C;POLR1F;POLR2I
prerank,protein homodimerization activity (GO:0042803),0.30271369573079965,1.0682452576456738,0.28442211055276384,1.0,1.0,127/590,17.73%,TENM2;ALDH1A3;F11R;INHBB;STC2;FGFR1;NR2F2;FOXP2;CEACAM1;CAMK2D;FAP;SLC8B1;AXIN1;PDLIM4;SLC39A13;GLCE;RDH5;TDG;MSH6;FXR2;KIF20B;NAGA;KMT2A;CAV2;TPD52;AADAT;ADD1;PHETA2;PAXX;S100A6;IRAK3;PIP4K2B;ATIC;TSG101;BHLHE40;CEP131;ADAM10;CLCN1;TMEM192;RABEP1;TRIM21;HOGA1;NRF1;TARS2;MCL1;NLRC4;MSH2;USF2;MAP3K5;DPP4;HSD17B4;S100B;DEFA6;COQ9;INPP5F;RPE;PDCD6IP;CASQ2;TBX18;PLEK;CUBN;ST6GAL1;PTPRT;CANT1;KARS1;ADRA2A;GSTZ1;GSTA4;TPR;RCHY1;KLHL7;CHMP4A;CHMP4B;MME;PAFAH1B2;GLDC;MZF1;XPNPEP3;EFEMP2;PRPS1L1;PRPS1;SNX2;CHMP4C;DGCR8;PGRMC1;CRPPA;MAP3K21;ABCD1;GEN1;PTPA;MYOM3;ABCB7;ATG7;STARD3;ERN1;SFPQ;AIMP1;FXR1;TXN;PTPRO;ERBB4;ABCB9;EXT1;FZD9;NECTIN3;TMEM266;ADCY8;TRIM5;MTMR1;TESC;SNX1;SCARB2;PRKRA;WARS1;BNIP3;CAMK2G;MAP3K9;CEP57;MIGA1;KYAT1;DCK;EXT2;ALS2;TERF2;DARS2;TYW5;LPL
prerank,aminoacyl-tRNA ligase activity (GO:0004812),0.3912589466632374,1.0678193073108855,0.3921015514809591,1.0,1.0,15/37,23.86%,RARS2;TARS2;VARS1;CARS2;DARS1;KARS1;WARS1;WARS2;DARS2;TARS1;SARS2;HARS2;TARS3;MARS2;PARS2
prerank,phosphatidylcholine transporter activity (GO:0008525),0.4483788144801601,1.066881747501746,0.3860759493670886,1.0,1.0,6/17,9.87%,ATP8B1;PITPNC1;PCTP;ATP8B2;ABCA1;ATP10B
prerank,poly(U) RNA binding (GO:0008266),0.4344840959814038,1.066626477122646,0.37745098039215685,1.0,1.0,4/20,7.86%,HNRNPC;PABPC4L;PABPC4;DIS3L2
prerank,pseudouridine synthase activity (GO:0009982),0.475601412250952,1.0644254274147704,0.3875838926174497,1.0,1.0,3/13,6.98%,RPUSD2;PUS7;PUS3
prerank,cysteine-type endopeptidase activity (GO:0004197),-0.2617775007814631,-1.063693665284975,0.3125,0.7703810489012837,1.0,19/78,17.68%,CTSH;USP28;CAPN15;USP1;CTSL;USP42;USP20;CASP3;CFLAR;USP18;LGMN;USP33;CASP12;USP36;USP30;CASP6;CASP8;CTSC;CASP4
prerank,protein phosphatase activator activity (GO:0072542),-0.4091403249524621,-1.060835425668997,0.37965260545905705,0.7711472298018744,1.0,8/13,32.61%,IGFBP3;CALM1;CALM3;PPP2R5A;PPP2R5E;PPP2R5D;PPP1R15A;B3GAT3
prerank,GDP-dissociation inhibitor activity (GO:0005092),0.4849281864510071,1.0606028354707517,0.40421792618629176,1.0,1.0,2/13,5.94%,RGS14;GDI1
prerank,steroid hydroxylase activity (GO:0008395),0.45080457013375064,1.0597683306680792,0.3973509933774834,1.0,1.0,2/16,3.79%,CYP7B1;CYP2S1
prerank,calcium:sodium antiporter activity (GO:0005432),-0.4458978330569604,-1.059618757075142,0.392018779342723,0.7678971213953257,1.0,3/10,2.74%,SLC24A3;SLC8A3;SLC8A1
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",0.48300618621015007,1.0592240932981338,0.3875,1.0,1.0,2/11,1.41%,ITPR2;ITPR3
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",0.3922022860873908,1.0567935254331926,0.39,1.0,1.0,11/34,10.07%,ARHGAP9;ARAP1;OGT;PHLDA3;RACGAP1;KIF16B;ZFYVE16;OBSCN;GAB2;MAPKAP1;FERMT2
prerank,protein serine/threonine kinase activator activity (GO:0043539),-0.32577495422116276,-1.0525515327429258,0.364741641337386,0.7808896671313503,1.0,9/34,14.92%,FAM20A;IGF2;CCNT2;CALM1;MAP2K2;CCNT1;RICTOR;CALM3;CDK5R1
prerank,TBP-class protein binding (GO:0017025),-0.3501747706468557,-1.0512580409517016,0.3924731182795699,0.7780240204690443,1.0,8/21,27.75%,RUVBL1;ESR1;DRAP1;AHR;HHEX;DR1;PSMC5;TAF11
prerank,DNA-binding transcription factor binding (GO:0140297),-0.2347223575593438,-1.0510573871377293,0.3488372093023256,0.7722280123820122,1.0,44/189,16.93%,SMAD3;RUNX1T1;RBPJ;MEF2D;PPARD;TBX3;LMO2;CHD4;PRDM5;EP300;CRTC3;CXXC5;RBL1;SIK1;NPM1;KLF4;HIRA;HDAC7;HDAC9;HDAC1;MEF2A;PRDM16;PTMA;CREB1;MAP3K10;PIAS3;AR;NFYB;ATF2;CRTC2;KDM1A;SP1;BBS2;NOC2L;TAL1;YWHAZ;ID2;MKKS;TLE5;RBL2;MYOCD;HHEX;MTDH;DDX20
prerank,chemorepellent activity (GO:0045499),-0.34077011757422343,-1.0485301372221152,0.358974358974359,0.7730190743596842,1.0,5/25,5.19%,EPHA7;SEMA6D;SEMA7A;SEMA3C;SEMA6A
prerank,phospholipase binding (GO:0043274),0.46962998064840566,1.0469066374794875,0.419672131147541,1.0,1.0,6/13,20.40%,SRC;PAFAH1B1;SYK;BTK;PDPK1;PRKN
prerank,zinc ion transmembrane transporter activity (GO:0005385),-0.3546474644318391,-1.0442399423693538,0.391644908616188,0.778653648705454,1.0,4/20,6.86%,SLC30A10;SLC39A10;SLC39A8;SLC39A14
prerank,ion channel activity (GO:0005216),0.34234123830217217,1.041920511232558,0.4215809284818068,1.0,1.0,11/80,9.86%,PIEZO2;NALCN;TRPM3;GRIA3;TRPV4;TMC2;CNGB1;PIEZO1;GRID1;TMC4;GRIA1
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),0.36897469259213767,1.0418416916262623,0.39727891156462586,1.0,1.0,3/38,4.90%,SERPINB2;SERPING1;SERPINH1
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),-0.4329113203961139,-1.0418407524973474,0.435665914221219,0.7788713305288534,1.0,3/10,19.57%,SETD5;SMYD2;ASH1L
prerank,potassium channel regulator activity (GO:0015459),0.3674451142071966,1.0417428938714732,0.38513513513513514,1.0,1.0,12/49,20.29%,NEDD4L;KCNIP4;KCNS3;KCNAB1;SGK1;SLC5A3;ENSA;YWHAE;CHP1;SUMO1;ADRB2;KCNIP1
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.3460169154534621,1.0412415343883457,0.4069767441860465,1.0,1.0,16/69,15.83%,MOGAT2;CERS6;MOGAT3;AWAT2;KAT6B;PLAAT5;ZDHHC1;SOAT1;ZDHHC7;ZDHHC13;CREBBP;ZDHHC20;KAT8;ZDHHC8;NAA10;NMT1
prerank,sulfate transmembrane transporter activity (GO:0015116),-0.38966336042855865,-1.0406425163558757,0.4252577319587629,0.7756785436522059,1.0,4/14,9.30%,SLC26A7;SLC26A2;SLC25A30;SLC25A11
prerank,FMN binding (GO:0010181),0.47778083301592045,1.040451857546341,0.40429338103756707,1.0,1.0,1/11,0.66%,POR
prerank,chemokine receptor activity (GO:0004950),0.41329543103571875,1.0380977570847671,0.4076335877862595,1.0,1.0,1/24,0.78%,ACKR3
prerank,histone acetyltransferase activity (GO:0004402),0.3926621234118083,1.0366417522944,0.4069264069264069,1.0,1.0,11/30,19.21%,HAT1;KAT6B;TAF10;NCOA3;CREBBP;KAT8;EPC2;TADA2A;MCM3AP;NAA40;NAA60
prerank,dipeptidyl-peptidase activity (GO:0008239),0.4924809206199814,1.0352504018460351,0.431740614334471,1.0,1.0,3/10,7.89%,FAP;NAALAD2;DPP4
prerank,adrenergic receptor binding (GO:0031690),-0.3719597682649042,-1.033982773901224,0.4244791666666667,0.7875140331287943,1.0,2/16,1.05%,RAPGEF2;GNAS
prerank,copper ion binding (GO:0005507),-0.2912983137569463,-1.0323540669966218,0.3939393939393939,0.785698134138044,1.0,5/42,5.38%,MOXD1;ATP7A;COMMD1;LACC1;SOD3
prerank,phosphotyrosine residue binding (GO:0001784),-0.30833801008425393,-1.0303087468851597,0.4315068493150685,0.7854361195561468,1.0,10/37,12.62%,PTPN3;PIK3R1;PIK3R3;SHE;PLCG2;CRK;CRKL;LDLRAP1;BCAR3;SAMSN1
prerank,endopeptidase activity (GO:0004175),0.30205774536558105,1.029428343290846,0.4233576642335766,1.0,1.0,50/257,17.26%,ADAMTS14;CORIN;MMP28;CTRC;ADAMTS12;ADAMTSL5;FAP;KLK2;ADAMTS1;PCSK5;ADAM19;MMP15;CD5L;ADAMTS19;USP8;ADAM10;ADAMTS2;DPP4;USP48;PSMB5;PCSK7;BACE2;USP47;USP13;MMP12;MME;PROC;CELA1;TASP1;KDM8;MMP16;ADAMTSL4;USP15;MIPEP;HTRA2;PSMB2;PSMA2;PSMA6;USP35;PLG;TYSND1;PSMA7;NLN;ZMPSTE24;ADAMTS20;BACE1;MBTPS1;MMP14;MASP2;USP37
prerank,GTPase activity (GO:0003924),0.3023742329176628,1.0257893853004336,0.4281081081081081,1.0,1.0,19/192,8.98%,GNA14;RAP1A;RAB8B;RAB29;MRAS;BMS1;GNAQ;MFN2;DNM1;RAC2;NRAS;KRAS;RHOJ;RAB3A;GNL2;ATL2;IRGM;GNG3;GNAL
prerank,magnesium ion binding (GO:0000287),0.31234451074014574,1.0256658553991433,0.419953596287703,1.0,1.0,41/135,20.41%,XYLT2;TDG;MSH6;STK38;IRAK3;THTPA;BRSK1;DXO;CERK;ABL2;NLRC4;STK38L;CLYBL;MSH2;MAP3K5;DIS3L2;PGM1;SRPK1;FOXK2;PLSCR1;STK3;SRPK2;NUDT18;GEN1;PRKACB;SIK3;ADPRS;ERN1;NT5C3A;RAN;PI4K2A;TESC;GEM;DYRK2;TDP2;PINK1;CDC42BPG;NME1;NUDT5;TKT;SIK2
prerank,phospholipase activity (GO:0004620),0.3401965952970184,1.0253573247634293,0.43586387434554974,1.0,1.0,8/67,8.30%,PLCE1;PLCB3;DDHD1;GPLD1;PLCL1;PLAAT5;PLD3;ABHD12
prerank,RNA polymerase core enzyme binding (GO:0043175),0.3826985813528918,1.0249119791314778,0.4170403587443946,1.0,1.0,18/33,26.42%,ZNF326;RPRD1B;PAF1;AGO1;SUPT4H1;RPRD1A;RTRAF;NCOA3;RECQL5;ERBB2;SPTY2D1;DHX9;CDC73;CCAR2;PCF11;URI1;AGO2;HNRNPU
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),0.45945172020476405,1.0240404998097528,0.4273204903677758,1.0,1.0,4/13,11.27%,GPAT3;AGPAT4;LCLAT1;AGPAT5
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.3324974722363748,1.023924772201102,0.41982864137086906,1.0,1.0,3/73,3.10%,SORCS2;KISS1R;MC5R
prerank,DNA binding (GO:0003677),0.2885036894909848,1.0198584130881088,0.44244244244244246,1.0,1.0,131/694,17.96%,RORA;MEOX2;NFATC2;GLI1;PPARGC1A;FOXD2;NR2F2;TSHZ3;RARB;FOXP2;ZNF423;FOXD1;ZBTB32;KLF12;PBX1;EGFR;MYBBP1A;ETV5;TDG;MSH6;NUFIP1;COLEC11;HIVEP2;GLI2;TFPT;CHD3;PCBP2;HLX;FOXO3;SOX9;PGR;WDR76;NPAS2;CHD8;HDAC4;CHD2;SATB1;NTHL1;BANF2;SMARCAD1;PDS5B;TSG101;GTF3C6;TAF4B;RFC3;ARID3A;STN1;NBN;ZDHHC1;C1D;SIRT3;CTCF;HIC1;PALB2;PAX3;TBX2;MSH2;MSL3;USF2;ILF2;RBM5;FOXK2;JRKL;ZBTB6;TET1;SLTM;MECP2;FOXJ1;HMGB1;ZMYM6;POU4F1;HDAC2;TRNP1;ERCC6;LONP1;MMP12;ILF3;SAP30L;RARG;EGR1;ERCC1;TDP1;ZBTB49;ZNF148;TOP1;ERF;MEN1;INO80;NFE2L2;MTERF2;POGK;CRLF3;CREBBP;ARID4A;NUCKS1;SFPQ;GTF3C5;MBD1;CBFB;RAD51AP2;POLG2;CAMTA2;REXO4;FOXF1;NR5A1;POU6F1;FAM111A;DEDD;AIFM2;POLE;FOXC2;KMT2D;DDB2;PBX4;SRRT;TSNAX;BATF;E2F1;QRICH1;ESRRA;HP1BP3;PPARG;RTF1;CUL4B;MTF2;TDP2;BRIP1;ORC1;CREM;RFC1;SYCP2
prerank,palmitoyltransferase activity (GO:0016409),0.39151818782876335,1.0192644091549816,0.4241486068111455,1.0,1.0,13/28,22.51%,ZDHHC1;ZDHHC7;ZDHHC23;ZDHHC13;ZDHHC20;GLUL;ZDHHC8;ZDHHC19;GOLGA7B;ZDHHC3;ZDHHC12;GOLGA7;ZDHHC5
prerank,actin binding (GO:0003779),0.3085538438671102,1.0155926334494303,0.4478114478114478,1.0,1.0,25/170,10.66%,UTRN;SORBS1;PARVA;PRKCE;COBL;CEACAM1;TLN2;PDLIM4;SPEF1;CAPZB;TRPV4;ADD1;PPP1R42;SHROOM2;ABL2;RDX;DAG1;TMOD1;MICAL3;CALD1;FLNB;CGN;FERMT2;GC;MTSS1
prerank,G protein-coupled photoreceptor activity (GO:0008020),0.45723929454171197,1.0132966279033986,0.4421052631578947,1.0,1.0,2/12,6.78%,OPN1MW;OPN1MW3
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),0.45089617771521384,1.0125369110397051,0.4337979094076655,1.0,1.0,3/13,4.65%,CDH5;SRC;BMP5
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),0.4402696170853303,1.0094653697812763,0.44763513513513514,1.0,1.0,4/15,11.27%,GPAT3;AGPAT4;LCLAT1;AGPAT5
prerank,histone demethylase activity (GO:0032452),-0.31980897655274176,-1.0089891354660967,0.44135802469135804,0.8372153669144218,1.0,6/27,12.83%,KDM5C;PHF8;KDM2B;JARID2;KDM1A;KDM7A
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),0.3976480257757115,1.0087070131971205,0.4462025316455696,1.0,1.0,11/24,22.42%,ZDHHC1;ZDHHC7;ZDHHC23;ZDHHC20;GLUL;ZDHHC8;ZDHHC19;GOLGA7B;ZDHHC3;ZDHHC12;GOLGA7
prerank,RNA stem-loop binding (GO:0035613),-0.40210723286350536,-1.008238627003215,0.4276018099547511,0.8328284361527988,1.0,5/12,18.06%,LARP6;MYH10;ZC3H12A;RC3H1;METTL16
prerank,metallopeptidase activity (GO:0008237),0.3164494261783727,1.0077539268855547,0.46403712296983757,1.0,1.0,24/113,17.48%,ADAMTS14;MMP28;ADAMTS12;ADAMTSL5;ADAMTS1;ADAM19;BRCC3;MMP15;ADAMTS19;RNPEP;ADAM10;ADAMTS2;LNPEP;MMP12;MME;MMP16;ADAMTSL4;MIPEP;COPS5;NLN;ZMPSTE24;ADAMTS20;MMP14;BMP1
prerank,anion:anion antiporter activity (GO:0015301),0.4175441148960523,1.0058999693161736,0.44552845528455287,1.0,1.0,2/17,2.36%,SLC4A3;SLC26A9
prerank,endopeptidase regulator activity (GO:0061135),0.3596694485569716,1.0054533675554607,0.4588068181818182,1.0,1.0,4/40,6.98%,SPINK1;APH1B;PSME3;NLRC4
prerank,calcium ion transmembrane transporter activity (GO:0015085),-0.2713767017747167,-1.0035034365249367,0.45525291828793774,0.8395411718250602,1.0,8/55,6.32%,SLC24A3;ITPR1;TRPC3;TRPC1;ANXA2;CACNB2;ORAI1;ATP2C1
prerank,BMP receptor binding (GO:0070700),0.4508990904079927,1.0025904485803587,0.45993031358885017,1.0,1.0,3/12,4.65%,CDH5;SRC;BMP5
prerank,poly-pyrimidine tract binding (GO:0008187),0.39947335033732745,1.0016910386461466,0.4503937007874016,1.0,1.0,4/23,7.86%,HNRNPC;PABPC4L;PABPC4;DIS3L2
prerank,ribonuclease P activity (GO:0004526),0.4618308961126668,1.0012582672525876,0.4558058925476603,1.0,1.0,6/11,24.92%,POP4;POP7;RPP14;RPP21;RPP30;PRORP
prerank,ionotropic glutamate receptor activity (GO:0004970),-0.3633988256433112,-0.9982657876837312,0.48525469168900803,0.8476109896251119,1.0,5/17,9.11%,GRIA2;GRIN3A;GRIN2B;GRIK2;GRIN1
prerank,sodium channel activity (GO:0005272),0.36762021813779566,0.9975018220715718,0.4801699716713881,1.0,1.0,5/37,7.04%,SCN10A;KCNK1;CACNA1H;SHROOM2;SLC4A11
prerank,lipid phosphatase activity (GO:0042577),0.44696981252655366,0.9969945339135201,0.474036850921273,1.0,1.0,2/14,4.15%,PLPP2;PLPP3
prerank,sodium:proton antiporter activity (GO:0015385),-0.40208051868979,-0.9968577426487297,0.4665071770334928,0.8452556158567617,1.0,5/11,18.66%,SLC9B2;SLC9A1;SLC9A9;SLC9A5;SLC9A2
prerank,sulfuric ester hydrolase activity (GO:0008484),0.4526419808517813,0.9956378216659287,0.47332185886402756,1.0,1.0,1/12,1.29%,SULF1
prerank,UDP-galactosyltransferase activity (GO:0035250),0.4634740249578458,0.9955806189870684,0.4643510054844607,1.0,1.0,2/10,5.83%,B3GALT1;A3GALT2
prerank,deubiquitinase activity (GO:0101005),0.31795414314741494,0.9945568551278787,0.4845869297163995,1.0,1.0,24/88,18.81%,USP50;BRCC3;TNFAIP3;USP8;OTUB2;USP48;MINDY3;MINDY2;USP47;PAN2;USP13;OTUD7B;MINDY4;USP15;USP4;USP35;COPS5;STAMBPL1;STAMBP;USP45;USP53;USP37;PSMD14;USP9X
prerank,RNA polymerase II complex binding (GO:0000993),0.3712990401841354,0.9937983099923158,0.47032640949554894,1.0,1.0,16/32,26.42%,ZNF326;RPRD1B;PAF1;AGO1;SUPT4H1;RPRD1A;RTRAF;NCOA3;RECQL5;DHX9;CDC73;CCAR2;PCF11;URI1;AGO2;HNRNPU
prerank,purine ribonucleoside triphosphate binding (GO:0035639),-0.20013753080047036,-0.9935823049690847,0.5714285714285714,0.8480823439694143,1.0,119/431,21.52%,PRKAG2;DAPK1;KSR1;RHOBTB1;INSR;MYO1B;ENPP1;MAP3K20;MARK1;LATS2;TGM2;CDC42;MTHFS;SNRK;TGFBR1;MFHAS1;AKT3;ATP7A;PDXK;ACVRL1;RPS6KA5;STK17B;RHOBTB3;SIK1;EEF1A1;BLM;MMAA;SMC4;TRNT1;HSPA8;TWF1;GBP3;HARS1;ABCC6;GBP4;MCM6;RHOC;ABCD4;GCH1;CDK6;UBA2;TAP2;SYN1;MKNK2;AKT1;MYH10;GTPBP10;RAB13;CDKL5;VPS4A;TUBB2A;RRAGC;RHOH;RHOB;TRIB1;MKNK1;GBP6;OXSR1;LRRK2;ACLY;ABCD2;PMVK;ABCE1;ABCA2;PXK;SMARCA5;GBP7;SPHK1;MYO18A;SYN3;TUBB6;REM1;MTHFD1L;TUBB4B;ABCG1;RRAGD;MVK;SEPHS1;MTPAP;P2RX7;NOA1;HACL1;PEX6;GBP2;TUBB4A;P2RX4;EIF4G1;ARF5;ANXA6;NOL9;PEX1;RERG;ARL2;TSR1;DHX36;RHOT1;CLP1;RAB4A;DIRAS2;RAB11B;MYH9;KCNJ8;RHOF;PIM1;GNL3;TUBA1C;RAB32;DAPK3;PFKM;RAB2A;TUBA4A;DYNC1LI1;TUBB2B;SYN2;ARF3;RAB7A;RIT1;HRAS;PANK3
prerank,GTPase regulator activity (GO:0030695),0.2914431016378203,0.992642571613094,0.48264984227129337,1.0,1.0,20/212,6.43%,ARHGAP42;SIPA1L1;DLC1;RGS6;RGS14;ARHGAP31;ARHGAP18;ARHGAP32;GRTP1;ARHGAP9;ARAP1;DOCK1;SGSM2;NF1;OPHN1;RACGAP1;GNAQ;GDI1;ARHGAP26;RAB3GAP2
prerank,ribonuclease P RNA binding (GO:0033204),0.4630750824003598,0.9903327151894763,0.4824561403508772,1.0,1.0,5/10,23.14%,POP4;POP7;RPP14;RPP21;RPP30
prerank,solute:anion antiporter activity (GO:0140323),-0.3846933313964765,-0.9898593594202997,0.4722222222222222,0.8522213300489128,1.0,3/14,6.77%,SLC7A11;SLC26A7;SLC26A2
prerank,MAP kinase phosphatase activity (GO:0033549),-0.3901565548197523,-0.9897903647364878,0.4601990049751244,0.8462324931844771,1.0,4/12,21.90%,DUSP10;DUSP3;DUSP7;DUSP1
prerank,neurexin family protein binding (GO:0042043),0.4706877089304671,0.9893894133973249,0.4903677758318739,1.0,1.0,2/10,4.70%,CEL;CPE
prerank,transcription regulatory region nucleic acid binding (GO:0001067),0.2926876120872501,0.9882611331747218,0.49280177187153934,1.0,1.0,52/188,21.85%,BNC2;GLI1;PBX1;ZBTB20;ETV5;CHD3;SPI1;FOXK1;FOXO3;GLIS2;HDAC4;CREB3L1;CTCF;NCOR1;LIN54;SUV39H1;FOXK2;TBX18;FOXJ1;HMGB1;TFEB;EGR1;MZF1;MEN1;NFE2L2;ARID4A;SOX4;SFPQ;ERBB4;FOXC2;YAP1;KMT2D;PER3;DMTF1;PSPC1;TFE3;MTERF3;PPARG;SUV39H2;GABPA;XRCC6;DHX9;CREB3L2;DDIT3;TAF2;ASH2L;PAX2;RUNX1;ZBED4;FOXC1;TCF7L2;JUN
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),0.3464579522977874,0.9871272910532811,0.4669365721997301,1.0,1.0,12/49,11.27%,TNIP3;BRCC3;WDR81;TNFAIP3;UBL7;TNIP1;UIMC1;MINDY2;SHARPIN;OTUD7B;TAB2;HDAC6
prerank,ubiquitin protein ligase binding (GO:0031625),-0.20487807137490666,-0.9870124964657412,0.5609756097560976,0.8476734704638369,1.0,60/254,16.39%,SNCAIP;SMAD3;FZD6;TXNIP;SMAD6;MFHAS1;FOXO1;CKB;TNK2;CCDC50;SQSTM1;SMAD5;RBX1;TRIOBP;HIF1A;BECN1;SPOP;TNFRSF1B;HSPA8;GABARAPL1;DNAJA1;ARIH1;TRAF6;UBE2N;NEDD8;DBT;SLF2;UBE2K;ACTG1;BCL10;ATP6V0C;NAE1;VCP;GPR37;GABARAP;SLF1;SLC22A18;TRIM28;UBE2J1;TPI1;TRIB1;RPL23;ANKRA2;RNF31;AMBRA1;CUL2;RAD18;BAG4;PRKAR2B;HERC2;ERLIN2;YWHAZ;NKD2;FZD8;ISG15;RNF8;TRIM37;LAPTM5;SMC6;CBS
prerank,tau-protein kinase activity (GO:0050321),-0.3455624502387761,-0.9864679576099153,0.44986449864498645,0.8431885952418327,1.0,5/20,12.53%,ROCK2;MARK1;GSK3A;TTBK1;TAOK2
prerank,kinase activity (GO:0016301),-0.24101862661872459,-0.9861994883807964,0.512987012987013,0.8377998975516935,1.0,26/109,14.92%,NADK2;CHKA;LYN;EPHA4;PDXK;CKB;PGM2L1;PAPSS1;ETNK1;AKT1;CAMK2A;PIK3C2A;DGKB;CDKL5;FCSK;PANK1;LRRK2;PMVK;CSNK2A1;IPMK;SPHK1;CDC7;DGKK;MVK;SEPHS1;CDK5R1
prerank,protein kinase C activity (GO:0004697),0.4355488521483083,0.9857389831193887,0.4906937394247039,1.0,1.0,2/14,4.28%,PRKCE;PRKCA
prerank,nucleoside-triphosphatase activity (GO:0017111),0.28664461144476094,0.9837428049329979,0.5130890052356021,1.0,1.0,25/248,8.98%,GNA14;KIF2A;RAP1A;RAB8B;RAB29;MRAS;KIF20B;CHD3;BMS1;VWA8;GNAQ;MFN2;DNM1;RAC2;THTPA;NRAS;KRAS;KIF3C;RHOJ;RAB3A;GNL2;ATL2;IRGM;GNG3;GNAL
prerank,proton transmembrane transporter activity (GO:0015078),0.35715540259786066,0.9808194078693528,0.46176470588235297,1.0,1.0,8/39,15.51%,OTOP1;COX5A;SLC4A11;COX15;NNT;COX5B;SLC46A1;CLCN5
prerank,carboxypeptidase activity (GO:0004180),0.36064604564346603,0.979826443775355,0.4843304843304843,1.0,1.0,7/35,9.66%,NAALAD2;AGBL4;CPE;CPA2;SCPEP1;BLMH;MINDY2
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),0.3642716361875782,0.9794258336638862,0.48516320474777447,1.0,1.0,18/33,26.42%,ZNF326;RPRD1B;LLPH;PAF1;AGO1;SUPT4H1;RPRD1A;RTRAF;NCOA3;RECQL5;DHX9;CDC73;CCAR2;PCF11;URI1;AGO2;TBP;HNRNPU
prerank,anion channel activity (GO:0005253),0.33270349833486823,0.9788287446923755,0.47903430749682335,1.0,1.0,9/61,12.25%,VDAC2;LRRC8D;SLC26A9;ANO6;GABRR2;GABRG2;BEST1;GABRG1;GABRB3
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",0.3883561827547242,0.9776640437422117,0.4856711915535445,1.0,1.0,9/25,10.01%,PHLDA3;SESTD1;KIF16B;PLEKHA4;OBSCN;TTPA;PLEK;GAB2;MAPKAP1
prerank,hyaluronic acid binding (GO:0005540),-0.4104367598209195,-0.977405318437336,0.49295774647887325,0.85478689109013,1.0,4/10,25.90%,LAYN;C1QBP;LYVE1;CHODL
prerank,low-density lipoprotein particle binding (GO:0030169),0.41318453573925534,0.9737085493393967,0.47929936305732485,1.0,1.0,1/16,0.50%,CDH13
prerank,cytokine activity (GO:0005125),0.29929330292912515,0.9720405455933254,0.5302857142857142,1.0,1.0,9/131,5.38%,INHBB;IL19;WNT10A;WNT2B;IL1A;WNT16;BMP5;WNT5A;BMP15
prerank,receptor tyrosine kinase binding (GO:0030971),0.3374758015039,0.9701733261912154,0.48874172185430464,1.0,1.0,8/56,10.34%,LRP4;SOCS5;ITGAX;PTPN14;TRADD;PIK3R2;GAB2;CBLB
prerank,chloride transmembrane transporter activity (GO:0015108),-0.35197355680523323,-0.9678559416498855,0.4973958333333333,0.8740248368482902,1.0,4/16,13.71%,SLC26A7;SLC26A2;SLC12A5;SLC1A1
prerank,chemokine receptor binding (GO:0042379),-0.2844673770533859,-0.967268516684891,0.4930555555555556,0.8696410419116511,1.0,25/35,52.22%,CXCL16;CXCL12;CCL13;CCL19;CCL2;CXCL10;CCL25;CCL28;CCRL2;CCL5;CXCL5;CCL11;CCL15;CXCL1;CCL4;PF4;CCL7;PPBP;CCL8;CKLF;CCL1;CCL3;XCL1;CXCL13;CXCL2
prerank,outward rectifier potassium channel activity (GO:0015271),-0.399352164990745,-0.9666790056360383,0.47877358490566035,0.8651818674132377,1.0,2/11,6.28%,KCNK2;KCNT1
prerank,protein serine/threonine kinase activity (GO:0004674),0.2763843518034641,0.9662264013392038,0.5361875637104995,1.0,1.0,43/335,9.79%,PLK2;FAM20C;CDK15;PRKCE;CAMK2D;EGFR;MINK1;CLK1;STK38;MAP3K1;CASK;MAPK10;EIF2AK3;BMPR1B;PRKCA;CDKL3;LIMK2;IRAK3;ACVR1C;TRIO;HIPK1;PIK3R4;BRSK1;NEK7;CDK13;BCKDK;CDK7;BMP2K;CLK4;STK38L;MAPK7;MAP3K5;SRPK1;DYRK1A;NRBP2;KALRN;CSNK1G3;STK24;STK3;GSK3B;RPS6KA3;MASTL;CSNK1A1
prerank,chemokine binding (GO:0019956),0.37167518924293025,0.9657265460795977,0.4805389221556886,1.0,1.0,5/30,21.16%,ACKR3;HMGB1;CCR5;ITGB1;CX3CR1
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),-0.2960781184707698,-0.9637912897287659,0.5107692307692308,0.866798958986362,1.0,7/33,10.31%,RNF217;RNF125;ARIH1;TRAF6;RNF144B;UBA2;RPS3
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),0.45158890488038717,0.9637462200204964,0.49466192170818507,1.0,1.0,3/11,10.60%,AKR1B10;RDH14;RDH13
prerank,protein phosphatase 2A binding (GO:0051721),-0.31745169305773446,-0.9613608323489847,0.5116959064327485,0.8672288969477248,1.0,7/23,14.30%,MFHAS1;FOXO1;CTTNBP2NL;GRIN3A;IGBP1;SPHK1;MAPT
prerank,protein kinase C binding (GO:0005080),-0.26847611545181715,-0.9605356309167218,0.4965034965034965,0.863642431862089,1.0,19/43,24.20%,GRK5;PARD6G;SQSTM1;HDAC7;HDAC9;ADCY4;PDLIM5;DACT2;HSPB1;HINT1;RACK1;PICK1;CAVIN3;NELL1;TOP2B;TOP2A;ADCY6;PRKCB;DSP
prerank,monovalent cation:proton antiporter activity (GO:0005451),-0.37758269644798403,-0.9597553505882627,0.5158150851581509,0.8598694395744263,1.0,5/12,18.66%,SLC9B2;SLC9A1;SLC9A9;SLC9A5;SLC9A2
prerank,ubiquitin conjugating enzyme binding (GO:0031624),-0.30691327722446926,-0.9584619597789293,0.5166666666666667,0.8575431893227049,1.0,5/27,7.26%,RNF217;RNF125;ARIH1;TRAF6;RNF144B
prerank,hormone receptor binding (GO:0051427),0.4202805507569052,0.9581622166953101,0.5276872964169381,1.0,1.0,6/14,26.35%,PTHLH;TYK2;JAK1;SOCS2;ADCYAP1;CCK
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",0.377141946088726,0.9558469746770155,0.5068493150684932,1.0,1.0,6/23,10.01%,PHLDA3;SESTD1;KIF16B;SH3PXD2B;PLEKHA4;MAPKAP1
prerank,snoRNA binding (GO:0030515),0.3629929507786436,0.9556730584523784,0.5091463414634146,1.0,1.0,6/30,12.72%,NUFIP1;BMS1;NOP14;SNU13;NOP56;NOP58
prerank,methyl-CpG binding (GO:0008327),-0.3231761234872438,-0.9551191471199282,0.5069637883008357,0.8604726511576922,1.0,5/22,13.17%,ZBTB38;CXXC5;WDR77;ZBTB21;LRWD1
prerank,cyclic nucleotide binding (GO:0030551),-0.31560234789483854,-0.9543660935131074,0.53125,0.8568302553354162,1.0,6/21,12.94%,RAPGEF2;PDE5A;KCNH1;PDE10A;PDE2A;PDE4A
prerank,"DNA binding, bending (GO:0008301)",0.424682267162682,0.9542478928339924,0.5117056856187291,1.0,1.0,3/14,11.04%,FOXD1;HMGB1;SAP30L
prerank,thiol-dependent deubiquitinase (GO:0004843),0.30546555787830876,0.9537940407408305,0.5320197044334976,1.0,1.0,22/83,18.81%,USP50;BRCC3;TNFAIP3;USP8;OTUB2;USP48;MINDY3;USP47;PAN2;USP13;OTUD7B;USP15;USP4;USP35;COPS5;STAMBPL1;STAMBP;USP45;USP53;USP37;PSMD14;USP9X
prerank,histone deacetylase activity (GO:0004407),0.39641374766515214,0.953747100344627,0.5048387096774194,1.0,1.0,5/19,11.27%,HDAC4;SIRT3;SIRT7;HDAC2;HDAC6
prerank,ribosomal small subunit binding (GO:0043024),-0.3409976797945108,-0.9517284065457533,0.5198019801980198,0.8582212135421294,1.0,9/17,28.27%,NPM1;CPEB2;MTIF2;ABCE1;PIM1;EIF1B;DHX29;ERAL1;DDX3X
prerank,tubulin binding (GO:0015631),0.27746486183741004,0.9516800245353648,0.5865687303252886,1.0,1.0,64/296,17.35%,DLEC1;RGS14;GTSE1;HOOK2;KIF2A;SPEF1;KIF20B;TTLL1;TRPV4;RACGAP1;FAM83D;AGBL4;DNM1;SMC3;KIF16B;CAPN6;BRSK1;KIF7;PPP1R42;IFT81;SPAST;KIF3C;DAG1;CKAP5;SGIP1;KIF13A;PAFAH1B1;EML1;FNTA;REEP3;IFT74;TUBGCP5;TPR;S100A9;CENPJ;APC;HDAC6;HOOK3;MAP4;CCDC170;RAB11FIP5;NDE1;MAP9;INO80;ARL8B;KIF26A;KIF5A;MAPRE2;EMD;KIF5B;HTT;POLB;FAM161A;CRIPT;TBCE;EZR;B9D2;SYBU;ARHGEF7;TTLL9;AGBL1;CEP57;CHP1;SETD2
prerank,metallocarboxypeptidase activity (GO:0004181),-0.2999442728882975,-0.950683512685417,0.5457227138643068,0.8553774000637556,1.0,8/26,18.40%,AEBP1;FOLH1;AGBL5;CPXM2;CPD;CPA6;ACE2;VASH1
prerank,amino acid:sodium symporter activity (GO:0005283),0.4401175037556261,0.9497858138712391,0.511986301369863,1.0,1.0,2/11,5.54%,SLC38A2;SLC6A13
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),-0.38594120979988766,-0.9496618722467812,0.5264367816091954,0.8524292123572387,1.0,6/12,17.45%,CDK12;CDK9;CDK6;CDK8;CDK4;CDK19
prerank,ribonuclease activity (GO:0004540),0.32606816492912377,0.9488757574691616,0.5353403141361257,1.0,1.0,16/56,23.66%,PIWIL2;EXOSC5;N4BP1;DIS3L2;AGO1;EXOSC10;CNOT7;EXOG;ERN1;DICER1;TSNAX;RNASE3;EXOSC7;SMG6;RNASE1;RNASEH1
prerank,microtubule motor activity (GO:0003777),0.33324773697427146,0.9476074662950321,0.5235531628532974,1.0,1.0,10/51,13.61%,KIF2A;KIF20B;SMC3;KIF16B;KIF7;KIF3C;KIF13A;KIF26A;KIF5A;KIF5B
prerank,protein kinase binding (GO:0019901),0.2697178780167077,0.945681506926269,0.6348088531187123,1.0,1.0,63/480,11.31%,ROR2;CAV1;TRIB2;UTRN;CSPG4;CEACAM1;CNKSR2;SLC12A2;CCND3;FAM83A;KCNA5;GYS1;NELL2;AXIN1;PARD6B;CDH5;STK38;MAP3K1;SPRED1;TRPV4;TJP2;CAV2;RACGAP1;PRKAG1;FOXO3;SOX9;SLC12A4;FAM83D;HNRNPA0;DNM1;RAC2;IRAK3;DACT1;PTPRC;IBTK;BANK1;TOM1L1;ANKRD2;ADAM10;TRIM21;SRCIN1;MSH2;MAPK7;RARA;FBXO5;PRKAR2A;PTPRJ;TNIP1;TEX14;IRGM;PLEK;GSK3B;TOM1L2;TICAM1;MAPKAP1;FERMT2;LAT;ADRA2A;TPR;CENPJ;APC;PRKCSH;SPAG9
prerank,adenylate cyclase binding (GO:0008179),0.44543227048794254,0.9432829092801885,0.5129087779690189,1.0,1.0,2/10,5.34%,AKAP12;ADCY5
prerank,ubiquitin-like protein ligase binding (GO:0044389),-0.19227733883917558,-0.9426417459185726,0.7368421052631579,0.8644427926357993,1.0,60/269,16.39%,SNCAIP;SMAD3;FZD6;TXNIP;SMAD6;MFHAS1;FOXO1;CKB;TNK2;CCDC50;SQSTM1;SMAD5;RBX1;TRIOBP;HIF1A;BECN1;SPOP;TNFRSF1B;HSPA8;GABARAPL1;DNAJA1;ARIH1;TRAF6;UBE2N;NEDD8;DBT;SLF2;UBE2K;ACTG1;BCL10;ATP6V0C;NAE1;VCP;GPR37;GABARAP;SLF1;SLC22A18;TRIM28;UBE2J1;TPI1;TRIB1;RPL23;ANKRA2;RNF31;AMBRA1;CUL2;RAD18;BAG4;PRKAR2B;HERC2;ERLIN2;YWHAZ;NKD2;FZD8;ISG15;RNF8;TRIM37;LAPTM5;SMC6;CBS
prerank,exoribonuclease activity (GO:0004532),0.4289873665900311,0.9420053618620883,0.5431034482758621,1.0,1.0,3/12,9.98%,EXOSC5;EXOSC10;CNOT7
prerank,cytochrome-c oxidase activity (GO:0004129),0.4117793944490918,0.9414658617441023,0.5483870967741935,1.0,1.0,3/15,13.17%,COX5A;COX15;COX5B
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),0.43083852182605503,0.9408304854701345,0.5303292894280762,1.0,1.0,2/11,5.22%,SLC22A3;SLC25A20
prerank,miRNA binding (GO:0035198),0.35468365228241944,0.9407429808490854,0.532258064516129,1.0,1.0,13/30,25.77%,DND1;RBM10;ZNF346;AGO1;PUM2;SPOUT1;PUM1;ELAVL1;ZC3H7B;DDX21;FMR1;PNPT1;AGO2
prerank,sequence-specific mRNA binding (GO:1990825),-0.3942581522456996,-0.9392055689054731,0.5480984340044742,0.8678986890135562,1.0,5/10,28.00%,SSB;LARP6;DHFR;SHFL;RBM24
prerank,bHLH transcription factor binding (GO:0043425),-0.3295087303513552,-0.9383266120459938,0.5413333333333333,0.8648790155955819,1.0,5/19,12.55%,SMAD3;LMO2;MAP3K10;KDM1A;SP1
prerank,neuropeptide receptor binding (GO:0071855),0.4185657158834609,0.9360411152067576,0.5251215559157212,1.0,1.0,5/14,28.12%,APLN;AGRP;PPY;SHANK1;NPY
prerank,H4 histone acetyltransferase activity (GO:0010485),0.44017561603894734,0.9359881410588303,0.5407279029462738,1.0,1.0,5/10,19.21%,HAT1;MSL3;KAT8;NAA40;NAA60
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),0.2779200071638534,0.9359119298268532,0.6210295728368017,1.0,1.0,30/181,14.88%,MDFIC;PPARGC1A;NFATC1;LDB2;SPI1;HDAC4;DACT1;BHLHE40;TAF4B;ANKRD2;ANXA4;NRIP1;TEAD3;NCOR1;PIAS2;ISL1;DDRGK1;GSK3B;PTPRT;HDAC2;NCOR2;FAF1;NCOA3;NFE2L2;CREBBP;NCOA2;TCERG1;BAZ2A;PSMA6;WWP2
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),0.34694242178256424,0.9358752506399741,0.532561505065123,1.0,1.0,7/34,16.02%,UBE2L6;UBE2E2;UBE2I;UBE2J2;UBE2D3;UBE2D1;UBE2R2
prerank,glycerophospholipid flippase activity (GO:0140333),0.4261181989405074,0.9338197649285592,0.5460992907801419,1.0,1.0,4/11,9.87%,ATP8B1;ATP11C;ATP8B2;ATP10B
prerank,intracellular ligand-gated ion channel activity (GO:0005217),0.43585881849660707,0.9326418159258458,0.5401709401709401,1.0,1.0,1/11,1.41%,ITPR3
prerank,filamin binding (GO:0031005),0.42592835825798536,0.930912856583686,0.542314335060449,1.0,1.0,1/11,1.25%,CEACAM1
prerank,Notch binding (GO:0005112),-0.3027821714875765,-0.9302827173984621,0.5636856368563685,0.8796515996361767,1.0,6/22,9.65%,SNED1;CCN3;GALNT11;JAG2;KCTD10;SNW1
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",0.4487991882334954,0.9302409388699964,0.5598591549295775,1.0,1.0,6/10,28.37%,GLCE;RPE;DSE;GNE;DSEL;RENBP
prerank,E-box binding (GO:0070888),-0.27632938630704484,-0.9285326633125902,0.5899053627760252,0.878213485310103,1.0,2/34,3.98%,TCF4;MITF
prerank,carboxylic acid binding (GO:0031406),-0.2673549783839401,-0.9275389554683188,0.5738255033557047,0.8750368811313609,1.0,11/38,20.39%,UBR1;NOS3;GRIN3A;GRIN2B;GRIN1;GLRA2;MAG;NOS1;GCLC;CASTOR2;CASTOR1
prerank,core promoter sequence-specific DNA binding (GO:0001046),-0.27555930762242115,-0.9252793498243871,0.5912162162162162,0.8751273620149477,1.0,8/35,18.12%,POU2F1;FOXP1;NPM1;HDAC1;DRAP1;TBPL1;DR1;TAF1C
prerank,calcium ion binding (GO:0005509),0.26806983769853987,0.9248903638682004,0.6567622950819673,1.0,1.0,29/323,9.05%,THBS4;SMOC2;CDH13;GUCA1A;ITPR2;ITPR3;CDH11;SLC25A12;GLCE;CDH5;ACER3;KCNIP4;COLEC11;CDH17;CDH9;TPD52;S100A6;NUCB1;CALR3;S100A7A;ANXA4;LTBP4;RCN1;CDH2;S100B;EML1;PLSCR1;CASQ2;CD320
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),-0.2907909864543469,-0.924825872724439,0.5753846153846154,0.87101028700009,1.0,2/29,1.72%,PRKAG2;PKIG
prerank,metal ion:proton antiporter activity (GO:0051139),-0.3510024767483903,-0.9201020028058938,0.5555555555555556,0.877016031047747,1.0,5/13,18.66%,SLC9B2;SLC9A1;SLC9A9;SLC9A5;SLC9A2
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),-0.38901776861341775,-0.9166099045820029,0.5786924939467313,0.8804744822609137,1.0,2/10,8.57%,PIK3R3;PIK3C2A
prerank,nuclear export signal receptor activity (GO:0005049),0.42298655625239834,0.915350886787403,0.579225352112676,1.0,1.0,6/11,26.06%,CSE1L;RAN;XPO5;XPO4;XPO7;RANBP17
prerank,RNA 7-methylguanosine cap binding (GO:0000340),0.4196401401643464,0.9142691796806193,0.5735537190082645,1.0,1.0,2/12,9.69%,CYFIP2;EIF4E
prerank,CCR chemokine receptor binding (GO:0048020),-0.2829469399289882,-0.9132435378295349,0.5956112852664577,0.8832403081157914,1.0,20/28,52.12%,NES;CCL13;CCL19;CCR2;CCL2;CCL25;CCRL2;CCL5;CCL11;CCL15;CCL4;CCL7;CCL8;MSMP;DEFB130A;CCL1;CCL3;XCL1;DEFB1;CXCL13
prerank,heme binding (GO:0020037),0.3045958826279184,0.9123112761264363,0.583011583011583,1.0,1.0,9/65,13.27%,STC2;PXDN;CYP2S1;SRC;COX15;SDHD;DGCR8;PGRMC1;CYP2U1
prerank,protein phosphorylated amino acid binding (GO:0045309),-0.26246904873938737,-0.9117960246523076,0.6531365313653137,0.8813111197735708,1.0,10/42,12.62%,PTPN3;PIK3R1;PIK3R3;SHE;PLCG2;CRK;CRKL;LDLRAP1;BCAR3;SAMSN1
prerank,voltage-gated cation channel activity (GO:0022843),-0.22443607133780363,-0.9099488347450406,0.6855345911949685,0.8804837623841612,1.0,37/97,35.00%,CACNA2D3;KCNB1;KCNMA1;GRIN3A;CACNB2;GRIN2B;KCNH1;KCNB2;KCNH5;GRIN1;CACNG7;KCNC3;CACHD1;OPRM1;CACNA2D4;TPCN2;KCNA2;KCND1;LRRC38;CACNG4;CACNA1B;KCNH2;KCNH8;HCN2;CACNA1D;KCNQ5;HVCN1;KCNQ1;LRRC55;KCNC4;CACNA2D1;CACNA1C;KCNG2;CACNB3;KCNH4;HCN4;CACNG5
prerank,phosphatidylinositol binding (GO:0035091),0.29600712353519415,0.909532169737871,0.6118500604594922,1.0,1.0,7/91,6.95%,PIGU;ITPR2;ITPR3;PITPNC1;SESTD1;ZFYVE16;SNX10
prerank,omega peptidase activity (GO:0008242),0.290781330349063,0.9094541083706539,0.603680981595092,1.0,1.0,23/89,18.81%,USP50;BRCC3;TNFAIP3;USP8;OTUB2;USP48;MINDY3;USP47;PAN2;USP13;OTUD7B;USP15;USP4;USP35;COPS5;GGT1;STAMBPL1;STAMBP;USP45;USP53;USP37;PSMD14;USP9X
prerank,organic cation transmembrane transporter activity (GO:0015101),0.3878969139408868,0.9073221960961186,0.5889070146818923,1.0,1.0,3/16,12.30%,SLC29A4;SLC22A3;SLC25A26
prerank,high voltage-gated calcium channel activity (GO:0008331),-0.37943516998949545,-0.905694338062445,0.5806451612903226,0.8853395697135445,1.0,5/10,34.16%,CACNB2;CACNA1B;CACNA1D;CACNA1C;CACNB3
prerank,DNA secondary structure binding (GO:0000217),0.33672497189912926,0.9035150429480753,0.5834564254062038,1.0,1.0,7/31,12.90%,MSH6;KMT2A;LIN54;MSH2;HMGB1;MEN1;GEN1
prerank,mannosyltransferase activity (GO:0000030),-0.29475393867168875,-0.9032774261383015,0.5884057971014492,0.8855904071807952,1.0,3/21,4.35%,TMTC2;TMTC1;DPM1
prerank,phospholipase activator activity (GO:0016004),0.42772882562926595,0.9031988302256792,0.565587734241908,1.0,1.0,4/10,18.55%,SRC;BTK;STX4;PDPK1
prerank,metal ion binding (GO:0046872),0.25760608947413594,0.9023827457174085,0.749238578680203,1.0,1.0,52/477,9.22%,THBS4;SMOC2;CDH13;GUCA1A;ITPR2;ITPR3;CDH11;SLC25A12;XYLT2;GLCE;CDH5;ACER3;TDG;MSH6;KCNIP4;COLEC11;CDH17;STK38;CDH9;TPD52;HMGCLL1;S100A6;NUCB1;IRAK3;THTPA;ACVR1C;CALR3;BRSK1;DXO;S100A7A;ANXA4;CERK;ABL2;LTBP4;NLRC4;STK38L;CLYBL;MSH2;MAP3K5;RCN1;CDH2;DIS3L2;PGM1;SRPK1;S100B;EML1;FOXK2;RPE;PLSCR1;CASQ2;CD320;STK3
prerank,single-stranded telomeric DNA binding (GO:0043047),0.40579408373471776,0.9009552311616935,0.5532286212914486,1.0,1.0,6/11,28.07%,STN1;TERF2;RAD50;RPA2;RPA1;TERF2IP
prerank,RNA binding (GO:0003723),0.2520570846256693,0.9007030973774495,0.875,1.0,1.0,347/1321,22.77%,AHNAK;DCN;DHX34;DHX8;PPARGC1A;RPSA;HNRNPC;ASS1;MYBBP1A;CCDC9;CSTF1;CDC42EP4;NUFIP1;FXR2;RBFOX2;HOXB6;DDX27;DND1;QKI;SF3B2;SF3B1;CHD3;BMS1;GIGYF2;PCBP2;RBM8A;DCP1B;SCG3;ADD1;MRPL37;RBM10;MRPL43;UBE2I;CELF1;SRSF4;BUD23;HNRNPA0;NOL8;SECISBP2;PABPC4L;DNM1;CHD2;SAMD4B;SERPINH1;RPUSD2;CAVIN1;SNRPF;HADHB;RBM15B;ZNF326;SON;PABPC4;LRRC59;DXO;ZNF346;HNRNPR;TLR7;CDK13;PUS7;TNS1;KPNA2;TUT1;ZC3H15;FASTKD2;SF3B5;C1D;EIF5B;PPIE;MRPS28;MRPS35;ZCCHC24;N4BP1;LLPH;RARS2;RDX;PRPF3;UTP15;NCOA5;FAM120A;ZFR;ARHGEF1;ALDH18A1;DDX17;CSTF3;CHERP;GNL2;TOP3B;MSI2;DDX46;NOP14;RBM22;ILF2;GOLGB1;SRPK1;RBM5;IGF2BP2;ELAVL2;GPATCH8;SIDT2;DARS1;PCDHGA9;NAF1;RPL35;AATF;WRAP53;AGO1;TCF20;DCAF13;LIN28B;PTCD3;SNU13;SLTM;MRPL41;FLNB;MECP2;CELF2;STAU2;HMGB1;PES1;POP4;EXOSC10;EIF4E;FCF1;CELF4;RPS13;HDAC2;RBM33;RBM27;HNRNPM;PRRC2A;EIF1AX;EIF1;TFB2M;KARS1;RRP12;PTBP3;MRPS15;DQX1;PPHLN1;RBM26;KHDRBS2;ZYX;TPR;POP7;RTRAF;LONP1;DDX43;SRPK2;ATXN2;ILF3;DBR1;MRPL3;LUC7L2;UPF3B;RPF1;UTP14A;CFAP20;HEXIM1;SREK1;TOP1;MAP4;ETF1;SRRM2;ANXA11;DGCR8;CSDE1;UBAP2L;ADAT1;NOP56;PTBP2;RPP14;STRBP;RBM18;LTA4H;NOP58;TEP1;KNOP1;SMG7;TAF15;NSUN5;ZFP36L2;DDX6;NUCKS1;TCERG1;SNRPA1;SFPQ;ALKBH1;NOL7;AIMP1;BAZ2A;NSRP1;MEX3A;TEFM;P4HB;PPIG;FXR1;UBA1;DDX42;CHCHD1;TIAL1;DDX52;RTN4;BZW1;TXN;PUM2;FASTKD1;PPIL4;PYM1;PSMA6;MRPL16;DICER1;REXO4;RBM38;CTNNA1;DHX16;PDCD11;TRA2B;SF1;BICC1;SUGP1;RAN;SEC23IP;CPEB3;ATP5F1A;FLYWCH2;ATP5F1C;DHX57;YWHAG;ZCCHC17;SPOUT1;SRRT;TSNAX;EZR;PSPC1;MRPL40;MRPL22;THOC5;PRKRA;MRM1;YWHAE;DHX40;SYNCRIP;GNL3L;CWC22;RTF1;XPO5;GLRX3;UBFD1;HMGN2;MRPL4;SPTBN1;DARS2;TYW5;ARCN1;ZCCHC7;NOC3L;PTCD1;SARS2;OAS2;NAP1L1;GTPBP1;MRPL2;SRFBP1;STRAP;RPUSD4;PNLDC1;SRSF3;ZNFX1;PEG10;SRBD1;CNOT1;TOE1;G3BP1;HARS2;LSM3;XRCC6;MTREX;GCN1;DHX38;PNISR;DHX9;YBX3;DDX56;SEPSECS;HNRNPD;SUMO1;MBNL2;LARP4;NCBP3;RPP21;NME1;NUDT5;TRMT1L;SAP18;EIF4G2;CS;ZC3H13;JAKMIP1;MKRN1;NUDT21;CCT3;TDRD9;RRS1;GFM1;SRSF12;NKAP;USO1;KCTD12;ADARB1;SRSF11;TIA1;HABP4;TSFM;MRPS7;LRRC47;CCAR2;ZBED4;ENO1;EXOSC7;SRSF10;DDX11;PUM1;SRP68;HSPA9;SECISBP2L;ELAVL1;JUN;FNDC3B;DDX25;YTHDC1;NMD3;THG1L;TFB1M;TRMT1;MRPL11;HELB;SMG6;HNRNPA3;GANAB;PKM;NOL12;PCF11;LSM2;JMJD6;ZC3H18;CPSF2;RBM6
prerank,sodium ion transmembrane transporter activity (GO:0015081),0.35297834236279046,0.8994389969177577,0.5929078014184397,1.0,1.0,6/27,11.17%,SLC8B1;SLC12A3;KCNK1;SLC4A11;SLC9A7;SLC9A6
prerank,L-glutamate transmembrane transporter activity (GO:0005313),0.391344250362611,0.8972792724900693,0.5618556701030928,1.0,1.0,5/14,12.99%,SLC25A12;SLC1A7;SLC1A6;SLC25A13;SLC25A22
prerank,potassium ion antiporter activity (GO:0022821),-0.3305042182182424,-0.896148304377821,0.6483790523690773,0.8971107295482998,1.0,5/15,18.66%,SLC24A3;SLC9A1;SLC9A9;SLC9A5;SLC9A2
prerank,chloride channel regulator activity (GO:0017081),0.3944047686933644,0.8951628468605153,0.5849056603773585,1.0,1.0,4/14,18.61%,STX1A;VAMP8;SGK1;CHRNA7
prerank,kinase inhibitor activity (GO:0019210),0.33562049342860506,0.8932257815768165,0.5977011494252874,1.0,1.0,12/33,22.31%,PARVA;SPRY4;GMFB;MAPK8IP1;HEXIM1;CDKN1C;SOCS1;WARS1;NCK1;GSKIP;YWHAB;TAOK3
prerank,MHC protein binding (GO:0042287),0.361458450370331,0.8931836116551496,0.573820395738204,1.0,1.0,5/20,16.11%,TAPBP;CD81;ABCB9;ATP5F1A;LAG3
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),0.3544659374043725,0.8929710077986364,0.6152647975077882,1.0,1.0,6/22,11.08%,WDR81;TNFAIP3;UIMC1;MINDY2;OTUD7B;TAB2
prerank,lipoprotein particle binding (GO:0071813),0.36849373184868406,0.8906520499096304,0.6078740157480315,1.0,1.0,1/20,0.50%,CDH13
prerank,growth factor receptor binding (GO:0070851),0.2855526473860602,0.8906505626969008,0.6420664206642066,1.0,1.0,19/95,17.09%,FGF7;EFEMP1;GLMN;FGF1;SRC;FER;NCSTN;PTPRJ;FGF18;PLSCR1;ATXN2;IL6ST;SNX2;ERN1;HBEGF;ERBB4;PIBF1;SNX1;ITGA5
prerank,mitogen-activated protein kinase binding (GO:0051019),0.34033782738742485,0.8898758861400698,0.6057838660578386,1.0,1.0,6/29,13.04%,NFATC1;MAPK7;PTPRJ;TNIP1;TPR;DUSP8
prerank,nuclear receptor coactivator activity (GO:0030374),0.30869888883424706,0.8897858833285602,0.6284584980237155,1.0,1.0,10/52,15.22%,PPARGC1A;SLC30A9;PSMC3IP;MED13;TMF1;NCOA3;NCOA2;BRD8;CCDC62;MED12
prerank,poly(A) binding (GO:0008143),-0.30615591149249427,-0.8882168222845713,0.6229508196721312,0.9105678753954698,1.0,5/21,9.67%,RBPMS;RBMS1;RBMS3;RBMS2;PABPC1
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),-0.36598569491860533,-0.8836067164006879,0.6117136659436009,0.9157199740339776,1.0,4/10,24.90%,ANKRD13A;DNAJB2;LAPTM5;ANKRD13D
prerank,phospholipid transfer activity (GO:0120014),-0.30534821356801445,-0.8834605139489072,0.625974025974026,0.9108136999939113,1.0,6/21,14.15%,PLTP;PITPNB;TNFAIP8L3;C2CD2L;PRELID2;PRELID3A
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",0.3773794694503083,0.8833331893816556,0.5865384615384616,1.0,1.0,2/16,5.82%,ALOXE3;BCO1
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),-0.3682119061702989,-0.8832785429383819,0.6106194690265486,0.906031835338396,1.0,5/11,23.68%,NUDT3;NUDT11;DCP2;NUDT16;NUDT16L1
prerank,ankyrin binding (GO:0030506),0.3657203081661874,0.883019879058268,0.6043613707165109,1.0,1.0,6/19,20.19%,PTPRC;OBSCN;FLNC;CDH1;SPTBN1;SPTB
prerank,mRNA binding (GO:0003729),0.2599780746259048,0.8826146198651772,0.7060063224446786,1.0,1.0,44/249,15.01%,HNRNPC;FXR2;RBFOX2;DND1;QKI;SF3B1;PCBP2;RBM8A;DCP1B;CELF1;SRSF4;HNRNPA0;SECISBP2;PABPC4L;SAMD4B;PABPC4;DXO;HNRNPR;TUT1;PPIE;N4BP1;CSTF3;RBM5;IGF2BP2;ELAVL2;RPL35;CELF2;CELF4;RPS13;HNRNPM;PTBP3;KHDRBS2;TPR;LUC7L2;UPF3B;ETF1;SRRM2;PTBP2;DDX6;NSRP1;FXR1;PUM2;TRA2B;SF1
prerank,ubiquitin-dependent protein binding (GO:0140036),-0.37254936026106295,-0.8796280750562898,0.5892857142857143,0.9093844969852807,1.0,5/10,26.19%,ANKRD13A;DNAJB2;LAPTM5;ANKRD13D;DNAJC2
prerank,organic anion transmembrane transporter activity (GO:0008514),0.2698197576491817,0.879458699090098,0.6789838337182448,1.0,1.0,22/134,11.57%,SLC35A1;SLC4A3;SLC25A12;SLC35D3;SFXN2;SLC26A9;SLC38A2;SLC1A7;SLC35B2;SLC27A1;SLC22A3;ABCC1;SLC6A13;SLC2A2;SLC4A11;SLC52A1;SLC35D2;SLC7A2;RTBDN;SLC16A1;SLC25A13;SLC3A1
prerank,epidermal growth factor receptor binding (GO:0005154),0.3459995040834046,0.8792839551640393,0.6161137440758294,1.0,1.0,8/25,16.42%,EFEMP1;FER;PLSCR1;ATXN2;SNX2;HBEGF;ERBB4;SNX1
prerank,carboxy-lyase activity (GO:0016831),0.347173220294703,0.8791583720068182,0.6124620060790273,1.0,1.0,3/23,8.58%,PISD;AZIN2;ACOD1
prerank,R-SMAD binding (GO:0070412),-0.3076124361910261,-0.878744759198382,0.6426666666666667,0.9062751127666128,1.0,2/18,1.65%,SMAD3;SMAD6
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.3408783700343731,0.8763382748616863,0.5922330097087378,1.0,1.0,8/24,23.51%,AK5;PPIP5K2;PPIP5K1;AK7;ITPKA;NME1;AK9;NME6
prerank,CXCR chemokine receptor binding (GO:0045236),-0.3591409848203889,-0.8761895978077922,0.6162790697674418,0.9066616668332215,1.0,2/11,10.15%,CXCL12;YARS1
prerank,methyltransferase activity (GO:0008168),0.3089002000996964,0.8755155739939549,0.6460055096418733,1.0,1.0,9/46,13.63%,MRM2;BUD23;SUV39H1;LRTOMT;GAMT;FTSJ1;ARMT1;MGMT;LCMT1
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),0.38747115523591835,0.8738025668349112,0.6142384105960265,1.0,1.0,1/14,1.84%,KCNA5
prerank,FAD binding (GO:0071949),0.35105680617702123,0.8735962705768754,0.6330275229357798,1.0,1.0,1/24,0.45%,PRODH
prerank,protein phosphatase regulator activity (GO:0019888),-0.23440088877986912,-0.8728777289650252,0.7107438016528925,0.9088564513947781,1.0,20/53,29.85%,PPP2R2B;PPP4R4;CALM1;IGBP1;PPP4R1;CALM3;PPP2R5A;RCAN2;PPP2R5E;STYXL1;PPP4R2;PTN;PPP2R1A;ARPP19;PPP2R5D;DMPK;PPP2R2D;SHOC2;PPP1R16B;PPP1R15A
prerank,four-way junction DNA binding (GO:0000400),0.3609613377136517,0.8719050586593163,0.6189683860232945,1.0,1.0,5/17,12.90%,MSH6;MSH2;HMGB1;MEN1;GEN1
prerank,MAP kinase activity (GO:0004707),-0.33049599634800464,-0.8714318600459545,0.6175,0.9068089856986911,1.0,2/14,6.93%,MAPK4;MAPK12
prerank,calcium activated cation channel activity (GO:0005227),-0.3149436534476518,-0.8709739018306262,0.6640826873385013,0.9029129476394869,1.0,4/17,10.42%,ANO1;KCNMA1;TMEM63B;KCNN2
prerank,phosphatidic acid binding (GO:0070300),0.3540446181894419,0.8684078866317159,0.6138933764135702,1.0,1.0,6/19,10.01%,PITPNC1;SESTD1;GRAMD1B;PACSIN2;RAPGEF6;MAPKAP1
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",0.2840626415482731,0.8674303086464803,0.6845386533665836,1.0,1.0,15/74,15.61%,FAM20C;DGKA;HK2;DGKZ;COASY;ADPGK;GALK1;IDNK;GALK2;GK;HYKK;PIK3C3;NT5C3A;PANK2;FGGY
prerank,nucleoside diphosphate kinase activity (GO:0004550),0.377684296866846,0.8674126047071756,0.6099290780141844,1.0,1.0,1/14,1.39%,AK5
prerank,ligand-gated cation channel activity (GO:0099094),0.28457669028051624,0.8673973920018669,0.6547029702970297,1.0,1.0,6/75,6.15%,KCNJ4;KCNJ16;GRIA3;KCNK1;KCNJ13;SHROOM2
prerank,GABA receptor activity (GO:0016917),0.3540023919234076,0.866433278019839,0.6078125,1.0,1.0,5/21,12.25%,GABBR2;GABRR2;GABRG2;GABRG1;GABRB3
prerank,microtubule binding (GO:0008017),0.2560431715665093,0.8644166736923031,0.7429501084598699,1.0,1.0,38/222,14.15%,RGS14;GTSE1;HOOK2;KIF2A;SPEF1;KIF20B;TRPV4;RACGAP1;FAM83D;DNM1;KIF16B;CAPN6;KIF7;SPAST;KIF3C;CKAP5;SGIP1;KIF13A;PAFAH1B1;EML1;FNTA;REEP3;TUBGCP5;S100A9;APC;HDAC6;HOOK3;MAP4;CCDC170;NDE1;CEP290;MAP9;KIF26A;KIF5A;MAPRE2;KIF5B;POLB;FAM161A
prerank,protein phosphatase inhibitor activity (GO:0004864),-0.28162159490209676,-0.8643036965738458,0.6617210682492581,0.9120193920003581,1.0,7/26,22.90%,PPP1R1A;PPP1R11;PPP1R14A;PABIR1;STYXL1;PTN;ARPP19
prerank,methylation-dependent protein binding (GO:0140034),0.29409670702200236,0.8614905130211945,0.6705577172503242,1.0,1.0,24/57,28.33%,MSH6;CHD8;CHD1;MORC3;MSL3;PYGO1;KDM8;SPIN1;KAT8;MTF2;CDYL;MBTD1;CBX2;FMR1;ATRX;BPTF;KDM5A;ING1;TDRD3;RRP8;GLYR1;KDM4A;ING3;ING2
prerank,phosphatase inhibitor activity (GO:0019212),0.3497329994846879,0.8614175747663309,0.6265822784810127,1.0,1.0,8/20,25.39%,STYX;BOD1L1;ENSA;TESC;LMTK2;PPP1R9B;URI1;PPME1
prerank,chloride channel inhibitor activity (GO:0019869),0.402546895015376,0.8594030654561635,0.6275229357798165,1.0,1.0,2/10,11.35%,STX1A;VAMP8
prerank,iron ion binding (GO:0005506),-0.24073260751954623,-0.8586199803398727,0.7519685039370079,0.9188358227261186,1.0,12/48,15.18%,EGLN1;PHF8;FTH1;FTL;AOX1;ETHE1;NFU1;FECH;ABCE1;KDM7A;FXN;ISCA2
prerank,poly(A)-specific ribonuclease activity (GO:0004535),0.3895921505262514,0.8570941993025025,0.6196943972835314,1.0,1.0,6/12,18.94%,CNOT7;PAN2;CNOT8;PNLDC1;CNOT1;TOE1
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),-0.3243723786960855,-0.8559592206190381,0.6771844660194175,0.9193497685608256,1.0,6/14,27.93%,CTSH;NOD1;RACK1;RPS27L;PYCARD;CASP1
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.2875466841951688,0.8554656189976434,0.6666666666666666,1.0,1.0,20/60,19.36%,PPM1A;CTDSPL;PPM1M;RPAP2;PHLPP1;MTMR6;MTMR3;PDP2;CTDSP1;PTEN;CTDSP2;PPP4C;CTDSPL2;CDC14A;CAMK2G;PPP1CA;PP2D1;PPTC7;ILKAP;PPP2CA
prerank,ubiquitin binding (GO:0043130),0.2784161584425317,0.8516125533027389,0.6829268292682927,1.0,1.0,14/73,13.44%,UBE2L6;NUP62;TOM1L1;TSG101;TNFAIP3;OTUB2;N4BP1;NPLOC4;SHARPIN;USP13;NEDD4;BUB3;FAF1;RNF185
prerank,kinesin binding (GO:0019894),0.3365901819338253,0.8512791492535672,0.6519823788546255,1.0,1.0,13/27,25.43%,RAB29;FAM83D;MAPK8IP1;SPAG9;ARHGEF10;KLC2;PRC1;SPTBN5;CLSTN1;MAPK8IP3;NEK6;TTBK2;KIFAP3
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),0.3466706672468669,0.8488334843160574,0.6446280991735537,1.0,1.0,2/18,9.42%,TNFAIP8;RPS6KA3
prerank,potassium channel activity (GO:0005267),-0.21033232582948197,-0.8480016994112831,0.8197674418604651,0.931079427999304,1.0,10/89,10.42%,KCNK2;KCNB1;ABCC9;KCNMA1;KCNH1;KCNT1;GRIK2;KCNB2;KCNH5;KCNN2
prerank,amino acid binding (GO:0016597),-0.25715450339986134,-0.847484731559366,0.6877076411960132,0.9271695222858224,1.0,11/31,20.39%,NOS3;DDAH1;GRIN3A;GRIN2B;GRIN1;GLRA2;NOS1;GCLC;AGXT;CASTOR2;CASTOR1
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",0.31735729368287546,0.8467373691087657,0.6286127167630058,1.0,1.0,5/29,13.32%,PGGHG;ACER3;NEU1;ABHD10;ADPRS
prerank,cation transmembrane transporter activity (GO:0008324),0.2951795515024552,0.8455614560725141,0.6563342318059299,1.0,1.0,5/48,4.89%,SLC8B1;SFXN2;SLC38A2;SLC29A4;SLC22A3
prerank,voltage-gated calcium channel activity (GO:0005245),-0.25093764300692833,-0.8444554611506665,0.7282229965156795,0.9286359496058534,1.0,15/37,35.00%,CACNA2D3;CACNB2;CACNA1G;CACNG7;CACHD1;OPRM1;CACNA2D4;TPCN2;CACNG4;CACNA1B;CACNA1D;CACNA2D1;CACNA1C;CACNB3;CACNG5
prerank,ADP binding (GO:0043531),0.32384202576645127,0.8438293927634132,0.6568778979907264,1.0,1.0,10/25,16.57%,MSH6;PRKAG1;COQ8A;MSH2;MIEF1;LONP1;ABCD1;ERN1;ATP5F1A;PGK1
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),-0.34524460086136116,-0.8433450252388316,0.6779661016949152,0.9258730351694237,1.0,4/12,20.15%,PHF8;KDM1A;KDM7A;KDM4D
prerank,N-acetyltransferase activity (GO:0008080),-0.2932276639787068,-0.8424632926137897,0.6692506459948321,0.9227460565572722,1.0,8/19,30.44%,EP300;SMARCE1;SAT1;KAT2B;NAT8L;NAT2;NAT10;NAA50
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),-0.2727891066809753,-0.8403410249430834,0.6947674418604651,0.9221133821196307,1.0,5/22,16.71%,ATP6V0A4;ATP2C1;ATP6V0C;ATP6V1C1;ATP6V1D
prerank,voltage-gated potassium channel activity (GO:0005249),0.2754580654683227,0.839067890888985,0.7148058252427184,1.0,1.0,6/80,5.58%,KCNJ4;KCNA5;KCNJ16;KCNS2;KCNK1;KCNJ13
prerank,ubiquitin conjugating enzyme activity (GO:0061631),0.3171361841288695,0.8381653676212673,0.6503703703703704,1.0,1.0,6/31,16.02%,UBE2L6;UBE2E2;UBE2J2;UBE2D3;UBE2D1;UBE2R2
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),-0.3392593430218611,-0.8368328440716999,0.6588785046728972,0.9242793197060706,1.0,4/11,30.78%,KCNJ8;KCNE4;KCNH2;KCNQ1
prerank,3'-5'-exoribonuclease activity (GO:0000175),0.3066182698420963,0.835311737647377,0.6953352769679301,1.0,1.0,10/34,18.94%,EXOSC5;DIS3L2;REXO2;EXOSC10;CNOT7;PAN2;CNOT8;PNLDC1;CNOT1;TOE1
prerank,fibroblast growth factor binding (GO:0017134),0.33862947632066653,0.8349003718015596,0.6687211093990755,1.0,1.0,1/21,0.70%,FGFR1
prerank,tumor necrosis factor receptor binding (GO:0005164),-0.3231579968723607,-0.8334306114181897,0.6704805491990846,0.9263943537857248,1.0,3/12,16.15%,TRAF6;BABAM2;TRIM37
prerank,ubiquitin-like protein ligase activity (GO:0061659),0.24528720260755743,0.8334053304166866,0.8029661016949152,1.0,1.0,28/232,11.37%,NEDD4L;PDZRN3;ZNRF2;DTX1;PELI2;RNF130;SH3RF2;IRF2BP1;UBE3C;RNF122;LRSAM1;TMEM129;TRIM21;UBR5;RNF24;PIAS2;SIAH1;ZNRF3;CUL3;AMFR;RNF220;SIAH3;DTX4;UBE3D;CBLB;RCHY1;ANAPC11;NEDD4
prerank,metalloexopeptidase activity (GO:0008235),0.286557055844087,0.8318984718408278,0.676056338028169,1.0,1.0,13/51,16.98%,MMP15;AGBL4;CPE;CPA2;RNPEP;LVRN;LNPEP;XPNPEP3;MMP16;LTA4H;ZMPSTE24;MMP14;AGBL1
prerank,RNA cap binding (GO:0000339),0.355637036382784,0.8317485984324171,0.6366459627329193,1.0,1.0,2/16,9.69%,CYFIP2;EIF4E
prerank,heparan sulfate sulfotransferase activity (GO:0034483),-0.31228459135526954,-0.8304024169039357,0.696969696969697,0.9278364105158688,1.0,5/15,12.53%,NDST3;HS3ST1;HS3ST3B1;HS6ST2;HS6ST1
prerank,CoA hydrolase activity (GO:0016289),0.358168352965514,0.8290346430230807,0.6699186991869919,1.0,1.0,4/16,12.75%,ACOT13;ACOT8;ACOT2;ABCD1
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),0.30451417431229477,0.8274502554154796,0.6873198847262247,1.0,1.0,9/34,18.16%,NDUFA6;NDUFB10;NDUFS3;NDUFS6;NDUFA3;NDUFV2;NDUFV1;NDUFA7;NDUFS2
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),0.30451417431229477,0.8274502554154796,0.6873198847262247,1.0,1.0,9/34,18.16%,NDUFA6;NDUFB10;NDUFS3;NDUFS6;NDUFA3;NDUFV2;NDUFV1;NDUFA7;NDUFS2
prerank,flavin adenine dinucleotide binding (GO:0050660),0.28411416349980934,0.8272102582237044,0.6945169712793734,1.0,1.0,5/53,8.50%,PRODH;POR;GFER;GCDH;MICAL3
prerank,phospholipase inhibitor activity (GO:0004859),-0.34452813488932715,-0.8264142949073972,0.7004716981132075,0.930559343973351,1.0,7/10,36.98%,ANXA2;ANXA1;ANXA9;ANXA5;APOC1;SNCA;SNCB
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),-0.32961607283381716,-0.825325797717219,0.7072072072072072,0.9279189193769808,1.0,4/11,14.10%,RBX1;UBE2K;UBE4A;UBE4B
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),-0.30462213141299965,-0.8237150037407672,0.7075718015665796,0.9259855906645181,1.0,8/16,21.17%,SLC13A3;SLC25A30;SLC25A11;SLC38A7;SLC1A1;SLC25A18;SLC1A4;SLC13A5
prerank,vitamin D receptor binding (GO:0042809),-0.3173163577841037,-0.8222723210129832,0.71,0.9240551465805549,1.0,7/14,31.08%,MED17;SNW1;MED24;MED14;MED30;TAF11;RXRA
prerank,poly-purine tract binding (GO:0070717),-0.26804050217607855,-0.8198647784270356,0.7429467084639498,0.9238111747932175,1.0,5/27,9.67%,RBPMS;RBMS1;RBMS3;RBMS2;PABPC1
prerank,G protein-coupled receptor activity (GO:0004930),0.2381934903741342,0.8186928561622778,0.8386752136752137,1.0,1.0,23/239,12.71%,HRH1;LPAR1;ADGRG5;ADGRG2;GPR161;SSTR1;KISS1R;MC5R;MRGPRF;P2RY14;OPN1MW;OPN1MW3;GABBR2;GPR135;TSHR;HCRTR2;GPR101;RORB;ADRA2A;GPR183;LANCL1;GRM1;GPR18
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),0.27760583114968707,0.8170060492806809,0.7006622516556291,1.0,1.0,11/57,15.67%,COX5A;NDUFA6;NDUFB10;NDUFS3;COX15;NDUFS6;NDUFA3;NDUFV2;COX5B;NDUFV1;NDUFA7
prerank,NF-kappaB binding (GO:0051059),-0.2619284376105693,-0.8159324573825216,0.736231884057971,0.9264257435748715,1.0,10/24,23.53%,EP300;RNF25;NPM1;HDAC1;BCL10;COMMD7;MTDH;CDK5RAP3;BRMS1;SETD6
prerank,vascular endothelial growth factor receptor binding (GO:0005172),0.36337897779138284,0.815307595840581,0.671118530884808,1.0,1.0,1/12,2.58%,CDH5
prerank,triglyceride lipase activity (GO:0004806),0.3359597683389056,0.8145034567465317,0.6784565916398714,1.0,1.0,3/20,17.73%,CEL;LIPE;LPL
prerank,UDP-glycosyltransferase activity (GO:0008194),-0.20856647527667888,-0.8120588733511055,0.8605769230769231,0.9287301076073432,1.0,11/70,14.97%,GXYLT2;MGAT4C;MGAT4A;CSGALNACT1;CSGALNACT2;CHPF2;B4GALT1;B3GALT2;LFNG;GCNT1;MFNG
prerank,thyroid hormone receptor binding (GO:0046966),0.3127406471829362,0.8107428883373523,0.6921921921921922,1.0,1.0,9/28,21.22%,NCOR1;MED13;JMJD1C;NCOA3;GTF2H1;BRD8;MED12;TACC1;MED16
prerank,sulfotransferase activity (GO:0008146),0.2940977054428219,0.8104564775943068,0.718475073313783,1.0,1.0,5/33,11.12%,UST;SULT1A1;CHST7;CHST2;CHST12
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),-0.23243929368560415,-0.8101862931565544,0.7986798679867987,0.9274823159936906,1.0,27/42,38.28%,CCNT2;CNPPD1;CCNT1;CDK5R1;CCNE2;CCNH;CCNJL;KAT2B;CCNY;CCND2;CCNF;CDKN2C;CDKN1B;CCNQ;CCNK;CDKN2D;CCND1;CCNB2;HEXIM2;CCNL1;CDKN2B;CCNL2;CKS2;CDK5R2;CCNI;CCNE1;INCA1
prerank,titin binding (GO:0031432),0.3510092381208074,0.809785673881852,0.6678200692041523,1.0,1.0,2/13,8.78%,CAMK2D;OBSCN
prerank,voltage-gated sodium channel activity (GO:0005248),0.32884865704863564,0.8091944638648617,0.6835637480798771,1.0,1.0,3/22,10.99%,SCN10A;CACNA1H;SCN2B
prerank,cAMP binding (GO:0030552),-0.3311719246952499,-0.8090589563522285,0.7058823529411765,0.9249480982946316,1.0,4/11,12.94%,RAPGEF2;PDE10A;PDE2A;PDE4A
prerank,single-stranded DNA binding (GO:0003697),-0.20235051063068893,-0.8080382856088426,0.8789808917197452,0.9225571915887099,1.0,39/93,32.04%,RAD51B;SAMHD1;TOP3A;RBMS1;BLM;MCM6;SUB1;PCBP1;SPRTN;SSBP1;POLA1;PMS2;MAPT;APTX;RAD23A;SMC6;DHX36;POLR2D;MCMDC2;ERCC4;CRY2;ERCC5;TWNK;HNRNPA1;NEIL3;WBP11;RAD51;NABP1;CDC45;FUBP1;HMCES;MCM3;CTC1;MCM9;MCM7;HSPD1;MCM5;MCM10;MCM2
prerank,ubiquitin protein ligase activity (GO:0061630),0.23787763849215768,0.807869507577692,0.844845908607864,1.0,1.0,27/228,11.37%,NEDD4L;PDZRN3;ZNRF2;DTX1;PELI2;RNF130;SH3RF2;IRF2BP1;UBE3C;RNF122;LRSAM1;TMEM129;TRIM21;UBR5;RNF24;SIAH1;ZNRF3;CUL3;AMFR;RNF220;SIAH3;DTX4;UBE3D;CBLB;RCHY1;ANAPC11;NEDD4
prerank,ribosomal large subunit binding (GO:0043023),-0.32889598142251264,-0.8070315431002574,0.7035294117647058,0.9198091545909329,1.0,3/11,12.33%,NPM1;CPEB2;DHX33
prerank,GABA-A receptor activity (GO:0004890),0.33759507557744545,0.8061122950589744,0.699685534591195,1.0,1.0,4/18,12.25%,GABRR2;GABRG2;GABRG1;GABRB3
prerank,galactosyltransferase activity (GO:0008378),0.3769932970933262,0.8057007034645265,0.7063063063063063,1.0,1.0,2/11,5.83%,A4GALT;A3GALT2
prerank,small GTPase binding (GO:0031267),0.2416466589077658,0.8041572721762863,0.8086283185840708,1.0,1.0,40/170,19.34%,CAV1;PLCE1;CDC42EP4;RAB29;SGSM2;GCC1;AKAP13;LZTR1;RAPGEF4;RAB3GAP2;RAPGEF6;OCRL;ABCA1;MAPKAP1;GCC2;DOCK7;RIC1;DVL3;DMXL2;RANBP2;EXOC5;EVI5;TRIP11;PDE6D;RAB34;UNC13B;CHM;AP3M1;TBC1D20;RTKN;XPO5;ARHGDIB;RALBP1;ALS2;SIKE1;EHD1;DENND10;ANKFY1;RAF1;YBX3
prerank,nucleosomal DNA binding (GO:0031492),0.3268724598245915,0.803101093683259,0.7016129032258065,1.0,1.0,3/21,9.89%,HNRNPC;SMARCD2;HDAC2
prerank,phosphatase activity (GO:0016791),0.26368779251604824,0.8021354793958402,0.7650834403080873,1.0,1.0,14/73,15.11%,DUSP12;PLPP2;ACP6;PLPP3;PTPN22;ACP5;ATP1A2;PTPMT1;PTPRJ;OCRL;ARMT1;DUSP8;PTPRO;PLPPR1
prerank,protein heterodimerization activity (GO:0046982),0.23931562396798164,0.7998019353735611,0.838569880823402,1.0,1.0,31/178,17.31%,TENM2;NPAS3;FXR2;ADD1;BUD23;SMC3;IRAK3;ATP1A2;BHLHE40;MCL1;GABBR2;USF2;PAFAH1B1;PIK3R2;SUPT4H1;ADRA2A;ZHX1;HEXA;PAFAH1B2;SNX2;P4HB;FXR1;EXT1;FZD9;RAN;ADCY8;ERBB2;SNX1;YWHAE;MIGA1;EXT2
prerank,thioesterase binding (GO:0031996),0.3686690097365372,0.7994947963136513,0.7008849557522124,1.0,1.0,7/11,23.34%,ARF6;ADRA2A;TRAF4;TRAF3;TRAF5;HAUS7;RAC1
prerank,methylated histone binding (GO:0035064),0.26993733300218936,0.7989786347295998,0.7538265306122449,1.0,1.0,25/62,28.33%,MSH6;CHD8;CHD1;MORC3;MSL3;PYGO1;KDM8;SPIN1;KAT8;MTF2;CDYL;MBTD1;CBX2;FMR1;ATRX;BPTF;KDM5A;TAF1;ING1;TDRD3;RRP8;GLYR1;KDM4A;ING3;ING2
prerank,transcription cis-regulatory region binding (GO:0000976),0.22618848675613012,0.7974457055906398,0.9120654396728016,1.0,1.0,62/406,17.11%,RORA;BNC2;GLI1;PBX1;ZBTB20;NPAS3;ETV5;CHD3;SPI1;FOXK1;FOXO3;SOX9;ZBTB8A;GLIS2;HDAC4;SATB1;KLF10;CREB3L1;ZFP3;SP3;ZFP90;CTCF;NCOR1;HOXC10;RREB1;RARA;SUV39H1;LHX6;ISL1;E4F1;FOXK2;AGO1;TBX18;FOXJ1;HMGB1;DBP;TFEB;LONP1;MMP12;EGR1;MZF1;MEN1;NFE2L2;PEG3;ARID4A;SOX4;SFPQ;ZFP57;ERBB4;FOXF1;NR5A1;FOXC2;YAP1;KMT2D;GBX1;PER3;DMTF1;PSPC1;TFE3;MTERF3;E2F1;PPARG
prerank,kinase binding (GO:0019900),0.2265138305612185,0.794238905291669,0.9112008072653885,1.0,1.0,79/435,17.26%,CAV1;UTRN;CSPG4;CEACAM1;CNKSR2;SLC12A2;EGFR;CCND3;FAM83A;KCNA5;GYS1;AXIN1;STX1A;MAP3K1;SPRED1;TRPV4;CAV2;RACGAP1;PRKAG1;FOXO3;SLC12A4;PTPN22;FAM83D;HNRNPA0;SRC;DNM1;RAC2;IRAK3;PTPRC;IBTK;TOM1L1;TRADD;ADAM10;TRIM21;SRCIN1;MSH2;FBXO5;PTPRJ;TEX14;IRGM;GSK3B;TOM1L2;TICAM1;DLG3;MAPKAP1;FERMT2;LAT;TAX1BP1;ADRA2A;CENPJ;WWC1;APC;LRBA;FAF1;MVP;CDC6;PKD1;SPRED2;CIT;RND2;HTT;LAPTM4B;TTC28;MTCP1;TNNI3;PTPN6;PLG;BAD;TRIM5;SOCS1;RELB;AP2A2;INKA2;UBQLN1;RGCC;ARHGEF7;WARS1;CHP1;USP37
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",0.34949802239587224,0.7942292541260922,0.6983333333333334,1.0,1.0,6/13,30.36%,GEN1;DICER1;SLX4;DNASE1L1;ENDOV;DNA2
prerank,protein kinase A catalytic subunit binding (GO:0034236),0.3634217264498435,0.7939686933433335,0.7181818181818181,1.0,1.0,4/13,16.37%,SOX9;PRKAR2A;GSK3B;EZR
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",-0.3047369897012461,-0.7897989768959799,0.7666666666666667,0.9447796043598561,1.0,12/14,41.97%,QDPR;MTHFR;DHFR;ALDH4A1;PYCR2;AASS;PYCR3;BLVRB;PYCR1;NOXRED1;CRYM;ALDH1L1
prerank,cAMP response element binding (GO:0035497),-0.3356783418753503,-0.7890246987569849,0.751131221719457,0.9415739834875978,1.0,3/10,11.59%,CREB5;CREB1;ATF2
prerank,MAP kinase kinase activity (GO:0004708),-0.29273117836440266,-0.7883042329287352,0.7356608478802993,0.9382407483457431,1.0,8/15,28.14%,MAP2K2;LRRK2;MAP2K3;MAPKAPK3;MAP2K6;MAP2K1;MAP2K4;MAP2K5
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",0.23594712050537187,0.7875921355201821,0.8469945355191257,1.0,1.0,27/173,13.86%,FOXP2;ZBTB32;KLF12;ZBTB20;FOXK1;FOXO3;FOXP4;SATB1;CREB3L1;HEYL;BHLHE40;ZFP90;CTCF;HIC1;TBX2;MYPOP;E4F1;FOXK2;ZBTB6;TBX18;MZF1;ZBTB49;ZNF148;ERF;PEG3;NFATC4;ZFP57
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",0.2894358211769039,0.786914473136353,0.7478134110787172,1.0,1.0,9/33,18.94%,EXOSC5;DIS3L2;REXO2;EXOSC10;CNOT7;PAN2;CNOT8;PNLDC1;TOE1
prerank,single-stranded RNA binding (GO:0003727),0.28516871095874957,0.7852052536582,0.7696476964769647,1.0,1.0,18/43,26.42%,TLR7;ZFR;AGO1;EXOSC10;LONP1;ILF3;STRBP;FXR1;DHX9;DDX11;JMJD6;IFIH1;DHX58;AQR;FMR1;AGO2;CNBP;HNRNPU
prerank,nuclear import signal receptor activity (GO:0061608),0.3413900125881536,0.7850324112395164,0.7371048252911814,1.0,1.0,2/15,5.83%,KPNA7;KPNA2
prerank,acyl-CoA hydrolase activity (GO:0047617),0.33825920489818767,0.7848172119579551,0.71869918699187,1.0,1.0,4/17,12.75%,ACOT13;ACOT8;ACOT2;ABCD1
prerank,tRNA binding (GO:0000049),-0.21991305521731835,-0.7847063560107634,0.8623188405797102,0.9395962106216804,1.0,21/43,39.51%,SSB;EEF1A1;TRNT1;TRMT9B;EIF2AK4;EIF2A;NSUN2;MRPS27;YRDC;XPOT;PUS1;HSD17B10;NAT10;AARS2;ELP1;FARS2;TRMT10C;CTU1;YARS2;NEMF;ELP5
prerank,RNA methyltransferase activity (GO:0008173),-0.27698761314980813,-0.7836611812110099,0.7919799498746867,0.936769693443083,1.0,8/19,24.74%,TGS1;TRMT13;TRMT9B;TRDMT1;FBL;TYW3;METTL8;TRMT12
prerank,potassium:proton antiporter activity (GO:0015386),-0.3230629839298307,-0.7835126731759355,0.7517084282460137,0.9325486854824466,1.0,4/10,18.66%,SLC9A1;SLC9A9;SLC9A5;SLC9A2
prerank,semaphorin receptor binding (GO:0030215),-0.2624981660631457,-0.783394430054599,0.7830985915492957,0.9282897742718622,1.0,4/23,5.19%,SEMA6D;SEMA7A;SEMA3C;SEMA6A
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",-0.2792471504778758,-0.7829318074095563,0.7546174142480211,0.9205124752472971,1.0,4/16,16.71%,ATP6V0A4;ATP6V0C;ATP6V1C1;ATP6V1D
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",-0.2792471504778758,-0.7829318074095563,0.7546174142480211,0.9205124752472971,1.0,4/16,16.71%,ATP6V0A4;ATP6V0C;ATP6V1C1;ATP6V1D
prerank,transferrin receptor binding (GO:1990459),0.3629604499197125,0.7827343260927752,0.7245841035120147,1.0,1.0,4/10,21.29%,SNX2;CD81;SNX1;RGMA
prerank,carbohydrate:cation symporter activity (GO:0005402),-0.31742082879080846,-0.7816723646649254,0.7634146341463415,0.9181827759440486,1.0,3/11,17.76%,SLC17A5;SLC2A10;SLC2A9
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),0.34585192272981624,0.7804304936178459,0.7154742096505824,1.0,1.0,4/14,20.49%,CAPN6;CAPN2;CAPN5;CAPN1
prerank,1-phosphatidylinositol binding (GO:0005545),0.34242891002602555,0.7792560115910869,0.7495987158908507,1.0,1.0,3/15,6.95%,SESTD1;ZFYVE16;SNX10
prerank,NADPH binding (GO:0070402),-0.3033560619295196,-0.7791141789380421,0.7958715596330275,0.9176953105102396,1.0,7/13,34.08%,QDPR;DHFR;MTRR;CRYZ;DUS2;LBR;NDOR1
prerank,cholesterol transfer activity (GO:0120020),0.33648159776568765,0.7773156494495215,0.7308319738988581,1.0,1.0,7/16,26.12%,GRAMD1B;ABCA1;STARD5;OSBPL2;STARD4;MTTP;NPC2
prerank,potassium ion leak channel activity (GO:0022841),0.34191796819740816,0.775229460167949,0.7106598984771574,1.0,1.0,4/15,13.89%,KCNK1;KCNK5;KCNK10;KCNK4
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),-0.3045615461217484,-0.7749830436898378,0.7406542056074766,0.9198143155793205,1.0,2/12,3.84%,PIK3R1;FRS2
prerank,lipase activity (GO:0016298),0.2746903276729178,0.7741591296415561,0.7680763983628922,1.0,1.0,9/43,19.49%,CEL;DDHD1;ABHD12;LIPE;PNPLA8;SEC23IP;LPL;PITPNM3;FAAH
prerank,adenylyltransferase activity (GO:0070566),0.31753031304526347,0.7701188520860662,0.7417218543046358,1.0,1.0,6/21,18.56%,TUT1;COASY;NMNAT3;KARS1;OAS2;PAPOLG
prerank,MHC class II protein complex binding (GO:0023026),0.3493401193218296,0.7693448357654994,0.7342657342657343,1.0,1.0,5/11,22.50%,ANXA11;CD81;YWHAE;MS4A1;PKM
prerank,nucleobase-containing compound kinase activity (GO:0019205),0.3214873466162627,0.769159646032634,0.7298657718120806,1.0,1.0,1/17,1.39%,AK5
prerank,MAP-kinase scaffold activity (GO:0005078),-0.30853284941995335,-0.7686960488412679,0.7595238095238095,0.9250330164855269,1.0,2/11,7.55%,KSR1;MAP2K2
prerank,acetylation-dependent protein binding (GO:0140033),0.31606285687614066,0.7679150493800456,0.7391975308641975,1.0,1.0,5/20,17.55%,MLLT3;KMT2A;BAZ2A;BRD3;PSME4
prerank,lysine-acetylated histone binding (GO:0070577),0.31606285687614066,0.7679150493800456,0.7391975308641975,1.0,1.0,5/20,17.55%,MLLT3;KMT2A;BAZ2A;BRD3;PSME4
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),0.3217092816151882,0.7677503825217287,0.7411944869831547,1.0,1.0,8/19,22.54%,GRID1;GABRG2;GABRG1;GRIK1;GRIK5;GABRA3;GRIK3;GRID2
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),0.29136306437174686,0.76760002703518,0.7558479532163743,1.0,1.0,14/32,24.95%,EGLN3;TET1;P4HTM;KDM8;ALKBH1;PHYH;KDM4B;HSPBAP1;TYW5;ALKBH4;ALKBH2;KDM2A;TMLHE;ALKBH3
prerank,calcium-activated potassium channel activity (GO:0015269),-0.31254210452502645,-0.7666960509829718,0.7692307692307693,0.9236782638405975,1.0,7/11,37.41%,KCNMA1;KCNN2;KCNN3;PKD2L1;KCNN4;KCNN1;KCNMB2
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),-0.25543161372037043,-0.7665324314863567,0.8161559888579387,0.919689439976544,1.0,13/21,50.77%,GRIK2;P2RX7;P2RX4;CHRNA4;CHRNB2;P2RX5;CHRNB1;P2RX6;CHRNA9;CHRNA5;CHRNA3;P2RX1;CHRNB4
prerank,ubiquitin-protein transferase activity (GO:0004842),0.22103760976113382,0.7663553239155263,0.9209445585215605,1.0,1.0,79/346,22.14%,NEDD4L;PDZRN3;UBE2L6;ZNRF2;DTX1;PELI2;UBE2E2;RNF130;SH3RF2;IRF2BP1;UBE3C;RNF122;LMO7;LRSAM1;TMEM129;TNFAIP3;TRIM21;UBR5;CHFR;RNF24;SIAH1;ZNRF3;CUL3;FBXO3;AMFR;RNF220;SIAH3;DTX4;UBE3D;CBLB;SHARPIN;OBI1;RCHY1;ANAPC11;NEDD4;KLHL21;FBXL5;TTC3;FBXO11;RFWD3;RNF185;FBXO21;ANKRD39;UBE2J2;UBE2D3;UBE2D1;ANAPC4;WWP2;FBXW8;TRIM5;DDB2;FANCL;UBE2R2;LTN1;FBXL3;ITCH;CUL4B;RNF7;VPS11;CDC23;RNF180;RNFT2;GID4;SEL1L;UBE2W;PRKN;MKRN1;RNF146;RNF14;MUL1;TRAF3;TRAF5;TRAF7;ZNRF1;AKTIP;RNF157;CUL5;MIB2;FBXW11
prerank,polynucleotide adenylyltransferase activity (GO:0004652),0.3487858482161872,0.7655804741120712,0.7266553480475382,1.0,1.0,4/12,18.56%,TUT1;TENT5C;TENT5D;PAPOLG
prerank,DNA polymerase binding (GO:0070182),0.31685430025149686,0.7640548726335731,0.7657512116316639,1.0,1.0,4/18,14.11%,HMGB1;LONP1;CDK2AP1;POLG2
prerank,glutamate receptor activity (GO:0008066),-0.2594128203642039,-0.7634525815675046,0.8174603174603174,0.9198921270690303,1.0,3/19,7.84%,GRM3;GRIA2;GRIK2
prerank,motor activity (GO:0003774),0.26052651779831154,0.7610551998885746,0.8136246786632391,1.0,1.0,10/60,13.61%,KIF2A;KIF20B;SMC3;KIF16B;KIF7;KIF3C;KIF13A;KIF26A;KIF5A;KIF5B
prerank,protein-arginine N-methyltransferase activity (GO:0016274),0.3472929673536151,0.7605680898157919,0.7352415026833632,1.0,1.0,5/11,25.76%,FBXO11;PRMT6;PRMT9;PRMT8;PRMT3
prerank,phosphatidate phosphatase activity (GO:0008195),0.3414823493543657,0.7601647126372403,0.7262295081967213,1.0,1.0,2/13,4.15%,PLPP2;PLPP3
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),0.28191536388843186,0.7596977663633585,0.7815126050420168,0.9993208216906879,1.0,8/38,11.71%,PHLDA3;SESTD1;LANCL2;KIF16B;SH3PXD2B;PLEKHA4;OBSCN;ZFYVE26
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),0.29498159868913826,0.7592105203806216,0.7601809954751131,0.9972334997903277,1.0,4/24,8.78%,SESTD1;LANCL2;CERT1;OBSCN
prerank,SH3 domain binding (GO:0017124),0.25750029447491457,0.7574708085098173,0.8052631578947368,0.9971516678990167,1.0,16/62,21.23%,WIPF1;PTPN22;CNTNAP1;SGIP1;PLSCR1;CBLB;SH3BP2;SOCS7;LANCL1;RUFY2;REPS1;ESPN;PTPN12;AFAP1;PRKN;RAD9A
prerank,nucleotidyltransferase activity (GO:0016779),-0.262532586551057,-0.7565538242956903,0.811046511627907,0.9255508523907305,1.0,6/19,19.72%,PAPSS1;TENT2;TUT7;MTPAP;YRDC;CGAS
prerank,acetyltransferase activity (GO:0016407),0.28638041717863477,0.7565099800959075,0.7651296829971181,0.9957941980665077,1.0,9/31,14.96%,KAT6B;ACAT1;SAT2;PAFAH1B2;NAT14;PAFAH2;CREBBP;KAT8;NAA10
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),-0.31653862544390743,-0.7561416678160058,0.7728285077951003,0.9219668913380619,1.0,7/10,38.28%,KAT2B;CDKN2C;CDKN1B;CDKN2D;HEXIM2;CDKN2B;INCA1
prerank,histone-lysine N-methyltransferase activity (GO:0018024),-0.21882877026431574,-0.755660907008711,0.8588709677419355,0.9185326264012941,1.0,5/44,8.59%,MECOM;SETD5;SETD1A;PRDM16;SMYD2
prerank,solute:sodium symporter activity (GO:0015370),-0.2418825460165277,-0.7555227961416405,0.8584070796460177,0.9146211370015432,1.0,2/27,4.87%,SLC4A10;SLC5A6
prerank,GTPase binding (GO:0051020),0.2239220534140349,0.754811072616218,0.8845738942826321,0.995648972739455,1.0,44/195,18.93%,CAV1;PLCE1;CDC42EP4;RAB29;SGSM2;GCC1;AKAP13;LZTR1;RAPGEF4;RAB3GAP2;RAPGEF6;OCRL;ABCA1;MAPKAP1;GCC2;DOCK7;RIC1;DVL3;DMXL2;RANBP2;EXOC5;EVI5;TRIP11;RRAGB;AIMP1;PDE6D;RAB34;UNC13B;CHM;AP3M1;TBC1D20;RTKN;BNIP3;XPO5;ARHGDIB;RALBP1;ALS2;SPTBN1;LCP1;SIKE1;EHD1;DENND10;ANKFY1;RAF1
prerank,N-acyltransferase activity (GO:0016410),0.2853444709407692,0.7545126443747631,0.7970588235294118,0.9932515783121177,1.0,7/32,15.83%,CERS6;PLAAT5;SAT2;SIRT7;NAT14;NAA10;NMT1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",0.26091746367908697,0.7539174483466801,0.8131868131868132,0.9914220198694009,1.0,9/54,11.27%,ACER3;HDAC4;NIT2;NADSYN1;NIT1;DARS1;SIRT7;HDAC2;HDAC6
prerank,endoribonuclease activity (GO:0004521),0.28490101102047766,0.7531184438032323,0.7805232558139535,0.9897834475659717,1.0,6/32,16.32%,PIWIL2;AGO1;EXOG;ERN1;DICER1;TSNAX
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),0.35546644663063426,0.7529143602128604,0.75,0.9872992816112501,1.0,3/11,13.82%,NTHL1;APEX2;ALKBH1
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),-0.3153714087082474,-0.7505778245562189,0.7878787878787878,0.9129457169917444,1.0,7/10,43.59%,DUSP10;DUSP7;DUSP1;DUSP4;DUSP5;DUSP16;DUSP2
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),-0.3153714087082474,-0.7505778245562189,0.7878787878787878,0.9129457169917444,1.0,7/10,43.59%,DUSP10;DUSP7;DUSP1;DUSP4;DUSP5;DUSP16;DUSP2
prerank,water transmembrane transporter activity (GO:0005372),0.3526932979333256,0.7494947528884104,0.7508833922261484,0.9895845639222447,1.0,2/11,12.99%,SLC4A11;AQP1
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),-0.2518145491934002,-0.7459662562266389,0.8501362397820164,0.9151230424435087,1.0,7/22,18.04%,RBMS3;CPEB2;ZC3H12A;CPSF1;ZFP36;DHX36;CPEB1
prerank,ubiquitin-specific protease binding (GO:1990381),0.3059007436110229,0.7455006999939222,0.7519500780031201,0.9928620964645307,1.0,8/19,22.70%,SELENOS;AMFR;PTEN;LCOR;SUMO1;PRKN;DERL1;RHBDD2
prerank,single-stranded DNA helicase activity (GO:0017116),-0.25627428848789024,-0.7453670702581227,0.8260869565217391,0.9119039769875598,1.0,12/19,37.80%,MCM6;POLQ;HELQ;RFC2;RAD51;RFC4;MCM7;MCM5;MCM2;RFC5;CHTF18;PIF1
prerank,neuropeptide binding (GO:0042923),0.3143554537498633,0.7405112710676506,0.7815384615384615,0.9973314594440352,1.0,1/18,2.40%,SSTR1
prerank,chloride channel activity (GO:0005254),0.2525225813403558,0.7401120850147042,0.8354591836734694,0.9950692778924222,1.0,9/59,12.25%,SLC26A9;ANO6;CLCN2;CLCN1;GABRR2;GABRG2;BEST1;GABRG1;GABRB3
prerank,aspartic-type endopeptidase activity (GO:0004190),0.32892806705921784,0.7386622311735154,0.7630662020905923,0.994375701488777,1.0,5/12,29.12%,BACE2;BACE1;HM13;SPPL3;CTSE
prerank,P-type ion transporter activity (GO:0015662),-0.2900561272942639,-0.7386438093855114,0.7797029702970297,0.9164644948455498,1.0,3/12,13.54%,ATP7A;ATP2C1;ATP2B3
prerank,lipase activator activity (GO:0060229),0.35657979996886424,0.7372765683899468,0.7672413793103449,0.9935881722077524,1.0,3/10,18.55%,SRC;BTK;PDPK1
prerank,MHC class I protein binding (GO:0042288),0.32284403500089465,0.7370873180059091,0.7738287560581584,0.9911310919321409,1.0,4/13,21.88%,TAPBP;ABCB9;ATP5F1A;DERL1
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",-0.21911641479018773,-0.7370308170073769,0.8788927335640139,0.9145704760052052,1.0,13/35,25.19%,TRMT13;QRSL1;TRIT1;TRMT9B;TRDMT1;PUS10;DUS3L;DUS1L;MRPL58;GATC;TYW3;TRMT12;TRPT1
prerank,tRNA methyltransferase activity (GO:0008175),0.3147683012159272,0.7369536472509415,0.7959183673469388,0.9886271242144752,1.0,6/16,18.39%,TARBP1;FTSJ1;TRMT5;THUMPD3;METTL2A;METTL2B
prerank,3'-5' exonuclease activity (GO:0008408),0.25831644930164926,0.7316959384869655,0.8196022727272727,0.9932807067700499,1.0,14/45,21.47%,EXOSC5;DIS3L2;REXO2;EXOSC10;CNOT7;PAN2;REXO4;REV3L;CNOT8;PNLDC1;TOE1;MRE11;RAD9A;EXOSC7
prerank,phosphoric ester hydrolase activity (GO:0042578),0.24760805879574646,0.7261122724117849,0.8527443105756358,0.9983819191919024,1.0,10/49,17.05%,DUSP12;ACP6;PTPN22;ATP1A2;PTPRJ;ARMT1;DUSP8;PTPRO;GDPD3;PPP1CA
prerank,nucleotidase activity (GO:0008252),-0.2656928443723968,-0.7250839631066124,0.8244274809160306,0.9251740213915135,1.0,5/15,18.92%,BPNT2;NT5C3B;NT5DC1;NT5C;NT5C1A
prerank,symporter activity (GO:0015293),-0.30502641613673115,-0.7228446618236314,0.8321678321678322,0.923824631522916,1.0,2/10,13.12%,SLC5A6;MFSD2A
prerank,sterol transfer activity (GO:0120015),0.3066599481881482,0.7204193518508456,0.7944983818770227,1.0,1.0,4/17,16.50%,GRAMD1B;ABCA1;STARD5;OSBPL2
prerank,5'-3' exonuclease activity (GO:0008409),0.3160600242012883,0.7174807864290713,0.7822299651567944,1.0,1.0,3/14,19.01%,DXO;EXOG;MRE11
prerank,microtubule plus-end binding (GO:0051010),-0.2435510813609254,-0.7138476002716725,0.8649425287356322,0.9297678604041557,1.0,2/20,3.37%,CLIP1;DST
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),0.27691447201024133,0.7136145201136114,0.8426323319027181,1.0,1.0,9/28,22.54%,GRID1;GABRG2;GABRG1;GRIK1;GRIK5;CHRNA7;GABRA3;GRIK3;GRID2
prerank,O-methyltransferase activity (GO:0008171),-0.29870136679477477,-0.7127436690177419,0.8208616780045351,0.9269659953848028,1.0,2/10,11.75%,COMT;COQ3
prerank,phosphatidylinositol kinase activity (GO:0052742),0.30514876325452955,0.7100992213139687,0.8067092651757188,1.0,1.0,4/15,20.36%,PI4K2B;PIK3C3;PI4K2A;PIK3C2B
prerank,ferrous iron binding (GO:0008198),-0.24116842478389378,-0.7073567231543584,0.8871391076115486,0.9287540988026198,1.0,5/21,14.08%,EGLN1;FTH1;FTL;FECH;FXN
prerank,rRNA binding (GO:0019843),-0.1998614616662361,-0.7069920601459149,0.9418181818181818,0.92522928204744,1.0,17/42,27.68%,RPLP0;MRPS6;RPS3;RPL23;NGRN;MRPL18;MRPS27;MRPS11;PPAN;RPL5;MTERF4;RPS9;RPS14;ERAL1;FASTKD5;RPF2;RPL11
prerank,Hsp70 protein binding (GO:0030544),-0.2224377354243608,-0.7069100839600849,0.9003322259136213,0.9214386905551164,1.0,18/31,39.87%,DNAJB2;DNAJA1;GPR37;RPS3;HDAC8;NOD2;DNAJC2;TSC1;DNAJB1;MVD;PPID;FICD;PACRG;SNCA;RNF207;PPEF2;DNAJB14;CYP2E1
prerank,microtubule minus-end binding (GO:0051011),-0.27408975129441515,-0.7066211600377467,0.837772397094431,0.9178958425706181,1.0,3/13,10.50%,TUBGCP4;CAMSAP1;MACF1
prerank,estrogen receptor binding (GO:0030331),0.2636927729730909,0.7059764419036505,0.8818316100443131,1.0,1.0,9/32,19.99%,TAF10;NRIP1;ISL1;DCAF13;STRN;LCOR;CCDC62;CNOT1;TACC1
prerank,cysteine-type peptidase activity (GO:0008234),0.23059352557367893,0.7047491869553596,0.8892988929889298,1.0,1.0,12/73,14.70%,USP50;TINAGL1;USP8;USP48;BLMH;USP47;USP13;OTUD7B;USP15;CAPN2;ATG4C;USP35
prerank,nuclear localization sequence binding (GO:0008139),0.29480681083962307,0.7036687705692357,0.8181818181818182,1.0,1.0,3/18,13.01%,KPNA7;KPNA2;NUP153
prerank,acylglycerol lipase activity (GO:0047372),0.31957746563330414,0.6931507832980326,0.7982608695652174,1.0,1.0,3/11,19.49%,ABHD12;LIPE;FAAH
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),0.30440788647494665,0.6909240729750081,0.8138385502471169,1.0,1.0,15/15,69.59%,PLA2G4A;PLA2G4C;PLA2G4E;PLA2G1B;PLA2G4D;PLA2G2E;PLA2G2F;PLA2G12A;PLA2G10;PLA2G2D;PLA2G2C;PLA2G3;PLA2G5;PLA2G4B;PLA2G4F
prerank,hexosyltransferase activity (GO:0016758),0.21825739106972392,0.6908386290351082,0.9372781065088758,1.0,1.0,12/101,10.85%,OGT;B3GALT1;A4GALT;GCNT4;B4GAT1;B3GLCT;PIGB;GCNT2;DPY19L4;POFUT1;ALG9;HEXA
prerank,endodeoxyribonuclease activity (GO:0004520),-0.23401164087577117,-0.6872920998634229,0.8864864864864865,0.9334689615070838,1.0,6/20,21.93%,RPS3;ZRANB3;ERCC4;DCLRE1C;APLF;ERCC5
prerank,protease binding (GO:0002020),0.2162567643209019,0.6871156363106863,0.9425837320574163,1.0,1.0,15/99,13.02%,FAP;SLC2A13;FN1;TNFAIP3;SELENOS;COL3A1;NLRC4;DPP4;AMFR;ATP9A;GSK3B;DVL3;COL1A1;PTEN;ADAMTSL4
prerank,nuclease activity (GO:0004518),0.23802655945415713,0.6868988020217142,0.8978779840848806,1.0,1.0,18/52,26.47%,NTHL1;N4BP1;DIS3L2;DFFB;PLSCR1;EXOG;REXO1;REXO4;RNASE3;MRE11;NME1;N4BP2;RNASE1;RNASEH1;DNASE1L1;OGG1;AEN;ANG
prerank,ligand-gated calcium channel activity (GO:0099604),0.28178814115815354,0.6865220880892686,0.8414442700156985,1.0,1.0,1/19,1.41%,ITPR3
prerank,guanyl ribonucleotide binding (GO:0032561),0.20309941292286088,0.6858094990858861,0.9579741379310345,1.0,1.0,22/196,9.34%,RAP1A;RAB8B;RAB29;MRAS;RASEF;BMS1;LANCL2;RAC2;ARL11;PIP4K2B;CNGB1;ARHGEF5;NRAS;KRAS;CNGA4;RHOJ;TUBG1;GNL2;ATL2;ARF6;MIEF1;ARL4A
prerank,SUMO binding (GO:0032183),0.3070145292339892,0.6851358004240307,0.8116438356164384,1.0,1.0,1/13,2.63%,TDG
prerank,ATPase regulator activity (GO:0060590),0.24580444176770716,0.6773521180585522,0.8728571428571429,1.0,1.0,10/38,19.35%,HSPH1;SIL1;BAG3;ATP1B3;AHSA1;BAG2;DNAJC24;DNAJB4;DNAJC19;GRPEL2
prerank,hexose transmembrane transporter activity (GO:0015149),0.30387280759862756,0.6725399084123198,0.8321799307958477,1.0,1.0,3/12,19.77%,SLC2A2;SLC5A3;MFSD4A
prerank,GTP binding (GO:0005525),0.20099403923577733,0.6721140044853976,0.9612831858407079,1.0,1.0,17/172,7.64%,RAP1A;RAB29;MRAS;RASEF;BMS1;LANCL2;RAC2;ARL11;PIP4K2B;ARHGEF5;NRAS;KRAS;RHOJ;TUBG1;GNL2;ATL2;ARF6
prerank,deoxyribonuclease activity (GO:0004536),-0.2598408692889225,-0.6719103465962161,0.8774509803921569,0.9433519699155676,1.0,5/14,21.93%,RPS3;ZRANB3;ERCC4;APLF;ERCC5
prerank,endonuclease activity (GO:0004519),0.23213119709335808,0.6699238226621422,0.8993464052287582,1.0,1.0,8/49,16.32%,PIWIL2;NTHL1;AGO1;EXOG;ERN1;DICER1;REXO4;TSNAX
prerank,glucose transmembrane transporter activity (GO:0005355),0.2828804241630196,0.6691223064092897,0.8495867768595041,1.0,1.0,3/17,12.77%,SLC2A2;SLC5A3;SLC5A11
prerank,glucuronosyltransferase activity (GO:0015020),0.2734926593156453,0.6672751203247302,0.8641975308641975,1.0,1.0,5/19,25.41%,B4GAT1;EXT1;EXT2;B3GAT2;CHPF
prerank,exonuclease activity (GO:0004527),0.232631339782298,0.6627511883661593,0.9089655172413793,1.0,1.0,10/46,14.69%,EXOSC5;DXO;REXO2;EXOSC10;CNOT7;EXOG;APEX2;REXO1;REXO4;REV3L
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),0.2525137592082325,0.6614772759834587,0.9086892488954345,1.0,1.0,6/29,14.92%,SLC25A12;SLC26A9;SLC1A6;SLC25A13;SLC25A22;SLC46A1
prerank,nuclear receptor binding (GO:0016922),0.2074624801958642,0.6595212070701116,0.9597633136094674,1.0,1.0,28/111,21.69%,PPARGC1A;TAF10;NRIP1;NCOR1;ISL1;DCAF13;MED13;TMF1;STRN;NCOR2;JMJD1C;NCOA3;NCOA2;GTF2H1;BAZ2A;BRD8;LCOR;CCDC62;MED12;CNOT1;TACC2;TACC1;STAT5B;RNF14;MED16;DAXX;ARID1A;TCF7L2
prerank,damaged DNA binding (GO:0003684),0.23335869592093508,0.6591290707839575,0.9182561307901907,1.0,1.0,8/44,17.29%,TDG;NTHL1;NBN;HMGB1;ERCC1;CREBBP;DDB2;CUL4B
prerank,carboxylic ester hydrolase activity (GO:0052689),-0.16146017773315785,-0.6588045509872399,1.0,0.9500030558281833,1.0,13/85,15.89%,ENPP2;NDST3;LYPLA1;NOTUM;ASPG;ABHD5;ABHD3;PNPLA6;ABHD2;LYPLAL1;LIPA;PGLS;CA2
prerank,double-stranded RNA binding (GO:0003725),0.21380989950043036,0.6580470962325368,0.9488428745432399,1.0,1.0,24/70,24.99%,ZNF346;TLR7;ZFR;ILF2;SIDT2;AGO1;STAU2;ILF3;DGCR8;STRBP;FXR1;DICER1;PRKRA;OAS2;DHX9;ADARB1;ELAVL1;IFIH1;ACTN1;DHX58;TUBA1B;PRKRIP1;DHX30;FMR1
prerank,retinoid X receptor binding (GO:0046965),0.3054554771711355,0.6578343995508743,0.8480138169257341,1.0,1.0,4/11,19.99%,NRIP1;RARG;PPARG;TACC1
prerank,U6 snRNA binding (GO:0017070),0.2871568164642452,0.6573245688103155,0.8618421052631579,1.0,1.0,2/14,7.89%,TUT1;RBM22
prerank,protein-lysine N-methyltransferase activity (GO:0016279),0.24276898011298162,0.6567685257103826,0.8822695035460993,1.0,1.0,10/34,22.64%,SUV39H1;MEN1;ATPSCKMT;SETD2;CAMKMT;ETFBKMT;KMT5A;SETDB1;VCPKMT;EEF2KMT
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),0.23537012406858698,0.6523909363354036,0.9216255442670537,1.0,1.0,11/40,18.81%,TARBP1;SUV39H1;LRTOMT;GAMT;METTL9;ARMT1;LCMT1;THUMPD3;METTL2A;METTL2B;ICMT
prerank,monocarboxylate:sodium symporter activity (GO:0140161),0.30621069035956594,0.652259531242343,0.8561525129982669,1.0,1.0,1/10,5.54%,SLC6A13
prerank,NAD+ binding (GO:0070403),0.29129957094947423,0.6489452320433777,0.8670120898100173,1.0,1.0,5/12,22.92%,SIRT3;HPGD;GLUD1;SIRT2;UXS1
prerank,phosphatidylglycerol binding (GO:1901611),0.2858399720575322,0.6484936356377012,0.8573913043478261,1.0,1.0,3/13,13.87%,PITPNC1;MME;GSDMD
prerank,protein kinase regulator activity (GO:0019887),0.20417355518054398,0.6437762547251539,0.9592592592592593,1.0,1.0,12/95,12.13%,PARVA;CCND3;PRKAG1;SPRY4;CCNG1;GMFB;PRKAR2A;CCNJ;MAPK8IP1;APC;HEXIM1;FAF1
prerank,transmitter-gated ion channel activity (GO:0022824),0.2487142949466575,0.6431215219567329,0.9017341040462428,1.0,1.0,11/29,23.75%,GRID1;GABRG2;GABRG1;GABRB3;GLRA3;GRIK1;GRIK5;GABRA3;GRIK3;GRID2;GRIA4
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),0.2580332540501527,0.6420790005901276,0.9111791730474732,1.0,1.0,3/22,13.04%,DUSP12;MTMR3;DUSP8
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),0.2885420476784307,0.6409725079103223,0.8754448398576512,0.9994714745449605,1.0,4/11,19.06%,SLC35B2;SLC17A9;SLC19A1;SLC25A17
prerank,5'-nucleotidase activity (GO:0008253),-0.24004708881909775,-0.6349836597726023,0.9132530120481928,0.9635249249905099,1.0,4/13,18.92%,NT5C3B;NT5DC1;NT5C;NT5C1A
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),0.2775957534410723,0.630093636942716,0.8777589134125636,1.0,1.0,3/15,20.71%,KMT2A;KMT2D;ASH2L
prerank,GABA-gated chloride ion channel activity (GO:0022851),0.28508182527202613,0.6289647235387184,0.8699186991869918,1.0,1.0,3/12,12.25%,GABRG2;GABRG1;GABRB3
prerank,pentosyltransferase activity (GO:0016763),0.2295640497212916,0.6270292067182885,0.92992700729927,1.0,1.0,6/36,14.68%,UPP2;SIRT3;PPAT;PARP11;PARP6;PARP8
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",0.23484303188417582,0.6244056852603178,0.9257057949479941,1.0,1.0,10/28,25.77%,POP4;POP7;DBR1;RPP14;DICER1;RPP21;RPP30;RNASEH1;PRORP;AGO2
prerank,nucleoside-diphosphatase activity (GO:0017110),-0.24812587732023525,-0.6241580687750715,0.9393258426966292,0.9665452265550677,1.0,1/12,1.28%,ENTPD1
prerank,muscle alpha-actinin binding (GO:0051371),0.2690566470467522,0.622140095566705,0.8849270664505673,1.0,1.0,1/15,2.25%,PDLIM4
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),0.27416980703286886,0.618279834949528,0.8912655971479501,1.0,1.0,4/12,19.06%,SLC35B2;SLC17A9;SLC19A1;SLC25A17
prerank,ligand-gated channel activity (GO:0022834),0.23585204451252534,0.6114696513282901,0.9252615844544095,1.0,1.0,4/29,9.86%,GRIA3;CNGB1;GRID1;GRIA1
prerank,aspartic-type peptidase activity (GO:0070001),0.2837161270096241,0.6087438375692807,0.9162210338680927,1.0,1.0,2/10,16.37%,BACE2;BACE1
prerank,retinoic acid receptor binding (GO:0042974),0.2611087719395693,0.6085814299074291,0.8966074313408724,1.0,1.0,5/17,19.99%,NRIP1;RARG;PPARG;CNOT1;TACC1
prerank,translation initiation factor activity (GO:0003743),0.2235586294535652,0.6078203781384717,0.938288920056101,1.0,1.0,6/36,14.89%,EIF2B3;EIF5B;EIF4E;EIF1;EIF2B4;COPS5
prerank,ligand-gated ion channel activity (GO:0015276),0.23395145642774973,0.6071851293397516,0.9274924471299094,0.9997647121107621,1.0,4/30,9.86%,GRIA3;CNGB1;GRID1;GRIA1
prerank,leucine zipper domain binding (GO:0043522),-0.24996996466768295,-0.6031129536516886,0.9284116331096197,0.9745401700048074,1.0,3/10,19.53%,PAWR;ATF4;DAPK3
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),0.2770644894126075,0.5875387797354377,0.9234527687296417,1.0,1.0,6/11,28.26%,NAA10;NAA40;NAA60;NAA30;NAA20;NAA80
prerank,histone deacetylase binding (GO:0042826),0.18889242090522476,0.5851586910668262,0.981226533166458,1.0,1.0,24/88,22.92%,SPI1;HDAC4;DACT1;KPNA2;HIC1;NCOR1;HDAC2;NCOR2;HDAC6;SFPQ;CAMTA2;LCOR;YWHAE;GMNN;MTA3;HDAC3;RBBP4;PRKN;NUDT21;MAPK8;RAD9A;BRMS1L;YWHAB;SIRT2
prerank,snRNA binding (GO:0017069),0.20477120166525026,0.5805324314384868,0.9616963064295485,1.0,1.0,6/42,13.66%,RNPC3;TUT1;RBM22;SNU13;HEXIM1;SNRPA1
prerank,DNA-directed DNA polymerase activity (GO:0003887),0.23624661557349447,0.5805024666235955,0.9284603421461898,1.0,1.0,8/21,24.43%,POLI;POLB;REV3L;POLE;CHRAC1;POLE2;PRIMPOL;REV1
prerank,histone methyltransferase binding (GO:1990226),-0.2316922508232514,-0.5789864482491401,0.9520383693045563,0.9817020567748552,1.0,1/11,4.33%,LCORL
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),-0.1872903437204492,-0.5729344759172651,0.9804469273743017,0.9803248184525855,1.0,9/25,29.26%,ART3;ZC3HAV1;PARP2;PARP10;PARP1;TNKS2;PARP3;PARP16;SIRT6
prerank,DNA polymerase activity (GO:0034061),0.23161156765372193,0.5724207672081408,0.9314641744548287,1.0,1.0,8/22,24.43%,POLI;POLB;REV3L;POLE;CHRAC1;POLE2;PRIMPOL;REV1
prerank,Hsp90 protein binding (GO:0051879),0.21402371025886374,0.5692788280025473,0.9615384615384616,1.0,1.0,6/33,16.12%,SLC12A2;NPAS2;HDAC6;AHSA1;ERN1;CHORDC1
prerank,CARD domain binding (GO:0050700),0.2457327423744859,0.5635234087541224,0.9476351351351351,1.0,1.0,2/14,8.83%,CARD10;IRGM
prerank,Toll-like receptor binding (GO:0035325),0.2586942875078469,0.5631412916712856,0.9398625429553265,1.0,1.0,11/11,74.15%,S100A9;TOLLIP;TIRAP;S100A8;TLR2;TLR1;DAB2IP;TLR6;CD36;UNC93B1;MYD88
prerank,ligand-gated anion channel activity (GO:0099095),0.23979697459493127,0.5582977610281921,0.9462875197472354,1.0,1.0,8/17,27.51%,GABRG2;GABRG1;GABRB3;GLRA3;GABRA3;GLRB;GABRG3;GABRA1
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),0.25630885122410557,0.5563566085304661,0.9236111111111112,1.0,1.0,11/11,74.39%,CHRNA7;CHRNA2;CHRNA10;CHRNA1;CHRNB4;CHRNA3;CHRNA5;CHRNA9;CHRNB1;CHRNB2;CHRNA4
prerank,disordered domain specific binding (GO:0097718),0.21797735836491744,0.5546305571593795,0.956973293768546,1.0,1.0,3/23,12.15%,FN1;DFFB;NCOA3
prerank,ATP hydrolysis activity (GO:0140603),0.20024807518702142,0.5540067020728996,0.9750692520775623,1.0,1.0,3/41,4.42%,KIF20B;CHD3;VWA8
prerank,purinergic nucleotide receptor activity (GO:0001614),-0.20366867969296873,-0.5490718532207998,0.9641025641025641,0.9849207088289519,1.0,8/15,39.32%,P2RX7;P2RX4;GPR34;P2RY12;P2RY1;PTAFR;P2RX5;P2RX6
prerank,extracellular ligand-gated ion channel activity (GO:0005230),0.2592124088970026,0.5460116824428792,0.945273631840796,1.0,1.0,2/10,11.18%,GABRG2;GABRG1
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),0.24520973381826866,0.539143084094996,0.9472817133443163,1.0,1.0,7/13,27.51%,GABRG2;GABRG1;GLRA3;GABRA3;GLRB;GABRG3;GABRA1
prerank,cardiolipin binding (GO:1901612),0.2477848411094662,0.5274422109765307,0.9376146788990826,1.0,1.0,4/10,23.46%,MME;GSDMD;STOML2;UQCC3
prerank,N-methyltransferase activity (GO:0008170),0.20973345675558952,0.5152010525927883,0.9712,1.0,1.0,6/20,22.36%,TFB2M;METTL5;TRMT1L;TRMO;TFB1M;TRMT1
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",0.2182693103100542,0.5136436763704142,0.9748031496062992,1.0,1.0,8/17,25.95%,DECR2;DHCR24;DECR1;BLVRA;PECR;MECR;PTGR1;PTGR2
prerank,neuropeptide hormone activity (GO:0005184),0.2071738174508451,0.5114611401748608,0.9736024844720497,1.0,1.0,22/22,79.31%,HCRT;AGRP;ADCYAP1;NPFF;PPY;CCK;NPY;OXT;CORT;QRFP;GHRH;NPPA;UCN;CALCB;GAL;CRH;VIP;NMB;PNOC;GRP;SPX;PENK
prerank,delayed rectifier potassium channel activity (GO:0005251),0.19231263213729027,0.5034733937618824,0.9899280575539569,1.0,1.0,1/32,1.84%,KCNA5
prerank,acetylgalactosaminyltransferase activity (GO:0008376),0.19684367614404663,0.502543737194812,0.9788519637462235,1.0,1.0,2/26,7.11%,B3GALT1;EXTL2
prerank,signal sequence binding (GO:0005048),0.18439041166382186,0.4980426333339509,0.9927536231884058,1.0,1.0,2/35,5.83%,KPNA7;KPNA2
prerank,DNA replication origin binding (GO:0003688),0.20256643060371735,0.49455234895995775,0.9861538461538462,0.9998351655274317,1.0,8/23,24.80%,ORC5;ORC3;CDC6;ORC1;DHX9;DDX11;MCM4;ORC4
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),0.18518167006484337,0.4945228557062954,0.9860031104199067,0.9975410691778084,1.0,2/30,9.42%,TNFAIP8;RPS6KA3
prerank,histone methyltransferase activity (GO:0042054),-0.1465565883657795,-0.48466896529476095,1.0,0.9956912846678101,1.0,16/32,40.94%,SMYD2;PRMT7;SUZ12;EED;FBL;EHMT2;SMYD3;TTLL12;KMT2E;NTMT1;EHMT1;SETD7;N6AMT1;CARM1;PRMT1;EZH2
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),-0.17836389610616987,-0.4812249568995752,0.9974489795918368,0.9921523136613895,1.0,8/15,48.69%,CMKLR1;CCR2;CCR9;GPR17;CCRL2;CCR1;ACKR4;CCR6
prerank,telomeric DNA binding (GO:0042162),0.17862252181992078,0.4800453339023199,0.9926253687315634,0.9986885907124724,1.0,11/32,28.07%,STN1;UPF2;SMG7;TERF2;XRCC6;HNRNPD;SMG6;RAD50;SMG5;RPA1;TERF2IP
prerank,translation elongation factor activity (GO:0003746),0.20138582614088388,0.4621487827735989,0.9881756756756757,0.9998439262454307,1.0,5/14,22.51%,EEFSEC;GTPBP1;GFM1;TSFM;GTPBP2
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",0.20769868028128538,0.4547824928266104,0.9862306368330465,0.9987604879430316,1.0,2/12,15.65%,DHRS4;AIFM2
prerank,peptide N-acetyltransferase activity (GO:0034212),0.2173873265176088,0.45058191754553,0.9764309764309764,0.9971270506340729,1.0,5/10,28.26%,NAA10;NAA60;NAA30;NAA20;NAA80
prerank,lysine N-methyltransferase activity (GO:0016278),0.1788541844669816,0.44069989301460233,0.9921507064364207,0.9962493626886604,1.0,6/20,22.64%,ATPSCKMT;SETD2;ETFBKMT;KMT5A;VCPKMT;EEF2KMT
prerank,phospholipase A2 activity (GO:0004623),0.15776578213700707,0.40591725737594236,0.9955882352941177,0.9973350136054568,1.0,5/26,25.95%,PLAAT5;PNPLA8;PRDX6;PLA2G4A;PLA2G4C
